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Early stage drug discovery would change dramatically if computational methods could ac-
curately and quickly predict binding modes and affinities of compounds in advance of ex-
periments. Simulation based approaches like classical molecular dynamics (MD) simulations
have gained traction as a useful tool for early stage drug discovery, as MD provides a full
atomistic and dynamic view of the biological system of interest. In principle, MD simulations
can be a powerful tool for lead optimization as MD can provide knowledge of the ligand’s
binding mode, dynamics, and even binding affinity. In order to accurately compute binding
affinities or predict ligand binding modes, simulations must run long enough to capture the
relevant biological event or sufficiently sample all the physically relevant conformations. My
research presents the development of new simulation approaches for accelerated sampling and
demonstrates the use of non-equilibrium candidate Monte Carlo moves with MD simulations
for predicting ligand binding modes to a pharmaceutically relevant target.
xiv
Introduction
In recent years, molecular dynamics (MD) simulations has become an increasingly valuable
tool in the pharmaceutical drug discovery process. With the capability of providing a dy-
namic and complete atomistic viewpoint of a protein and bound ligand, it is no surprise that
MD simulations are emerging as a powerful tool in the drug development process. Using
MD simulations, chemists can gain knowledge of a ligand’s binding mode(s), dynamics, and
even binding affinity–making it an extremely powerful tool. But, the accuracy in computed
binding affinities and capabilities for identifying ligand binding modes hinges on sufficient
sampling of all relevant confirmations and biological motions.
Often, sufficient sampling requires running extremely long simulations in order to capture
biological motions as MD simulations resolve dynamics by taking small discrete timesteps
(i.e 1-4 femtoseconds); whereas, biological motions often occur at the millisecond timescale.
This means MD simulations must take millions of femtosecond timesteps in order to capture
relevant conformational changes which occur on timescales which are orders of magnitude
higher; a problem which is often referred to as the ‘timescale gap’. Before the development of
general purpose-graphic processing unit (GP-GPU) computing, MD simulations were largely
bounded to simulations at the nanosecond timescale, but now microsecond timescales are
becoming much more feasible with the use of GPUs. Specialized hardware, like ANTON, has
even been developed to make millisecond timescale simulations a reality. Regardless, chal-
lenges in proper sampling remains a problem in the field, as MD simulation often remained
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trapped in local energy minima–requiring longer timescales to escape before a new state can
even be sampled. If challenges in sampling can be addressed, MD simulations will provide
even more utility toward drug discovery efforts by providing a means for computing binding
affinities and predicting ligand binding modes.
Throughout this dissertation, I present my work which explores the use of MD simulations
for the purpose of binding affinity calculations (Chapter 1), studying membrane-protein
insertion (Chapter 2), and ligand binding mode predictions (Chapter 4, 5, 6). Given that
MD simulations face challenges in sampling, I will also present my work in developing a
software package which aims to accelerating sampling in ligand binding modes and provides
a foundation for enhancing sampling in a variety of ways (Chapter 3).
Summary
One common approach to compute binding affinities from MD simulations is a technique
called alchemical free energy perturbations (FEP). This approach works by ‘alchemically’
(i.e. non-physical) modifying the ligand forces–taking it through a non-physical pathway–
and computing the change in free energy throughout the process. When combined with
an enhanced sampling technique like replica exchange with solute tempering (REST), us-
ing a FEP+REST type of approach can provide accurate predictions in binding affinities.
Recently, this approach has been demonstrated to be successful in accurate calculations of
binding free energies at large scales (1). In Chapter 1, I explore how sensitive calculated
free energies are to small conformational changes in the protein using a simple model system
with a congeneric series of small ligands (2). In this study, I calculate relative binding free
energies (RBFE) using the FEP+REST approach between the series of ligands bound to
the commonly used model system called T4 lysozyme L99A (3). Despite using an enhanced
sampling approach, modifications to the enhanced sampling region (i.e. including a helix
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by the binding site) were required to get free energy calculations which no longer depended
on the starting conformation. Here, my findings demonstrates the importance of sampling
protein conformational changes in order to get accurate calculated binding free energies.
To demonstrate other ways MD simulations can be used, I use alchemical FEP calculations
to study the membrane-protein insertion free energy of from diptheria toxin T domain (DTT)
in Chapter 2. This particular protein plays a role in the delivery of the diptheria toxin by
facilitating the formation of a pore once inserted into a membrane. In this study, I compute
the differences in free energies when residue E362, located on the pore of the translocation
domain, is charged and neutral via alchemical FEP calculations. From the calculated free
energies, I provide some insight on the importance of the particular residue E362 and its
charge state during the membrane insertion process. Here, I found that the neutral state
of the residue was significantly more favorable over the charged state during the insertion
process and discovered the neutral state of the protein also facilitated formation of a larger
pore–which supported experimental studies (4).
From Chapter 1, I showed how critical it was to properly sample conformational states if
I wanted to achieve accurate binding free energies. Thus, in Chapter 3, I present my work
in co-developing a software package which aims to accelerate sampling of ligand binding
modes and provide the framework for enhancing sampling in other ways. This software
package is called BLUES: Binding modes of Ligands Using Enhanced Sampling (5), which
uses a hybrid simulation approach that combines non-equilbirum candidate Monte Carlo
(NCMC) (6) move proposals with MD simulations. In this framework, we first implemented
random rotational move proposals which are performed on the bound ligand. Here, the
goal is to search for and propose moves to alternative binding modes via randomly rotating
the ligand during simulation; thereby, accelerating the sampling of ligand binding modes
over traditional MD. In our first BLUES study, we demonstrate the NCMC+MD approach
can be successfully used to accelerate binding mode sampling in a simple model system,
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toluene bound to T4 lysozyme L99A (7). In Chapter 3, I discuss how to install and use
the software, detail the functions and modules in the codebase, and provide an overview
on design principles I had implemented to ensure the software can easily be maintained
and extended beyond our initial implementation. From our initial implementation (using
random ligand rotations), studies have been done which use BLUES to identify the various
binding modes of caffeine (8). In Chapter 6, I also present my work in applying BLUES
(using random ligand rotations) to identify ligand binding modes for a series of fragments.
From my extensible design, several projects in the Mobley lab were able to use the BLUES
framework and implement new NCMC move types beyond simple ligand rotations. Some of
these moves include sidechain rotations (9), ligand torsional rotations, and localized water
motions which all enhance sampling in different ways than our initial implementation.
In the interest of using MD simulations for predicting ligand binding modes, in Chapter 4, I
present work where I use MD simulations to identify ligand binding modes for various RNA
nucleoside analogs which bind to the protein uridine cytidine kinase 2 (UCK2) (10). The
Spitale lab had developed novel RNA nucleoside analogs which would become incorporated
into the nascent RNA strands produced from UCK2. They were interested in gaining some
structural insights on how their analogs would bind, in comparison to the endogenous ligand,
within the binding site of UCK2, In this study, I utilize docking and molecular dynamics
(MD) simulations to validate their hypothesis of their nucleoside analogs binding in the
same binding mode as the endogenous ligand, cytidine, as well as uncover a novel binding
mode, representative of the post-catalytic state of UCK2. The predicted binding modes
for their RNA nucleoside analogs that I had found via MD simulations were later validated
by obtaining X-ray crystallographic structures of the protein-ligand complexes. For this
system, I demonstrate that a computational method like MD simulations can indeed be used
to predict binding modes.
Continuing to apply MD simulations for predicting ligand binding modes, in Chapter 5,
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I present my work in using microsecond long MD simulations to identify binding modes
for fragments which bind to a protein called soluble epoxide hydrolase (SEH). Posed as
a retrospective blinded study, our collaborators at OpenEye Scientific Software provided
us with a series of fragments and the SEH binding site to dock to. Here, I use a combined
docking-MD simulation approach and investigate if enough sampling of ligand binding modes
can occur at the microsecond timescale and if the populations (i.e. % simulation time) of the
binding modes sampled would help us identify the dominant (crystallographic) binding mode
and any additional binding modes. From this study, I found that even with microsecond
long MD simulations, I could not sufficiently sample binding modes and ultimately, failed
to identify the crystallographic binding modes. This failure highlighted the need to use an
enhanced sampling technique so as to acquire better sampling of ligand binding modes.
To address the failures from Chapter 5, I revisit the study using the (NCMC+MD) BLUES
approach for predicting the SEH fragment binding modes in Chapter 6. Here, I investigate if
BLUES can be applicable beyond a simple model system, like T4 lysozyme L99A, and apply
it to a system with pharmaceutical relevance–SEH. Using BLUES, I observed significantly
better sampling in ligand binding modes than with microsecond long MD simulations, which
lead to higher success in sampling near the crystallographic binding modes. From this study,
I demonstrate that BLUES can indeed be used to accelerate binding mode sampling to
more complex systems and illustrate that it can potentially be used as a tool for predicting
fragment binding modes.
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Chapter 1
Sensitivity in binding free energies due
to protein reorganization
Authors: Nathan M. Lim, Lingle Wang, Robert Abel, and David L. Mobley
J. Chem. Theory Comput., 2016, 12 (9), pp 4620–4631
doi:10.1021/acs.jctc.6b00532
Publication Date (Web): July 27, 2016
1.1 Abstract
Tremendous recent improvements in computer hardware, coupled with advances in sampling
techniques and force fields, are now allowing protein-ligand binding free energy calculations
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to be routinely used to aid pharmaceutical drug discovery projects. However, despite these
recent innovations, there are still needs for further improvement in sampling algorithms to
more adequately sample protein motion relevant to protein-ligand binding. Here, we report
our work identifying and studying such clear and remaining needs in the apolar cavity of
T4 Lysozyme L99A. In this study, we model recent experimental results that show the
progressive opening of the binding pocket in response to a series of homologous ligands
(2). Even while using enhanced sampling techniques, we demonstrate that the predicted
relative binding free energies (RBFE) are sensitive to the initial protein conformational state.
Particularly, we highlight the importance of sufficient sampling of protein conformational
changes and demonstrate how inclusion of three key protein residues in the ’hot’ region of
the FEP/REST simulation improves the sampling and resolves this sensitivity.
1.2 Introduction
Proteins play a central role in many biological processes by modulating many key signaling
pathways. It is unsurprising to find that proteins make up the vast majority of pharmaceuti-
cal drug targets. Many small-molecules on the market today induce their therapeutic effect
by modulating the proteins’ biological activity through binding(11; 12; 13). Thus, optimiza-
tion of protein-ligand binding affinities is a central goal in early pharmaceutical drug design
projects.
Recent advancements in technology and computational chemistry have led to increasing use
of computer-aided drug design techniques to assist in lead optimization in pharmaceutical
drug discovery. Since accuracy and reliability of the approach being used is critical for
success, it is here where the most rigorous of methods like free energy calculations can be
applied in the prediction of protein-ligand binding affinities. Using alchemical methods like
free energy perturbation (FEP), thermodynamic integration, and λ-dynamics on molecular
7
dynamics (MD) simulations, the difference in binding free energies between two ligands
can be computed in a robust and accurate manner. By computing relative binding free
energies, much of the computational cost and difficulties of absolute binding free energy
calculations is avoided(14; 15; 16; 17; 18; 19; 20). Other advancements in forcefields, sampling
algorithms, and emergence of GPU computing have considerably improved the accuracy and
robustness of alchemical calculations. The recent development of FEP+, a fully automated
alchemical protocol implemented with modern methodologies, reduces overall workload and
the potential for human error in setup and analysis of these types of calculations. Using
this protocol, previous studies(1) have demonstrated it to yield highly accurate free energy
predictions in a wide range of pharmaceutically relevant protein targets and ligands. The
accuracy and reliability of FEP+ makes it a very powerful tool in the hands of medicinal
chemists for efficient optimization of lead compounds.
Although the previous report on FEP+(1) demonstrates its robustness, the primary concern
focuses on the size of the ligand perturbation or the initial ligand pose and how these fac-
tors impact the accuracy of calculated free energies(21; 22). Careful consideration of effects
arising from protein conformational changes have generally received less attention due to
the difficulty in addressing the sampling challenges encountered when simulating proteins.
The difficulty in protein sampling lies primiarly in the timescales required to adequately
capture a complete biomolecular event. Timescales of such events can range from nanosec-
onds to milliseconds (or even seconds)(23). In MD simulations, the system evolves in time
through series of short time steps (i.e. 2 fs) by repeatedely computing the forces on each
individual atom in accordance to Newton’s laws of motion at each time step. Not only must
a computer perform numerous calculations at each time step, but it must repeat this pro-
cess an enourmous amount of times to generate a trajectory that is on timescale for your
biological process of interest(24). Furthering the difficulty, with using ‘vanilla’ MD simu-
lations, the system will more than likely remain kinetically trapped in an energy minima,
thereby preventing any further exploration of the protein conformational space and obtain-
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ing proper sampling. Some computational studies have shown even small simple changes in
the protein—like a side-chain rotamer flipping—can cause large errors in affinity predictions
if not properly sampled(25; 26; 27; 28). Overcoming these high energy barriers is no easy
feat; whereby a number of distinct approaches like metadynamics(29), accelerated MD(30),
and temperature accelerated MD(31) aim to solve this problem of kinetic traps but may fall
short in some cases(32). Thus, careful sampling of protein conformational changes is critical
for accurate and reliable affinity predictions.
In the previous FEP+ study(1), other than simply restricting ourselves to congeneric series
with multiple reported crystal structures, no effort was made to either include or exclude
cases where the protein or ligand binding mode may reorganize. However, it is entirely
possible some of the outliers reported in that work may be due to protein conformational
reorganization. The testing of the FEP+ technology on cases where protein reorganization
has been well-characterized experimentally may provide an opportunity to probe potential
pathological cases, and further provides an opportunity to discover how to further improve
the technology. While some studies suggest protein reorganization on ligand binding can be
relatively common (i.e. as reviewed by (33)), it is far from well understood how often this can
be a challenge for binding prediction. Regardless, it is clear that protein-ligand binding can
be highly complex, and multiple stable protein conformations may be populated even for the
same ligand (34; 35; 2). Thus, there is a great need to understand how protein conformational
changes and the choice of starting protein conformation may affect the reliability of free
energy predictions.
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(a) T4 lysozyme (L99A) (b) F-helix (residues 107-115)
(c) Closed State (d) Intermediate State (e) Open State
(f) Ligand Set
Figure 1.1: In Fig.1.1a are overlaid cartoon representations of T4 lysozyme using the protein-
ligand bound crystal structures of the toluene(4W53), butylbenzene(4W57), and hexylben-
zene(4W59) complexes where the F-helix region is highlighted in yellow. Fig.1.1b illustrates a
closer view of strictly the F-helix in the closed(purple), intermediate(cyan), and open(green)
conformational states and their corresponding ligands as found in the crystal structure.
Below are the molecular surface representations of the binding cavity in the closed(1.1c),
intermediate(1.1d), and open(1.1e) states with the ligands represented in an orange space-
filling model. In Fig.1.1f is the full series of congeneric ligands used in this study; their
protein state occupancies can be found in Table 1.1. Images were created using Maestro(36).
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Here, we apply the now-standard FEP protocol used in (1), which utilizes replica exchange
with solute tempering (FEP/REST)(37), to a very simple model binding site in an engi-
neered mutant of T4 lysozyme (L99A). In this mutant, the L99A mutation creates a small
apolar binding site that has been studied extensively experimentally(38; 39; 40; 41) and com-
putationally by docking(42; 43; 44; 2) and free energy methods(26; 45; 46; 47; 48; 49; 37; 50).
Recent studies on this binding site have found that the protein adopts three discrete con-
formations in response to ligand binding(2). Through a series of eight congeneric ligands
(Fig 1.1f), each growing by addition of a single methyl, the protein responds by a single
helix rearrangement to accommodate the growing ligand (Fig 1.1). As the ligand grows,
the binding cavity was observed to incrementally reorganize into three discrete conforma-
tions which we will refer to as the closed (Fig 1.1c), intermediate(Fig 1.1d), and open states
(Fig 1.1e). Using the FEP/REST protocol and the aforementioned homologous ligand series,
we calculate relative protein-ligand binding affinities between ligands that occupy different
discrete protein conformational states. In this study—while using the implemented default
FEP/REST protocol—we demonstrate how the kinetically distinct protein states and struc-
tural rearrangement affects the accuracy and reliability of our predicted relative binding
affinities. Further, we illustrate the importance of sufficient sampling of protein conforma-
tional changes and how modification of the REST region can potentially address this issue.
1.3 Methods
1.3.1 Protein/Ligand preparation
All proteins were prepared and aligned in Maestro(36) using the ‘Protein PreparationWizard’(51;
52; 53; 54; 55) tool and with the following settings enabled (as they appear in the Maestro
GUI menu):
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• Preprocess: Assign bond orders, Add hydrogens, Create zero-order bonds to metals,
Create disulfide bonds, Cap termini, Delete waters beyond 5Å from het groups
• Refine: Sample water orientations, Use PROPKA pH: 7.0, Remove waters with less
than 3 H-bonds to non-waters, and restrained minimization.
Protein structures were taken from PDBs: 4W52, 4W53, 4W54, 4W55, 4W56, 4W57, 4W58,
and 4W59 corresponding to protein-ligand bound structures of benzene, toluene, ethyl-
benzene, propylbenzene, sec-butylbenzene, butylbenzene, pentylbenzene, and hexylbenzene,
respectively(2). Each simulation starts from either the protein closed state (PDB:4W52) or
the open state (PDF:4W59). Using LigandFEP, our system preparation follows a similar
workflow to the tutorial(56). Generally, two options were taken:
(1a) If the simulation starts from the protein closed state, the benzene crystal position was
used as a reference for fragment building (PDB:4W52).
(1b) The corresponding ligand in the transformation was built by duplicating benzene in
place and adding methyl groups.
(2a) If the simulation starts from the protein open state, the hexylbenzene crystal position
was used as reference for fragment building (PDF:4W59).
(2b) The corresponding ligand in the transformation was built by duplicating hexylbenzene
in place and deleting methyl groups.
Ligand tail fragments were added using the Build/Fragments toolbar in Maestro and were
not overlaid or docked. As the ligand tails were built, bonds were manually rotated so that
the tail was oriented in a similar manner as in their corresponding crystal structure. Follow-
ing, the newly added atoms in the tail were locally minimized while leaving the core in its
initial position. This was done in an attempt to correct bond angles and minimize the core
RMSD, which LigandFEP uses to determine the core atoms between the two ligands.
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1.3.2 Classification of alchemical transformations and color coding
Here, we classified ligands based on the primary protein conformation (closed, intermedi-
ate, or open) the ligand occupies from the experimental studies (Table 1.1). To be explicit,
the set of closed ligands refers to benzene, toluene, ethylbenzene, and propylbenzene; (sec-
)butylbenzene for intermediate; and pentyl/hexylbezene for open ligands. The various pro-
tein states and ligands are then assigned a color accordingly: purple for closed, cyan for
intermediate, and green for the open state.
Table 1.1: Experimental protein-ligand occupancies and affinitiesa
PDB Ligand C I O ∆Gexp σexp Set
4W52 benzene 90 - - -5.19 0.16 C
4W53 toluene 80 20 - -5.52 0.04 C
4W54 ethylbenzene 50 50 - -5.76 0.07 C
4W55 propylbenzene 60 40 - -6.55 0.02 C
4W56 sec-butylbenzene 40 60 - N/A - I
4W57 butylbenzene 10 60 30 -6.70 0.02 I
4W58 pentylbenzene 30 - 70 N/A - O
4W59 hexylbenzene 30 - 70 N/A - O
a Listed are the PDB codes of the corresponding protein-ligand complex crystal structures
and the ligand occupancies(2) for the closed(C), intermediate(I), and open(O) protein
conformations by percentage. Under the ‘Set’ column, shaded in grey, is each ligand’s
primary state of occupancy which we use to categorize our alchemical transformation sets.
Binding affinities for pentylbenzene and hexylbenzene were inaccessible due to solubility
limits(2). Experimental binding free energies and their uncertainties are in units of
kcal/mol(40).
Our sets of alchemical transformations consisted of 3 groups: ‘closed-intermediate’, ‘closed-
open’, and an ‘experimental’ ligand set. The first two sets were classified based on the ex-
pected conformational change that would result from the alchemical transformation. For ex-
ample, the alchemical transformation of benzene to butylbenzene falls into closed-intermediate
while benzene to hexylbenzene is a closed-open transformation. In our experimental set, we
perform all possible combinations of transformations for ligands with available experimental
binding affinities (Table 1.1). Ligands with available experimental binding affinities consisted
of benzene, toluene, ethylbenzene, propylbenzene, and butylbenzene. This gives a total of 26
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alchemical transformations in this study, 8 from ‘closed-intermediate’, 8 from ‘closed-open’,
and 10 from the experimental set.
1.3.3 FEP protocols
Using the Schrödinger application suite (release 2015-3)(57), we utilize a similar protocol to
FEP+(1) called LigandFEP(56). FEP+ is a fully automated work flow that plans pertur-
bation pathways based a variant of LOMAP(58) mapping algorithm which uses the max-
imum common substructure (MCS) between any pair of compounds. LigandFEP is an
academic toolkit that generates the configuration files to perform the free energy calcu-
lation but is limited in the sense that the user must plan each perturbation path instead.
Both LigandFEP and FEP+ use the same Desmond relaxation protocol and the FEP/REST
methodology(59; 60; 37; 50). By utilizing LigandFEP, we demonstrate LigandFEP can be a
powerful tool for academics as it strictly differs only in the level of automation.
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(a) Selected residues in pREST
(b) Residue Glu108 (c) Residue Val111
Figure 1.2: Fig. 1.2a highlights the 3 residues selected to be included into the REST region
for ‘pREST’ simulations. Fig. 1.2b and Fig. 1.2c illustrates the motion of the Cα’s during
the transition between the protein closed and open states, where the Cα in Glu108 undergoes
a motion of approximately 2Å, while in Val11 the Cα move approximately 3.5Å.
15
1.3.4 REST region selection
In this study, by default, only heavy atoms in the ligand were included in the REST region
unless specified otherwise. Further details on the temperature profile and how the REST
region is normally selected can be found in previous studies(37; 1) in the supporting infor-
mation. Simulations that included protein heavy atoms in the REST region are referred to
with the ‘pREST’ label, where selection of the particular residues is described as follows.
Based on visual inspection of our molecular dynamics simulations and considering the F-
helix spans residues 107-115, we selected residues Glu108, Val111, and Gly113 to include
into the REST region (Fig 1.2a). Glu108 sits near the start of the helix which appears as a
hinge point for the opening and closing of the binding cavity (Fig 1.2b). Following, Val111
appears in the middle of the helix and was observed to undergo the largest motion during
protein conformational changes (Fig 1.2c). Gly113 was included in order to collectively have
hot regions approximately at the start, middle and end points of the helix.
1.3.5 Simulation details
Desmond(61; 62; 63; 64) simulation protocols have been described previously in the support-
ing information(1) or can be found in greater detail in the Desmond User Manual(65). The
relaxation protocol begins with a simulation where solute molecules are restrained to their
initial positions while minimizing using a Brownian dynamics NVT integrator for 100ps,
followed by 12ps simulations at 10K with a NVT ensemble and then a NPT ensemble using
the Langevin method(66). Next is a 24ps simulation followed by a final 240ps simulation
with solute molecules unrestrained, both are carried at room temperature with a NPT en-
semble using Langevin. Production simulations with the default REST region were ran for
the default setting of 5ns. Initial ‘pREST’ production simulations were also simulated for
5ns and then were carried out to a length of up to 55ns for all closed-open transformations.
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For closed-intermediate transformations, we extended ‘pREST’ production simulations up
to 25ns, only for cases that were far from convergence with the 5ns simulation time. Here,
we use the final 15ns for closed-open simulations and the final 10ns for closed-intermediate
to calculate our final free energies, discarding the initial time as additional equilibration
time. FEP/REST simulations were run on four GeForce GTX Titan Black GPUs using the
Desmond/GPU engine with the recently developed OPLS3(67) forcefield parameters.
1.3.6 Calculation of free energies and measurement of inconsistency
Throughout this study, we measure the inconsistency (∆∆Gεn) between the final calculated
free energies between simulations that start from the protein closed state (∆∆GCn) versus
the protein open state (∆∆GOn) by simply taking the difference.
∆∆Gεn = |∆∆GCn −∆∆GOn| (1.1)
Then we compute the overall inconsistency—referred to as the ’Root-Mean-Square-Inconsistency’
(RMSI)—for each set of alchemical transformations. The RMSI is calculated by using the
differences (∆∆Gεn) obtained from the comparisons between protein open and closed sim-
ulations.
RMSI =
√∑
n(∆∆Gεn)
2
n
(1.2)
Similarly, we compute the ’Root-Mean-Square-Error’(RMSE) when comparing with exper-
imental free energies for both simulations starting from the protein closed and open state.
RMSEO =
√∑
n(∆∆GOn −∆∆Gexpn)2
n
RMSEC =
√∑
n(∆∆GCn −∆∆Gexpn)2
n
(1.3)
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Calculated free energies were determined using the Bennett acceptance ratio(68) (BAR)
with error estimations using both bootstrapping and BAR analytical error prediction(69).
Hysteresis around closed thermodynamic cycles and best estimates of the free energies
with their errors were calculated using the cycle closure algorithm discussed in a previous
publication(37).
1.3.7 Determining the protein conformation state using RMSD
In this study, we determine the state of the protein by computing the ’Root-Mean-Square-
Deviation’ (RMSD) of the protein backbone atoms spanning the F-helix relative to their po-
sitions found in the closed (PDB:4W53), intermediate (PDB:4W57), and open (PDB:4W59)
crystal structures (Fig 1.1b). The set of RMSDs—that is, the RMSD relative to the closed,
intermediate, and open states—is computed at each frame over the course of the entire
simulation. Then, we use the protein conformational state with the lowest RMSD to corre-
spondingly color each time point in our analyses of ‘RMSD/time’ and ‘Color maps’. Again,
we use purple to denote the protein closed state, cyan for the intermediate state, and green
for the open state. Here, we use VMD (70; 71) to align and compute the RMSD of our
Desmond trajectories relative to crystal structures. Further details on the procedure and the
scripts used for these analyses are provided in the supplementary info.
For the ‘RMSD/time’ analysis, see Figure 1.3b) for reference. Here, we plot the RMSD to the
closed helix, represented by the black line, where each time point is colored according to the
lowest RMSD state. We apply the RMSD/time analysis only to the simulation corresponding
to the end state ligand of interest (λ11). By tracking the RMSD relative to the closed helix,
we can monitor if the protein opens (by high RMSD with green points) or closes (by low
RMSD with purple points). Additionally, we gain some insight on the time required to
capture the opening or closing of the binding cavity.
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It is important to note that by restraining our analysis to only the end-state replica, we
limit our ability to completely view the effects of coordinate swapping during replica ex-
changes. We address this limitation by analyzing all replicas in what we call ‘Color maps’,
see Figure 1.5b for an example. Essentially, our ’Color map’ analysis is the same as our
’RMSD/time’ plots but without the RMSD line plot. In other words, we color time points
according to the protein state of lowest RMSD and do this for all replicas but do not track
the RMSD relative to the closed state. Through a collective view of all replicas, we gain a
better perspective of the overall protein conformational sampling and the states they occupy
over each replica’s separate trajectories. Using color maps, it becomes visually easy to see if
intermediate—higher temperature—lambda windows are able to sample, say the open state,
and if this leads to an enhancement in sampling at the end states via replica exchange.
1.4 Results
1.4.1 Calculated free energies depend strongly on starting protein
conformation
Using the default FEP/REST methodology(37), we find calculated free energies significantly
depend on the protein starting conformation, especially for large perturbations (i.e. opening
the cavity from the closed state). To illustrate this, we begin our molecular dynamics
simulations both from the protein closed and open conformations then perform alchemical
transformations to ligands that occupy another protein conformational state. For example,
in the alchemical transformation of benzene to hexylbenzene—starting from the protein
closed state—we expect to see opening of the binding cavity when the ligand is in the
fully interacting hexylbenzene state. In this study, we demonstrate using the default FEP
protocol settings of a 5ns simulation time and REST region selection does not generate
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adequate sampling of the motion in the F-helix and does not eliminate the dependence on
the initial protein state.
(a) Protein closed simulation
(b) Protein open simulation
Figure 1.3: Plotted is the RMSD(Å) relative to the closed helix conformation (black line),
where each time point is colored according to the protein state of lowest RMSD to the tra-
jectory. Here, using the default protocol in the transformation of benzene to hexylbenzene,
RMSD/time plots correspond to the final end state of hexylbenzene (λ11). Fig. 1.3a cor-
responds to the simulation that began from the protein closed state and Fig. 1.3b is from
the simulation started from the protein open state. The legends indicate the percentage of
sampling of each protein conformational state from the trajectory.
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Closed-Open Ligand Transformations An examination of the largest alchemical trans-
formation, benzene to hexylbenzene, clearly highlights the sampling challenges faced when
using the default FEP/REST protocol. From experimental data of ligand occupancies (Ta-
ble 1.1), we expect in our simulations of hexylbenzene to see the protein primarily in the
open state over the closed state. Instead, we find the protein remains trapped in its initial
conformational state whether we start from closed (Fig 1.3a) or open (Fig 1.3b) over the
course of the 5ns simulation. From the protein closed simulation, the protein only briefly
samples the intermediate state around 3ns but never enters the open conformation. As
the protein tries to accommodate hexylbenzene and enter its preferred open state, protein-
ligand strain results, yielding a positive value for ∆∆Gcalc(+4.13 kcal/mol). On the other
hand, in the protein open simulations, the protein already begins in its preferred state for
hexylbenzene and stays only in this open state. As expected, the ∆∆Gcalc is negative(-0.61
kcal/mol) as there is no occurrence of large protein-ligand strain in order to open the cavity.
By remaining trapped in the initial state, we under-sample the open state if we begin from
the closed state or over-sample it if we begin from the open state. Ultimately, we arrive at
two very different relative free energies values, where the inconsistency is as large as +4.74
kcal/mol for the same transformation of benzene to hexylbenzene.
In the overall set, we similarly observe protein closed simulations to yield positive free energies
and negative for protein open simulations. In turn, we find the overall inconsistency to
be very high with a RMSI of +4 kcal/mol (Fig 1.6a, Table S1.5). Clearly, despite the
use of implemented default FEP/REST protocol, we are unable to get sufficient sampling
in the protein within the standard 5ns time frame. This is perhaps unsurprising since
in the default calculation, only the perturbed ligand R-group is added to the enhanced
sampling region. Instead, we encounter sampling problems as the protein remains in its
initial conformational state throughout the simulation. As a result, our calculated free
energies exhibit high dependence on the initial protein configuration which is reflected by
the large RMSI.
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Closed-Intermediate Ligand Transformations In the case of closed-intermediate al-
chemical transformations, we find that the calculated free energies still have some (albeit
much smaller) dependence on the initial protein conformation, using the default protocol.
For this set of alchemical transformations, we find the RMSI to be +0.60 kcal/mol (Fig 1.6c,
Table S1.2). Considering this set involves a smaller protein conformational change and
smaller perturbations to the ligand, it is unsurprising to find the RMSI to be much smaller
than our closed-open transformation set.
Although, the collective RMSI for closed-intermediate transformations falls in the acceptable
range of less than 1 kcal/mol, we can still see a dependence on the initial protein configu-
ration by viewing transformations involving butylbenzene. For these cases in particular, we
observe the same pattern of protein closed simulations yielding positive free energies and
negative for protein open simulations. We do not see this pattern for transformations with
sec-butylbenzene as it does not partially occupy the open state, unlike butylbenzene (Ta-
ble 1.1). Through this observation, we demonstrate further that the default protocol does
not completely eliminate the free energy dependence on the protein starting conformation,
even for smaller perturbations. Although, the level of discrepancy (0.6 kcal/mol) is quite
small for this set.
Experimental Ligand Transformations Now, when we compare ∆∆Gcalc against ∆∆Gexp,
we find that simulations starting from the protein closed conformation are further from con-
verging to ∆∆Gexp than when starting from the protein open conformation. Here, we cal-
culate the RMS-’Error’ with experiment and find the RMSE for protein closed simulations
to be +1.0 kcal/mol and +0.58 kcal/mol with protein open (Fig 1.8a,Table S1.8). Our total
RMSI falls within our acceptable range at 0.68 kcal/mol. However, the fact that protein open
simulations are much closer to ∆∆Gexp, once again does demonstrate our calculated free en-
ergies depend on the initial protein state. Unsurprisingly, the relatively larger RMSE seen
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(a) Protein closed simulation
(b) Protein open simulation
Figure 1.4: RMSD/time plots correspond to the final end state of butylbenzene (λ11) while
using the default protocol for transformation of benzene to butylbenzene. Fig. 1.4a and
Fig. 1.4b correspond to simulations that were started from the protein closed or open state,
respectively. The legends indicate the percentage of sampling of each protein conformational
state from the trajectory.
for protein closed simulations primarily comes from transformations involving butylbenzene.
Evidently, we find the simulations involving butylbenzene remain trapped in their respective
starting conformations, resulting in inadequate sampling in the protein closed simulations
(Fig. 1.4a) versus the protein open simulations (Fig. 1.4b). Despite performing much smaller
alchemical transformations, this shows we still encounter some sampling problems that re-
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sult in ∆∆Gcalc that depend on the initial protein conformation, evident when comparing
to ∆∆Gexp.
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1.4.2 Including protein residues into the REST region (pREST)
improves sampling
(a) Default (b) pREST
(c) pREST extended
Figure 1.5: Color maps of simulations starting from the protein closed state for the benzene
to hexylbenzene alchemical transformation. Lines at every frame are colored accordingly to
the protein state of lowest RMSD (purple-closed, cyan-intermediate, green-open). Fig. 1.5a
corresponds to simulations using the default protocol. Fig. 1.5b represents simulations using
the modified REST region protocol (pREST). Fig. 1.5c illustrates the enhancement in protein
conformational sampling through extending the pREST simulation time up to 55ns.
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Primarily, we encounter major sampling problems when we begin our simulations from the
protein closed state and attempt a mutation which should result in the binding cavity open-
ing. In order to facilitate protein motion, thereby enhancing protein sampling, we included
3 key residues spanning the F-helix region into the REST region, which we will denote sim-
ulations using this with ‘pREST’ (Fig 1.2a). By expanding the REST region, we are able
to drive the F-helix out its initial state trap by locally heating up key regions and thereby
reduce our sampling problem.
To demonstrate the REST improvement over the default protocol, we return to the case
of benzene to hexylbenzene. Here, we show the facilitation of the helix motion by first
referring to Figure 1.3a which shows that there is no sampling of the open state for the
default protocol. Now with pREST, we see a few open state points around 3ns and even a
single open point before closing again after our initial step (Fig 1.7a). Alternatively, we can
further illustrate the enhancement of protein sampling by viewing all replicas collectively,
using the color maps. In reference to Figure 1.5a and Figure 1.5b, we illustrate that there
is far less sampling of the intermediate or open protein states in default simulations versus
the pREST simulations.
Collectively, we find only some minor improvements in the RMSI for all our closed-open and
closed-intermediate transformations while using pREST. For closed-open transformations
(Table S1.6), the RMSI reduces to +2.82 kcal/mol (previously +4 kcal/mol). On the other
hand, for closed-intermediate, the RMSI raises slightly to +0.79 kcal/mol (previously +0.60
kcal/mol), which may be due to statistical noise (Table S1.3). Generally, simulations starting
from the closed state had ∆∆Gcalc values that moved towards favorability (i.e. more negative
∆∆Gcalc), while for protein open simulations ∆∆Gcalc values tended towards unfavorability
(i.e. more positive ∆∆Gcalc). This is indicative of the fact that pREST is indeed improving
sampling, but it is evident that our ∆∆Gcalc are still far from convergence, given the RMSI
is still large, especially for closed/open transformations.
26
1.4.3 Long simulations enhances protein conformational sampling
from more exchanges
(a) Closed-Open: Default (b) Closed-Open: pREST
(c) Closed-Intermediate: Default (d) Closed-Intermediate: pREST
Figure 1.6: ∆∆Gcalc from MD simulations beginning from the protein closed versus open
state. Fig. 1.6a plots relative free energies obtained using the default protocol from the
‘closed-open’ alchemical transformations set, yielding a RMSI of 4.0 kcal/mol. Fig. 1.6b are
the final computed free energies with simulations carried out to 55ns using pREST, giving
RMSI of 0.57 kcal/mol. Fig. 1.6c plots relative free energies from the ‘closed-intermediate’
set using the default protocol which gives an RMSI of 0.6 kcal/mol. Fig. 1.6d are free
energies with simulations carried out up to 25ns using pREST, giving RMSI of 0.43 kcal/mol.
Numerical data for each plot can be found in Tables S1.2, S1.4, 1.5, and SS1.7.
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Although we see improvements in sampling with pREST, the standard implemented time
frame of 5ns clearly is not long enough to gain adequate sampling, particularly if we start
from the protein closed state. By running longer, we allow our simulations to perform more
exchanges across replicas and thereby allow for better sampling of all conformational states
at the relevant end state replicas.
(a) Protein closed simulation, pREST
(b) Protein closed simulation, pREST extended
Figure 1.7: Using the modified REST region (pREST) in the transformation of benzene to
hexylbenzene, we plot the RMSD/time corresponding to the hexylbenzene state (λ11) with
the simulation starting from protein closed for the first 5ns (Fig. 1.7a) and the final 10ns
from an extended run up to 55ns (Fig. 1.7b).
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Returning to our most extreme transformation, benzene to hexylbenzene, we have shown
pREST alone does not facilitate adequate sampling of the open state (Fig 1.7a). Now, when
we run much longer we see far more sampling of the open protein conformational state in
the final 10ns window (Fig 1.7b). Note that, for closed-open transformations we use the final
15ns to compute the final free energies. We only show the final 10ns in our RMSD/time
analysis to avoid overcrowding data points. In viewing all the replicas (Fig 1.5c), we illustrate
the dramatic increase in protein conformational sampling in stark contrast to our previous
5ns simulations (Fig 1.5b). An additional analysis comparing the protein-ligand contacts
between the default and pREST protocol can be found in the Supporting Information (Fig.
S1).
By simulating longer with pREST we dramatically increase our sampling of the intermediate
and open protein states and almost entirely eliminate the dependence on the initial protein
conformational state. For the set of closed-open transformations the RMSI dramatically
falls to +0.57 kcal/mol (Fig. 1.6b,Table S1.7) and a RMSI of +0.43 kcal/mol for the closed-
intermediate (Fig. 1.6d,Table S1.4). Similarly, for experimental ligand transformations, our
RMSE for protein closed simulations falls to +0.54 kcal/mol and the RMSI reduces to 0.31
kcal/mol (Fig. 1.8b,Table S1.9). Now, all our inconsistencies in the final calculated free
energies and error from experiment fall within a much more reasonable range of less than
+1 kcal/mol.
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(a) Default (b) pREST
Figure 1.8: ∆∆Gcalc from MD simulations beginning from the protein closed (purple) and
open (green) state compared against ∆∆Gexp. Fig. 1.8a plots free energies obtained using
the default protocol which gives a 1.0 kcal/mol and 0.58 kcal/mol RMSE for protein closed
and open simulations, respectively. Total RMSI using the default protocol is 0.68 kcal/mol.
Fig. 1.8b plots the final free energies after applying pREST, yielding an RMSE of 0.54
for protein closed and 0.50 kcal/mol for protein closed simulations. Total RMSI using the
pREST protocol is 0.31 kcal/mol. Numerical data for each plot can be found in Tables S1.8
and S1.9.
It is very interesting to note that this overall level of agreement (a typical error of less than
1 kcal/mol) between our calculated values and experiment for the compounds for which we
have affinity data – the smaller compounds, for which the inconsistency is relatively low – is
actually quite good, better than what was reported in the previous work (1). This may be
due to the relative simplicity of the ligand modifications (methyl groups only) as well as the
high quality of the experimental binding assay, ITC. In contrast, larger apparent errors in
other tests may in some cases be due to lower quality experimental data.
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1.5 Discussion
In this study, we find that relative free energy calculations for this system can suffer from
substantial convergence problems, likely due to the changes being related to the reorgani-
zation of a secondary structure element. Although the protein conformational changes in
T4 lysozyme (L99A) are extremely localized to a rearrangement of a single helix (Fig 1.1),
we still encounter challenges in sampling, likely due to the slow timescale associated with
the reorganization of protein secondary structure. These problems have clear implications
for the accuracy of computed relative free energies in these cases. Particularly, we find that
calculated relative free energies can depend on the initial protein conformational state by up
to 4 kcal/mol.
By looking at alchemical transformations that involve a conformation change in the protein,
we show the ∆∆Gscalc may be sensitive to the initial protein conformational state when
utilizing the default implemented FEP protocol. This sensitivity occurs primarily when the
alchemical transformation involves mutating ligands that mainly occupy the closed state
(i.e. benzene to propyl) into ligands that occupy the intermediate state (i.e. (sec-)butyl)
or, especially, the open state (pentyl/hexyl) (Table 1.1). By our RMSD analyses, we show
the protein remains trapped in its initial state throughout the simulation when using the
implemented default protocol. Because it remains trapped, we are unable to adequately
sample the necessary protein conformational states and thereby obtain inconsistent ∆∆Gscalc
depending on whether we start simulations from the open or closed protein configuration.
This inconsistency can be large, especially for the larger compounds which bind primarily in
the open conformation, for which we do not have experimental binding affinities. However,
interestingly, when we start our simulations from the open structure, the lack of adequate
sampling of the closed structure does not lead to particularly large errors for the smaller
ligands which bind primarily in the closed structure (Table S1.2).
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Without prior knowledge of preferred protein conformational states on ligand binding, we
can arrive at very different binding affinity predictions based on the initial protein state being
used in the simulation. By starting from the protein closed state and growing the ligand we
obtain ∆∆Gcalc values that appear overly positive or unfavorable due to high protein-ligand
energy strain and inability to sample the open state, for this system.
However, when we begin with the protein open state our ∆∆Gcalc values appear slightly too
negative or favorable, resulting from inability to sample the closed state and not encountering
protein-ligand strain. If we only had the crystal structure of the closed protein-ligand com-
plexes, we would blindly conclude that the much larger, open-ligands bind to T4 lysozyme
worse than smaller ones. On the other hand, if only the open protein-ligand complexes were
available, the opposite would be concluded in that larger ligands are better binders than
smaller ligands; experimental data will be needed to determine which is the case.
By including key residues into the REST region and simulating longer, we reduce the ∆∆Gcalc
dependence on the initial protein configuration to a more reasonable range of less than 1
kcal/mol. Through expanding the REST region, intermediate lambda windows are able
to more easily access the intermediate and open conformations by effectively heating key
residues that facilitated protein motion, illustrated in Fig 1.5b. Further, by simulating
longer we allow for more exchanges between replicas, which in turn enhances sampling at
our physically relevant end state replica (Fig 1.5c). With these modifications to the default
protocol, we almost completely converge our ∆∆Gcalc to the same value regardless of the
starting protein conformation.
Generally, our brute-force approach of simulating longer and multiple trials with varied pro-
tein structures is not a desirable or feasible approach, especially in early drug discovery
phases. At the industrial level, ligand libraries can be large—driving computational cost ex-
ponentially if we simulate longer—or experimental structures can be sparse for new therapeu-
tic protein targets. For future studies, approaches using Markov State Models (MSMs)(72)
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can potentially be of great use for identifying discrete protein conformations. MSMs build
a representation of the conformational space from batches of short molecular simulations,
whereby the discrete states and transition rates between them can be determined in an ef-
ficient manner. Utilizing MSMs can thereby provide useful insight on the various protein
conformational states before running free energy predictions.
1.6 Conclusions
Overall, we have shown that the presence of kinetically distinct protein conformational states
could impact the accuracy of free energy calculations by up to 2-5 kcal/mol, especially so
when the R-group modification introduces a severe steric clash with the receptor. It would
have been especially challenging as there would essentially be no indicators that the final free
energies were sensitive to the initial protein configuration. Only from prior knowledge of the
discrete states and by our tedious systematic trials were we able to identify and address the
bias in our final calculated free energies. It should be comforting that even without this prior
knowledge, good to very good agreement with experiment is obtained for the majority of
ligands. Further, one should keep in mind that this study was carefully designed to probe the
potential difficulties caused by these conformational changes; most lysozyme ligands studied
previously do not induce such significant conformational changes.
Although alchemical free energy calculations have shown tremendous recent successes on a
variety of protein targets(1), we demonstrate challenges in protein sampling remain. Using
T4 lysozyme (L99A) as our simple model system, we highlight sampling problems even
from a relatively small ( 1-3.5Å) and localized single helix rearrangement in response to a
series of growing ligands. Through this study, we show using a typical 5ns simulation with
only ligand atoms in the REST region, yields free energies that are sensitive to the initial
protein conformation. This is especially true for ligand perturbations that induce large
33
protein conformational changes. By longer simulation times and expansion of the REST
region to include key protein residues, we were able to get converged predictions and nearly
eliminate the depdendence on the starting conformation, even for some challenging cases.
This study demonstrates that special attention and care should be exercised when performing
alchemical free energy calculations where regions of flexibility surround the binding site.
More importantly, prior to performing binding free energy calculations, we present strong
evidence on the importance of identifying the occurrence of protein conformational changes
upon ligand binding,
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1.8 Supporting Information: Sensitivity in binding free
energies due to protein reorganization
The Supporting Information contains ‘Simulation Interaction Diagrams’ analyzing hydropho-
bic protein-ligand contacts pertaining to hexylbenzene bound to the protein closed and open
state using the default protocol and the pREST protocol. Tables for each alchemical trans-
formation set have been provided containing the final free energies and inconsistency mea-
surement for each individual transformation. A link to download the input files for the data
set and analysis tools have been provided. Complete trajectories have been included for the
transformations involving benzene to hexylbenzene.
1.8.1 Simulation Interactions Diagrams
Using the ‘Simulation Interactions Diagram’ tool provided with Desmond, we count the
number of hydrophobic contacts between the ligand and each of the surrounding protein
residues at each frame. Hydrophobic contacts are categorized into three groups: pi-Cation,
pi−pi, and Other. The pi-Cation contact is defined as an aromatic and charged group that are
within 4.5Å. pi − pi contacts are when two aromatic groups are stacked face-to-face or face-
to-edge. Hydrophobic contacts that are classified as Other are when hydrophobic side-chains
are within 3.6Åof a ligand’s aromatic or aliphatic carbons.
Through this protein-ligand contact analysis, we can see if the ligand forms the same interac-
tions regardless of the initial protein configuration. In Figure 1.1, we analyze the hydrophobic
contacts for hexylbenzene in either the protein closed (purple) or open (green) MD simula-
tions and represent the difference in red. Here, we represent the number of protein-ligand
hydrophobic contacts as a percentage for the length of the MD simulations. Again, we
analyze frames from 0-5ns with the default protocol and 45-55ns with the pREST protocol.
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Given hexylbenzene prefers the open conformation, we should expect to see Val111 contact
the hexylbenzene at a percent closer to that of the protein open simulation. Using the default
protocol, we show Val111 is in contact with hexylbenzene for 40.4% of the protein closed
simulation and 9.6% of the protein open simulation, approximately a 30.8% difference in the
interaction percentage. On the other hand, with the pREST protocol—where Val111 is in-
cluded into the REST region—this difference dramatically reduces to 0.5%. Now, regardless
of our initial protein starting conformation, Val111 comes in contact with the ligand 7.9%
and 8.4% of the protein closed and open simulations, close to what we would have expected
judging from our protein open simulation using the default protocol. Furthermore, we can
compute the mean absolute difference (MAD) across all residues to yield 10.5% for the de-
fault protocol and 2.8% with the pREST protocol. Overall, the reduction in the difference
in protein-ligand contacts indicates the bias from the initial protein configuration is almost
entirely eliminated from using pREST.
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Figure 1.1: Bar plot of interaction percentage of protein-ligand hydrophobic contacts over
the course of a trajectory. From the benzene to hexylbenzene transformation, these plots
correspond to the hexylbenzene (λ11) state from closed (purple) and open (green) simula-
tions using the default versus pREST protocols. The mean absolute difference (MAD) in
interaction percentage is represented in red. MAD for the default protocol is 10.5% and
2.8% for the pREST protocol.
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1.8.2 Tables
Table 1.2: Closed-Intermediate Transformationsa
Ligand 1 Ligand 2 ∆∆GC σC ∆∆GO σO ∆∆Gε
benzene butylbenzene 0.58 0.07 -0.59 0.08 1.17
toluene butylbenzene -0.28 0.06 -1.27 0.09 0.99
ethylbenzene butylbenzene 0.24 0.06 -0.23 0.07 0.47
propylbenzene butylbenzene 0.99 0.06 0.63 0.04 0.36
benzene sec-butylbenzene 2.36 0.09 2.14 0.11 0.22
toluene sec-butylbenzene 1.47 0.07 1.14 0.08 0.33
ethylbenzene sec-butylbenzene 1.90 0.08 1.77 0.08 0.13
propylbenzene sec-butylbenzene 2.86 0.06 2.67 0.05 0.19
a Calculated free energies and their uncertainties in ‘closed-intermediate’ alchemical
transformations from simulations that were started from the protein closed state(∆∆GC)
versus the protein open state(∆∆GO). Free energies are in units of kcal/mol. The
inconsistency(∆∆Gε) is obtained from the difference in the relative free energies between
protein closed and open simulations. Inconsistency is highlighted red or green if above or
below 1 kcal/mol, respectively. RMSI is 0.6 kcal/mol. Table is represented in Fig 1.6c.
Table 1.3: Closed-Intermediate Transformations pRESTa
Ligand 1 Ligand 2 ∆∆GC σC ∆∆GO σO ∆∆Gε
benzene butylbenzene -0.07 0.10 -0.72 0.12 0.65
toluene butylbenzene 0.89 0.10 -0.42 0.08 1.31
ethylbenzene butylbenzene -0.20 0.09 -0.43 0.08 0.23
propylbenzene butylbenzene 1.02 0.06 0.49 0.06 0.53
benzene sec-butylbenzene 0.45 0.08 1.34 0.12 0.89
toluene sec-butylbenzene 0.60 0.12 0.60 0.10 0.00
ethylbenzene sec-butylbenzene 1.09 0.10 1.69 0.09 0.60
propylbenzene sec-butylbenzene 1.88 0.07 3.05 0.07 1.17
a Calculated free energies and their uncertainties in ‘closed-intermediate’ alchemical
transformations from ‘pREST’ simulations that were started from the protein closed
state(∆∆GC) versus the protein open state(∆∆GO). Free energies were calculated using
frames from 0 to 5ns. Free energies are in units of kcal/mol. The inconsistency(∆∆Gε) is
obtained from the difference in the relative free energies between protein closed and open
simulations. Inconsistency is highlighted red or green if above or below 1 kcal/mol,
respectively. RMSI is 0.79 kcal/mol. Table is represnted in Fig 1.6d.
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Table 1.4: Closed-Intermediate Transformations pREST Extendeda ,b
Ligand 1 Ligand 2 ∆∆GC σC ∆∆GO σO ∆∆Gε
benzene butylbenzene -1.14b 0.09 -0.72 0.12 0.42
toluene butylbenzene -0.62b 0.09 -0.96a 0.09 0.34
ethylbenzene butylbenzene -0.20 0.09 -0.43 0.08 0.23
propylbenzene butylbenzene 0.51b 0.06 0.49 0.06 0.02
benzene sec-butylbenzene 0.45 0.08 1.34 0.12 0.89
toluene sec-butylbenzene 0.60 0.12 0.60 0.10 0.00
ethylbenzene sec-butylbenzene 1.09 0.10 1.69 0.09 0.60
propylbenzene sec-butylbenzene 1.88 0.07 1.84b 0.06 0.04
a Calculated free energies and their uncertainties in ‘closed-intermediate’ alchemical
transformations from ‘pREST’ simulations that were started from the protein closed
state(∆∆GC) versus the protein open state(∆∆GO). Free energies were calculated using
frames from 15 to 25ns. Free energies are in units of kcal/mol. The inconsistency(∆∆Gε)
is obtained from the difference in the relative free energies between protein closed and open
simulations. Inconsistency is highlighted red or green if above or below 1 kcal/mol,
respectively. RMSI is 0.43 kcal/mol. Table is represnted in Fig 1.6d.
b Only these alchemical transformations were extended up to 25ns of simulation time in
order to lower the inconsistency and error with experiment.
Table 1.5: Closed-Open Transformationsa
Ligand 1 Ligand 2 ∆∆GC σC ∆∆GO σO ∆∆Gε
benzene pentylbenzene 2.36 0.12 -1.33 0.10 3.69
toluene pentylbenzene 1.77 0.09 0.34 0.10 1.43
ethylbenzene pentylbenzene 2.45 0.08 0.46 0.09 1.99
propylbenzene pentylbenzene 3.46 0.08 -0.22 0.07 3.68
benzene hexylbenzene 4.13 0.16 -0.61 0.15 4.74
toluene hexylbenzene 2.90 0.13 -1.63 0.08 4.53
ethylbenzene hexylbenzene 3.63 0.11 -0.76 0.09 4.39
propylbenzene hexylbenzene 5.85 0.10 0.13 0.06 5.72
a Calculated free energies and their uncertainties in ‘closed-open’ alchemical
transformations from simulations that were started from the protein closed state(∆∆GC)
versus the protein open state(∆∆GO). Free energies were calculated using frames from 0
to 5ns. Free energies are in units of kcal/mol. The inconsistency(∆∆Gε) is obtained from
the difference in the relative free energies between protein closed and open simulations.
Inconsistency is highlighted red or green if above or below 1 kcal/mol, respectively. RMSI
is 4.0 kcal/mol. Table is represented in Fig 1.6a.
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Table 1.6: Closed-Open Transformations pRESTa
Ligand 1 Ligand 2 ∆∆GC σC ∆∆GO σO ∆∆Gε
benzene pentylbenzene 1.49 0.13 0.07 0.10 1.42
toluene pentylbenzene 1.41 0.12 0.79 0.13 0.62
ethylbenzene pentylbenzene 2.90 0.10 1.23 0.09 1.67
propylbenzene pentylbenzene 4.25 0.09 1.01 0.07 3.24
benzene hexylbenzene 2.75 0.14 1.25 0.11 1.50
toluene hexylbenzene 3.22 0.11 -1.15 0.11 4.37
ethylbenzene hexylbenzene 3.34 0.12 -0.22 0.11 3.56
propylbenzene hexylbenzene 4.93 0.12 1.21 0.11 3.72
a Calculated free energies and their uncertainties in ‘closed-open’ alchemical
transformations from ‘pREST’ simulations that were started from the protein closed
state(∆∆GC) versus the protein open state(∆∆GO). Free energies are in units of
kcal/mol. The inconsistency(∆∆Gε) is obtained from the difference in the relative free
energies between protein closed and open simulations. The inconsistency is highlighted red
or green if above or below 1 kcal/mol, respectively. RMSI is 2.82 kcal/mol.
Table 1.7: Closed-Open Transformations pREST Extendeda
Ligand 1 Ligand 2 ∆∆GC σC ∆∆GO σO ∆∆Gε
benzene pentylbenzene 1.37 0.08 1.41 0.08 0.04
toluene pentylbenzene 1.08 0.08 0.81 0.07 0.27
ethylbenzene pentylbenzene 1.71 0.08 1.50 0.07 0.21
propylbenzene pentylbenzene 3.20 0.06 2.34 0.05 0.86
benzene hexylbenzene 2.15 0.09 1.14 0.08 1.01
toluene hexylbenzene 0.32 0.10 1.10 0.07 0.78
ethylbenzene hexylbenzene 1.96 0.08 2.17 0.07 0.21
propylbenzene hexylbenzene 3.38 0.07 3.12 0.06 0.26
a Calculated free energies and their uncertainties in ‘closed-open’ alchemical
transformations from extended ‘pREST’ simulations that were started from the protein
closed state(∆∆GC) versus the protein open state(∆∆GO). Free energies are in units of
kcal/mol. Free energies were calculated using frames from 40 to 55ns. The
inconsistency(∆∆Gε) is obtained from the difference in the relative free energies between
protein closed and open simulations. Inconsistency is highlighted red or green if above or
below 1 kcal/mol, respectively. RMSI is 0.57 kcal/mol. Table is represented in Fig 1.6b.
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Table 1.8: Experimental Ligand Transformationsa
Ligand 1 Ligand 2 ∆Gexp σexp ∆∆GC σC ∆∆GO σO
benzene toluene -0.33 0.16 0.71 0.04 0.59 0.05
benzene ethylbenzene -0.19 0.17 0.15 0.05 -0.09 0.06
benzene propylbenzene -1.36 0.16 -0.82 0.06 -0.69 0.08
benzene butylbenzene -1.51 0.16 0.58 0.07 -0.59 0.08
toluene ethylbenzene -0.24 0.08 -0.59 0.04 -0.40 0.05
toluene propylbenzene -1.03 0.04 -2.21 0.05 -0.89 0.05
toluene butylbenzene -1.18 0.04 -0.28 0.06 -1.27 0.09
ethylbenzene propylbenzene -0.79 0.07 -0.86 0.05 -0.80 0.03
ethylbenzene butylbenzene -0.94 0.07 0.24 0.06 -0.23 0.07
propylbenzene butylbenzene -0.15 0.03 0.99 0.06 0.63 0.04
a Experimental and calculated free energies with their uncertainties in alchemical
transformations involving ligands with available experimental affinities. Calculated free
energies are from simulations that were started from the protein closed state(∆∆GC)
versus the protein open state(∆∆GO). Free energies are in units of kcal/mol. Here, we
compare ∆∆GC and ∆∆GO against ∆Gexp to compute the error with experiment.
RMSE is 1.0 kcal/mol and 0.58 kcal/mol for closed and open simulations, respectively.
RMSI is 0.68 kcal/mol. Table is represented in Fig 1.8a.
Table 1.9: Experimental Ligand Transformations pRESTa
Ligand 1 Ligand 2 ∆Gexp σexp ∆∆GC σC ∆∆GO σO
benzene toluene -0.33 0.16 0.10 0.08 0.31 0.06
benzene ethylbenzene -0.19 0.17 -0.20 0.08 -0.62 0.08
benzene propylbenzene -1.36 0.16 -1.57 0.09 -1.26 0.09
benzene butylbenzene -1.51 0.16 -1.14 0.11 -0.72 0.12
toluene ethylbenzene -0.24 0.08 -0.84 0.07 -0.83 0.07
toluene propylbenzene -1.03 0.04 -1.91 0.09 -1.44 0.08
toluene butylbenzene -1.18 0.04 -0.62 0.09 -0.96 0.09
ethylbenzene propylbenzene -0.79 0.07 -1.08 0.07 -0.80 0.06
ethylbenzene butylbenzene -0.94 0.07 -0.20 0.09 -0.43 0.08
propylbenzene butylbenzene -0.15 0.03 0.51 0.06 0.49 0.06
a Experimental and calculated free energies with their uncertainties in alchemical
transformations involving ligands with available experimental affinities. Calculated free
energies are from ‘pREST’ simulations that were started from the protein closed
state(∆∆GC) versus the protein open state(∆∆GO). Free energies are in units of
kcal/mol. Here, we compare ∆∆GC and ∆∆GO against ∆Gexp to compute the error
with experiment. RMSE is 0.54 kcal/mol and 0.50 kcal/mol for closed and open
simulations, respectively. RMSI is 0.31 kcal/mol. Table is represented in Fig 1.8b.
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Data Sets and Analysis Tool Download
All related data sets and analysis tools are available online and described below. The files
can be downloaded at http://n2t.net/ark:/b7280/d1js3b (doi:10.7280/D1JS3B).
Prepared protein-ligand crystal structures: xtal\_prepped.tar.gz
Contains the reference protein-ligand crystal structures that have been aligned and
prepared through the ‘Protein Preparation Wizard’ tool as .mae files.
RMSD analysis: scripts.tar.gz
Contains the scripts RMSD-analysis.tcl and plot-RMSD.py used for RMSD analysis.
A README.txt file has been provided which details how to generate the RMSD/time
and Colormap plots found in the paper.
FEP data: C-I\_default.tar.gz, C-I\_pPREST.tar.gz, C-O\_default.tar.gz,
C-O\_pREST.tar.gz, EXP\_default.tar.gz, and EXP\_pREST.tar.gz
Contains archived data from the FEP calculations for each alchemical transformation
set, where within each archived set are directories for individual FEP calculations.
These contain input .mae files containing the protein/ligand structures, the simulation
configuration .msj files, energy files, and a README.txt that summarizes information
about each FEP calculation. Complete trajectories are included.
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Chapter 2
Computational studies of Diphtheria
Toxin T Domain: role of acidic residue
E362 in membrane-protein insertion and
pore formation.
Authors: Alexander Kyrychenko, Nathan M. Lim, Victor Vasquez-Montes, Mykola V. Rodnin, J.
Alfredo Freites, Linh P. Nguyen, Douglas J. Tobias, David L. Mobley, and Alexey S. Ladokhin
Excerpt from: ‘Refining Protein Penetration into the Lipid Bilayer Using Fluorescence Quenching
and Molecular Dynamics Simulations: The Case of Diphtheria Toxin Translocation Domain’ (4)
J. Mem. Bio., 2018, 251 (9), pp 379–391
doi:10.1007/s00232-018-0030-2
Publication Date (Web): March 17, 2018
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Figure 2.1: Thermodynamic cycle for calculating membrane-protein insertion free energies of
DTT for neutralized E362 relative to charged E362. The vertical legs relate to the membrane
insertion free energies of DTT which is obtained from the equivalent horizontal legs calculated
from the alchemical free energy calculations. Residue E362 is represented with van der Waals
spheres in each image. For figures of the protein, the TH8-TH9 helices are shaded differently
from the rest of the protein and S336 is displayed to illustrate its position on the TH8 helix
relative to E362.
2.1 Introduction
Recent experimental studies on the Diphtheria Toxin T domain (DTT) characterized the importance
in protonation of acidic residue E362 in the membrane insertion process (73). Through mutagenesis
studies of E362Q–whereby the charge is effectively removed–it was demonstrated that this residue
plays a key role in the insertion of the TH8-TH9 helices. In order to quantitatively understand
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the role of the charged residue E362 and the energetics in the insertion mechanism of DTT, we
compute the membrane-protein insertion free energy. In this study, we utilize an all-atom (ex-
plicit solvent & membrane) molecular dynamics (MD) simulation with the alchemical free-energy
perturbation (FEP) approach. Here, we compute the change in free energies between the charged
and neutral states of E362 from simulations carried out in solution and membrane environments.
Our free energy predictions indicate high favorability (approximately -6kcalmol ) for neutral E362 in
the membrane-protein insertion pathway–which seems consistent with experimental mutagenesis
results (73). Additional profiling of the pore formed by DTT indicates neutralized E362 induces
larger perturbations to the membrane, providing further evidence E362 plays a key role during
insertion.
2.2 Methods
2.2.1 Molecular Dynamics simulation & Free energy calculation
protocols
The initial protein configurations were based on the crystal structure of wild-type diphtheria toxin
(PDB ID 1f0l). The protein in the solution simulation system consisted of the full T domain
(residues 202–378), and in the membrane system, of the TH8–TH9 hairpin (residues 319–380).
TH8 is a hydrophobic helix while TH9 exhibits a significant hydro- phobic moment. In the crystal
structure TH8 appears fully protected by the rest of the T domain, therefore, in order to produce an
initial protein configuration with favorable interactions with the membrane environment, we rotated
TH9 180° about its principal axis so as to orient the polar face towards TH8 and away from the lipid
bilayer hydrocarbon core. Titratable side chains were modeled consistent with neutral pH in the
solution system, and with acidic pH in the membrane system. Specifically, in the solution system,
all histidine residues were neutralized and acidic residues were ionized. In the membrane system,
all histidine residues were charged and, except for E362, all acidic residues were neutralized. The
solution simulation system was generated using VMD (74). The final solution system consisted of
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one T domain, 2768 waters and, 10 counterions for a total of 11,032 atoms. The membrane system
was set up by inserting the TH8–TH9 hairpin in a 1:1 POPC–POPG bilayer in excess water using
the CHARMM–GUI membrane builder (75) and VMD. The final mem- brane system consisted of
one TH8–TH9 hairpin, 250 lipids, 11,724 waters, and 122 counterions for a total of 68,872 atoms.
Equilibration simulations were carried out at con- stant pressure (1 atm) and temperature (300 K)
for approximately 40 and 113 ns for the aqueous and membrane systems, respectively.
The simulations were run with the NAMD (v2.11) software package (76) under three-dimensional
periodic boundary conditions (PBC). The protein was modeled using the CHARMM22 force field
(77) The CHARMM36 force field was used for lipids (78) and the TIP3P (79) model was used
for water. A reversible multiple-time- step algorithm (80) was used to integrate the equations of
motion with a time step of 4 fs for the long- range electrostatic forces, and 2 fs for the short-
range non- bonded forces and the bonded forces. The smooth particle mesh Ewald method (81)
was used to calculate electrostatic interactions. The short-range interactions were cutoff at 12 A˚
using a force-based switching scheme. All bond lengths involving hydrogen atoms were held fixed
using the SHAKE (82) and SETTLE (83) algorithms. A Langevin dynamics scheme was used for
thermostating. Nose´–Hoover–Langevin pistons were used for pressure contro ((84);(85)).
Alchemical free energy calculations were divided into 40 equally spaced windows with production
simulations running for 5 ns per stage, giving a total of 200 ns for each system. Each production run
was preceded by an equilibration protocol consisting of 10,000 steps of conjugate-gradient energy
minimization and a 1 ns MD run. Free energies were calculated using Bennett Acceptance Ratio
(? ) as implemented by the PyMBAR program (86; 87). Corrections to the final free energies were
performed using a scheme based on a continuum-electrostatics analysis, which corrects for spuri-
ous interactions encountered when simulations are carried out with periodic boundary conditions
(88).
Trajectory analyses were performed using VMD and MDtraj (89). Molecular graphics were gener-
ated using VMD (74). Analysis of the pore resulting from the TH8–TH9 hairpin insertion in the
membrane was done using dxTuber (v0.28) (90). OpenDX density maps were generated using the
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VolMap(v1.1) plugin in VMD with the following settings: resolution: 1.0 A˚ atom size: 1.0 ×
radius, weights: mass Density maps were combined over the final 64 ns from the membrane MD
simulations. For analysis with dxTuber, we used a combination of two settings: (1) time-averaged
for both the protein and solvent and (2) minimum protein density and time-averaged solvent den-
sity. Trajectory frames were aligned by the hairpin backbone using the starting frame as reference
and then wrapped about the hairpin’s center of mass using MDtraj (89).
2.3 Results & Discussion
Table 2.1: Initial and corrected(88) free energies obtained from alchemical free energy calcu-
lations which transformed E362 from charged to neutral in both the aqueous and membrane
environments. The membrane-protein insertion free energies are obtained from the difference
in free energies between the two environments.
∆Gkcal
mol
∆Gkcal
mol
Corrected
∆GE362mem(Chg → Ntrl) 84.4 93.3 (+/- 0.3)
∆GE362aq (Chg → Ntrl) 86.0 99.5 (+/- 0.2)
∆∆GE362aq→mem(Ntrl) -1.6 -6.2 (+/- 0.4)
2.3.1 Free Energies indicate high favorability for neutralized E362.
In our free energy calculations, we alchemically transform the glutamic acid residue at position 362
from its charged to neutral state by effectively creating or annihilating a proton on the terminal
oxygen atom, denoted as OE2 from the CHARMM 22 topology. Our initial state is with the
charged residue in the aqueous solution and our end state is that of the neutral residue within
the membrane environment. To determine the T-domain insertion free energies, we apply the
thermodynamic cycle illustrated in Figure 2.1 and obtain equation 2.1. Here, we define our four
terms: ∆GE362aq (Chg → Ntrl) represents the change in free energy of altering the charged residue
E362 to neutral in the aqueous environment while ∆GE362mem(Chg → Ntrl) represents the same
charge change but in the membrane environment. The membrane-protein insertion free energy is
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represented by the terms ∆GE362aq→mem(Ntrl) and ∆GE362aq→mem(Chg), whereby residue E362 is either
in the neutral (Ntrl) state or the charged (Chg) state.
0 = ∆GE362aq (Chg → Ntrl)+∆GE362aq→mem(Ntrl)−∆GE362mem(Chg → Ntrl)−∆GE362aq→mem(Chg) (2.1)
From rearranging, we show that the free energy difference from insertion of the neu- tral versus
charged system is equivalent to the free energy change resulting from the perturbation of the residue
in the aqueous versus membrane environment (Eq. 3). (eqn. 2.2).
∆GE362aq→mem(Ntrl)−∆GE362aq→mem(Chg) = ∆GE362mem(Chg → Ntrl)−∆GE362aq (Chg → Ntrl) (2.2)
Thus, the total membrane-protein insertion free energy can be obtained from either pair of terms.
Since we cannot conduct MD simulations corresponding to the vertical legs from Figure 2.1 to
obtain the free energies denoted in equation 2.3, we instead obtain the insertion free energy from
the equivalent terms in the cycle. Thus, from equation 2.4, the total insertion free energy can
obtained from the MD free energy simulations where we perturb the residue in both the aqueous
and membrane environments.
∆∆GE362aq→mem(Ntrl) = ∆G
E362
aq→mem(Ntrl)−∆GE362aq→mem(Chg) (2.3)
∆∆GE362aq→mem(Ntrl) = ∆G
E362
mem(Chg → Ntrl)−∆GE362aq (Chg → Ntrl) (2.4)
From our calculations (Table 2.1),the free energy change obtained from alchemically creating a
proton to neutralize the charged glutamic residue was +84.4kcalmol in the membrane and +86.0
kcal
mol in
the aqueous environment, yielding a final insertion free energy of −1.6kcalmol . As our simulated system
was neutralized with counterions when E362 was charged, the alchemical modification being made
here results in the overall system becoming non-neutral. This gives rise to significant artifacts arising
from self-interactions through neighboring periodic copies, which can dramatically impact our free
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energy differences(88). A correction scheme for the self-interactions has been previously described
in a similar membrane-insertion free energy study, conducted on outer membrane phospholipase
A (OmpLA) (91). In this scheme described by Gumbart and Roux, they intentionally neglect the
self-interaction from the charged residue and its periodic replicas–on account of the term being
negligible due to the pore waters shielding the charge. As our simulations of T-domain involve a
much narrower pore and thus were uncertain if water would effectively shield the charge, we employed
a more thorough correction scheme based off a continuum-electrostatics analysis(88). After applying
the analytical continuum-electrostatics scheme described by Rocklin et. al, our corrected insertion
free energy was −6.2(+/ − 0.4)kcalmol , which suggests high favorability for the neutralized residue in
the membrane insertion pathway.
2.3.2 Neutralized E362 produces a larger membrane pore.
We have examined the effect of protonation state of E362 on the local perturbation of the bilayer.
Through time-averaged density maps of the protein and solvent over the course of the MD simula-
tions, we show that the pore created by T-domain TH8–9 hairpin and the inner tunnel-like cavity
are larger when residue E362 is neutralized. Thus, we provide supporting evidence on the impor-
tance of residue E362 and its pH-dependent conformational switching for perturbing the membrane
to allow for insertion.
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Figure 2.2: Hydrogen bond network between the TH8-TH9 helices involving residues S336,
S337, E362, S363, and N366. The red arrow points to the H-bond formed between residues
S337/S363 which are the two closest points of contacts between the helices. When E362
is charged (Fig.2.2A; green), residues N366/S336 are oriented inward but are flipped away
when E362 is neutral (Fig.2.2B; blue). Fig. 2.2C shows the shift of the TH8 helix when
E362 is charged by overlaying the protein structure from neutralized E362.
From our MD simulations, we found that the exposure of the charge on residue E362 within the
membrane environment results in the two helices moving closer together to effectively shield the
unfavorable charge in the center of the surrounding non-polar membrane environment. When residue
E362 is charged, the two helices are pulled together by formation of a hydrogen bond network
primarily involving residues surrounding E362. From Figure 2.2, we show that resi- dues S336 and
S337 on the TH8 helix are oriented inward in order to more closely interact with residues N366, S363,
and charged E362 on the opposing TH9 helix. From calculating the percent occupancy of hydrogen
bond contacts between S336 and S363—the two closest residues on opposing helices-—we find
that when residue E362 is neutral, hydrogen bonding occurs in roughly 57% of trajectory frames,
but when E362 is charged the hydrogen bonding occurs in approximately 88% of the trajectory
frames. Our analysis of the MD trajectories indicates that when E362 is charged, the two helices
are drawn closer together, thereby decreasing the overall perturbation to the membrane. This finding
suggests favorability for neutralized over charged E362 during the membrane insertion mechanism
as formation of a larger pore could better facilitate delivery of the catalytic domain across the
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membrane.
Table 2.2: Mean cross-sectional area along the Z-axis of the pore formed by DTT when E362
is charged versus neutral. Calculated from dxTuber(90), using average solvent densities with
average versus minimum protein densities.
E362 State Avg(2) Min(2)
Neutral 740 318
Charged 750 217
Figure 2.3: Solvent accessibility map using average protein and average solvent densities
over the 64ns MD simulation. The time-averaged solvent densities are shown for when E362
is charged (Fig.2.3A; green) and when E362 is neutral (Fig.2.3B; blue). Solvent densities
are colored red for high density and blue for low density. Fig.2.3C plots the cross-sectional
area along the Z-axis with the mean cross-sectional areas being 750Å2 for neutral E362 and
740Å2 for charged E362 (Table 2.2).
In order to approximate the pore size from T-domain insertion, we use dxTuber to calculate the
cross-sectional area along the membrane normal over the course of the MD trajectories. By using
the average protein and average solvent densities, we generate a time-averaged map of solvent ac-
cessibility around the protein (Fig.2.3). Solvent accessibility is colored by according to the averaged
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density (red=high density; blue=low). From our analysis (Table 2.2), we find that the average
cross-sectional area when residue E362 is neutral is 750Å2 and when charged is 740Å2. Next, by
using the minimum protein densities with averaged solvent densities, we filter out regions of high
protein flexibility. This yields a map of the areas with maximum solvent accessibility, which appears
to map the solvent accessibility of pore interior (Fig.2.4). The average cross-sectional area through
the inner cavity when residue E362 is neutral is 318Å2 and when charged is 217Å2. Both the aver-
age and minimum protein profiles indicate the overall pore formed in the membrane by T-domain
insertion is greater in size when residue E362 is neutralized. This analysis provides further evidence
that membrane perturba- tion starts with the initial insertion of TH8–9 domain and that E362 may
play multiple roles in modulating the inser- tion mechanism of the T-domain.
Figure 2.4: Maximum solvent accessibility map for when E362 is charged (Fig.2.4A; green)
and neutral (Fig.2.4B; blue), using minimum protein and average solvent densities over the
64ns MD simulation. Fig.2.4C plots the cross-sectional area along the Z-axis with the mean
cross-sectional areas being 318Å2 for neutral E362 and 217Å2 for charged E362 (Table 2.2).
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2.4 Summary
In our alchemical free energy calculations, we alchemically transform the glutamic acid residue at
position 362 from its charged to neutral state by effectively creating or annihilating a proton on
the side chain atoms. Our simulations use a previously constructed model of the full T domain
(seq. 202-378) in aqueous solution with residue E362 charged, all histidine residues neutralized, and
aspartic/glutamic acid residues ionized. Simulations involving the membrane use a partial T-domain
model of just the TH8-TH9 helices (seq. 319-380) embedded into the membrane, where all histidine
residues were ionized and aspartic/glutamic acid residues were neutralized. These protonation states
were as recommended by our experimental collaborators in view of the experimental data.
From our initial results, the free energy change calculated from alchemically creating a proton to
neutralize the charged glutamic residue was +84.4kcalmol in the membrane and +86.0
kcal
mol in the aqueous
environment, yielding an insertion free energy of −1.6kcalmol . This result indicates some favorability
for the neutral state over the charged state in the membrane, by at least 1.6kcalmol . However, this
analysis neglects corrections to computed free energies due to finite-size effects. After applying a
correction scheme based off a thorough continuum-electrostatics analysis(88), we obtain a predicted
final insertion free energy of −6.2(+/− 0.4)kcalmol .
Here, the alchemical free energy calculations for the critical titratable residue E362 (2.1; 2.1) re-
vealed a 6 kcal/mol difference favoring the membrane partitioning of the protonated form versus the
ionized form, thus providing important thermodynamic insights into pH-triggered conformational
switching during bilayer insertion. Solvent accessibility calculations revealed that neutral form of
E362 perturbs the integrity of the lipid bilayer (Figs. 2.3, 2.4), providing atomistic insights into pH-
dependent interactions of the T-domain with the lipid bilayer. Overall, the proposed methodology
in this study, which combines MD simulations and free energy calculations, can be used for un-
derstanding thermodynamic details relevant to physiological action of a variety of bilayer-inserted
proteins.
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Chapter 3
Designing an extensible tool for
accelerating sampling and predicting
ligand binding modes and affinities.
3.1 Introduction
Our hypothesis is that utilizing the NCMC (92) framework with MD simulations will dramatically
enhance sampling of ligand binding modes, allowing prediction of the most favorable binding pose
or poses. We are developing a method known as BLUES (Binding mode of Ligands Using Enhanced
Sampling) (7), which provides a way to move the ligand into alternate poses and subsequently allows
the system to relax to the new ligand position in a MD simulation.
During a MD simulation, BLUES will perform a random rotation of the bound ligand and then
allow the system to relax through alchemically scaling off/on the ligand-receptor interactions. The
thermodynamic work required in turning on the ligand interactions—in its newly rotated position—
is then used to accept or reject the rotational move based on the Metropolis acceptance criterion
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(93) which ensures the condition of "detailed balance" is met. Put alternatively, proposed moves
are accepted or rejected with certain probabilities such that the system will eventually visit states
with the correct equilibrium distribution of populations. We can then compute the relative binding
free energies of different binding modes from the binding mode populations (i.e time spent in each
pose) that were randomly ‘explored’ by the ligand over the simulation.
Thus, this method can be used to determine where the fragment tends to bind and its most favorable
binding mode. Specifically, this approach can be used for identifying and ranking favorable binding
modes, such as from fragment-based screening or poses for use in binding free energy predictions.
The application of the BLUES simulation package for fragment binding mode prediction will be
discussed in the final chapter. In this chapter, I present work done in designing the BLUES simu-
lation package to ensure the software can be easily extended for other use cases and discuss design
principles which were implemented to ensure the software can be easily maintained.
3.2 BLUES Software Design Principles
BLUES(? ) is a freely available toolkit designed as an extension for OpenMM (94). Again, the
toolkit utilizes a hybrid simulation approach which combines MD simulations and the NCMC (92)
framework to enhance ligand binding mode sampling. Our recent study (7) indicates more than a
100x speed up in pose sampling over traditional MD simulations from performing random rotational
moves on a small and rigid ligand bound in a simple model system. BLUES with random ligand
rotations has more recently been used to study and identify the binding modes of caffeine (8) and
fragment binding modes to soluble epoxide hydrolase 6.
A significant amount of my work involved incorporating the best practices in software development
as outlined by the Molecular Sciences Software Institute (95). These best practices include: (1)
version control, (2) testing and code coverage, (3) continuous integration, (4) automated build
systems, (5) standardized code style, and (6) documentation. These best practices are discussed
and presented in the following sections.
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3.2.1 GitHub and Travis-CI
GitHub is a website and a service which allows users to publicly store and host their software
packages, like our BLUES package. By hosting the BLUES software through GitHub, we incorporate
some of the best practices (1-4) in software design. GitHub uses ‘git’, an open source version control
software which keeps track of any changes made to the code. Version control is not only important
for having a history all your changes as the project progresses, but it also provides a way to ensure
collaborators are all using the same version.
BLUES has been designed to be as modular as possible, meaning there are a lot of different pieces
that all work together in order to execute the simulation. As different pieces of the code must
interact with each other, this effectively means that changes made in one part of the code base can
affect other parts of the code. This highlights the importance of keeping the code tested, which
I have done through writing tests for nearly every function found in the BLUES code base (also
called unit testing). When a change is made in one part of the code, the unit tests ensure that the
new changes haven’t affected anything other functions.
Travis-CI is a continuous integration service that is linked to GitHub; this allows for automatic
building and testing of the BLUES software package on a variety of platforms. When new code is
added to the public repository, Travis-CI gets triggered to build the software package and run the
unit tests. Building and testing for different platforms helps to ensure that the code will run on
the end users machine. When the software package is marked as a release candidate, the contin-
uous integration pipeline will upload the built packages onto Anaconda Cloud–a python package
management service that facilitates easy installation and trigger generating the documentation on
ReadTheDocs.
In summary, I have designed BLUES to utilize many of the features and services provided by GitHub
and Travis-CI to ensure the software abides by good software design principles. Hosting the BLUES
software package on GitHub makes it publicly available, version controlled and connects with the
Travis-CI service. The Travis-CI service provides automated building and testing of BLUES software
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package, making sure that future changes do not break the core functionality of the code base.
3.2.2 ReadTheDocs
ReadTheDocs is a website and service which provides automatic building, versioning, and hosting–
much like GitHub–except for the documentation. Documentation is critical for not only the code’s
longevity, but goes towards making the code more accessible and usable by others. Documen-
tation includes: (1) in-code docstrings which details how to use each module, class, and func-
tion ; (2) installation instructions; (3) usage examples and (4) guidelines for further development.
These rules for documentation were followed when writing the documentation for BLUES which is
available on ReadTheDocs. The following sections are excerpts from the BLUES documentation
which help to explain how to install the software (Sec. 3.3), use the software package (Sec. 3.4),
documentation on individual modules (Sec. 3.5), and design principles implemented in BLUES
(Sec. 3.6). The complete documentation can be found on ReadTheDocs ( https://mobleylab-
blues.readthedocs.io/en/master/).
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3.3 Installation
BLUES is compatible with MacOSX/Linux with Python>=3.6 (blues<1.1 still works with Python
2.7)
This is a python tool kit with a few dependencies. We recommend installing miniconda. Then you
can create an environment with the following commands:
conda create -n blues python=3.6
conda activate blues
Stable Releases
The recommended way to install BLUES would be to install from conda.
conda install -c mobleylab blues
Development Builds
Alternatively, you can install the latest development build. Development builds contain the latest
commits/PRs not yet issued in a point release.
conda install -c mobleylab/label/dev blues
In order to use the SideChainMove class you will need OpenEye Toolkits and some related tools.
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conda install -c openeye/label/Orion -c omnia oeommtools packmol
conda install -c openeye openeye-toolkits
Source Installation
Although we do NOT recommend it, you can also install directly from the source code.
git clone https://github.com/MobleyLab/blues.git
conda install -c omnia -c conda-forge openmmtools openmm numpy cython
pip install -e .
To validate your BLUES installation run the tests.
pip install -e .[tests]
pytest -v -s
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3.4 Usage
This package takes advantage of non-equilibrium candidate Monte Carlo moves (NCMC) to help
sample between different ligand binding modes using the OpenMM simulation package. One goal
for this package is to allow for easy additions of other moves of interest, which will be covered below.
The integrator from BLUES contains the framework necessary for NCMC. Specifically, the inte-
grator class calculates the work done during a NCMC move. It also controls the lambda scaling of
parameters. The integrator that BLUES uses inherits from openmmtools.integrators.Alchemica
lExternalLangevinIntegrator to keep track of the work done outside integration steps, allowing
Monte Carlo (MC) moves to be incorporated together with the NCMC thermodynamic perturbation
protocol. Currently, the openmmtools.alchemy package is used to generate the lambda parameters
for the ligand, allowing alchemical modification of the sterics and electrostatics of the system.
The BLUESSampler class in ncmc.py serves as a wrapper for running NCMC+MD simulations.
To run the hybrid simulation, the BLUESSampler class requires defining two moves for running
the (1) MD simulation and (2) the NCMC protcol. These moves are defined in the ncmc.py module.
A simple example is provided below.
Example
Using the BLUES framework requires the use of a ThermodynamicState and SamplerState
from openmmtools which we import from openmmtools.states:
from openmmtools.states import ThermodynamicState, SamplerState
from openmmtools.testsystems import TolueneVacuum
from blues.ncmc import *
from simtk import unit
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Create the states for a toluene molecule in vacuum.
tol = TolueneVacuum()
thermodynamic_state = ThermodynamicState(tol.system, temperature=300*unit.kelvin)
sampler_state = SamplerState(positions=tol.positions)
Define our langevin dynamics move for the MD simulation portion and then our NCMC move which
performs a random rotation. Here, we use a customized openmmtools.mcmc.LangevinDynamicsMo
ve which allows us to store information from the MD simulation portion.
dynamics_move = ReportLangevinDynamicsMove(n_steps=10)
ncmc_move = RandomLigandRotationMove(n_steps=10, atom_subset=list(range(15)))
Provide theBLUESSampler class with an openmm.Topology and these objects to run the NCMC+MD
simulation.
sampler = BLUESSampler(thermodynamic_state=thermodynamic_state,
sampler_state=sampler_state,
dynamics_move=dynamics_move,
ncmc_move=ncmc_move,
topology=tol.topology)
sampler.run(n_iterations=1)
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3.5 Modules
3.5.1 Nonequilibrium Candidate Monte Carlo (NCMC)
Provides moves and classes for running the BLUES simulation.
ReportLangevinDynamicsMove
class blues.ncmc.ReportLangevinDynamicsMove(n_steps=1000,
timestep=Quantity(value=2.0, unit=femtosecond),
collision_rate=Quantity(value=1.0, unit=/picosecond),
reassign_velocities=True, context_cache=None, reporters=[])
↪→
↪→
↪→
'''
Langevin dynamics segment as a (pseudo) Monte Carlo move.
This move class allows the attachment of a reporter for storing the data
from running this segment of dynamics.This move assigns a velocity from the
Maxwell-Boltzmann distribution and executes a number of Maxwell-Boltzmann
steps to propagate dynamics. This is not a true Monte Carlo move, in that
the generation of the correct distribution is only exact in the limit of
infinitely small timestep; in other words, the discretization error is
assumed to be negligible. Use HybridMonteCarloMove instead to ensure
the exact distribution is generated.
Warning: No Metropolization is used to ensure the correct phase space
distribution is sampled. This means that timestep-dependent errors will
remain uncorrected, and are amplified with larger timesteps.
Use this move at your own risk!
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'''
Parameters
• n_steps (int, optional) – The number of integration timesteps to take each time the
move is applied (default is 1000).
• timestep (simtk.unit.Quantity, optional) – The timestep to use for Langevin integration
(time units, default is 1*simtk.unit.femtosecond).
• collision_rate (simtk.unit.Quantity, optional) – The collision rate with fictitious bath
particles (1/time units, default is 10/simtk.unit.picoseconds).
• reassign_velocities (bool, optional) – If True, the velocities will be reassigned from
the Maxwell-Boltzmann distribution at the beginning of the move (default is False).
• context_cache (openmmtools.cache.ContextCache, optional) – The ContextCache to
use for Context creation. If None, the global context cache is used (default is None).
• reporters (list) – A list of the storage classes inteded for reporting the simulation data.
This can be either blues.storage.(NetCDF4Storage/BLUESStateDataStorage).
Methods
def apply(thermodynamic_state, sampler_state):
'''
Propagate the state through the integrator.
This updates the SamplerState after the integration.
'''
Parameters
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• thermodynamic_state (openmmtools.states.ThermodynamicState) – The ther-
modynamic state to use to propagate dynamics.
• sampler_state (openmmtools.states.SamplerState) – The sampler state to apply
the move to. This is modified.
Example
First we need to create the thermodynamic state and the sampler state to propagate. Here,
we create an alanine dipeptide system in vacuum.
from simtk import unit
from openmmtools import testsystems
from openmmtools.states import SamplerState, ThermodynamicState
test = testsystems.AlanineDipeptideVacuum()
sampler_state = SamplerState(positions=test.positions)
thermodynamic_state = ThermodynamicState(system=test.system,
temperature=298*unit.kelvin)↪→
Create reporters for storing our simulation data.
from blues.storage import NetCDF4Storage, BLUESStateDataStorage
nc_storage = NetCDF4Storage('test-md.nc',
reportInterval=5,
crds=True, vels=True, frcs=True)
state_storage = BLUESStateDataStorage('test.log',
reportInterval=5,
step=True, time=True,
potentialEnergy=True,
kineticEnergy=True,
totalEnergy=True,
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temperature=True,
volume=True,
density=True,
progress=True,
remainingTime=True,
speed=True,
elapsedTime=True,
systemMass=True,
totalSteps=10)
Create a Langevin move with default parameters
move = ReportLangevinDynamicsMove()
or create a Langevin move with specified parameters.
move = ReportLangevinDynamicsMove(timestep=0.5*unit.femtoseconds,
collision_rate=20.0/unit.picoseconds,
n_steps=10,↪→
reporters=[nc_storage, state_storage])
Perform one update of the sampler state. The sampler state is updated with the new state.
move.apply(thermodynamic_state, sampler_state)
np.allclose(sampler_state.positions, test.positions)
>>> False
The same move can be applied to a different state, here an ideal gas.
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test = testsystems.IdealGas()
sampler_state = SamplerState(positions=test.positions)
thermodynamic_state = ThermodynamicState(system=test.system,
temperature=298*unit.kelvin)
move.apply(thermodynamic_state, sampler_state)
np.allclose(sampler_state.positions, test.positions)
>>> False
NCMCMove
class blues.ncmc.NCMCMove(n_steps=1000, timestep=Quantity(value=2.0,
unit=femtosecond), atom_subset=None, context_cache=None, nprop=1,
propLambda=0.3, reporters=[])
↪→
↪→
'''
A general NCMC move that applies an alchemical integrator.
This class is intended to be inherited by NCMCMoves that need to
alchemically modify and perturb part of the system. The child class has
to implement the _propose_positions() method. Reporters can be attached
to report data from the NCMC part of the simulation.
You can decide to override _before_integration() and
_after_integration() to execute some code at specific points of the
workflow, for example to read data from the Context before the it is
destroyed.
'''
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Parameters
• n_steps (int, optional) – The number of integration timesteps to take each time the
move is applied (default is 1000).
• timestep (simtk.unit.Quantity, optional) – The timestep to use for Langevin integration
(time units, default is 1*simtk.unit.femtosecond).
• atom_subset (slice or list of int, optional) – If specified, the move is applied only to
those atoms specified by these indices. If None, the move is applied to all atoms (default
is None).
• context_cache (openmmtools.cache.ContextCache, optional) – The ContextCache to
use for Context creation. If None, the global context cache is used (default is None).
• reporters (list) – A list of the storage classes inteded for reporting the simulation data.
This can be either blues.storage.(NetCDF4Storage/BLUESStateDataStorage).
Methods
def apply(thermodynamic_state, sampler_state):
'''
Propagate the state through the integrator.
This updates the SamplerState after the integration.
'''
Parameters
• thermodynamic_state (openmmtools.states.ThermodynamicState) – The ther-
modynamic state to use to propagate dynamics.
• sampler_state (openmmtools.states.SamplerState) – The sampler state to apply
the move to. This is modified.
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RandomLigandRotationMove
class blues.ncmc.RandomLigandRotationMove(n_steps=1000,
timestep=Quantity(value=2.0, unit=femtosecond), atom_subset=None,
context_cache=None, nprop=1, propLambda=0.3, reporters=[])
↪→
↪→
'''
An NCMC move which proposes random rotations.
This class will propose a random rotation (as a rigid body) using the
center of mass of the selected atoms. This class does not metropolize
the proposed moves. Reporters can be attached to record the ncmc
simulation data, mostly useful for debugging by storing coordinates of
the proposed moves or monitoring the ncmc simulation progression by
attaching a state reporter.
'''
Parameters
• n_steps (int, optional) – The number of integration timesteps to take each time the
move is applied (default is 1000).
• timestep (simtk.unit.Quantity, optional) – The timestep to use for Langevin integration
(time units, default is 1*simtk.unit.femtosecond).
• atom_subset (slice or list of int, optional) – If specified, the move is applied only to
those atoms specified by these indices. If None, the move is applied to all atoms (default
is None).
• context_cache (openmmtools.cache.ContextCache, optional) – The ContextCache to
use for Context creation. If None, the global context cache is used (default is None).
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• reporters (list) – A list of the storage classes inteded for reporting the simulation data.
This can be either blues.storage.(NetCDF4Storage/BLUESStateDataStorage).
Methods
def apply(thermodynamic_state, sampler_state):
'''
Propagate the state through the integrator.
This updates the SamplerState after the integration.
'''
Parameters
• thermodynamic_state (openmmtools.states.ThermodynamicState) – The ther-
modynamic state to use to propagate dynamics.
• sampler_state (openmmtools.states.SamplerState) – The sampler state to apply
the move to. This is modified.
Example
First we need to create the thermodynamic state, alchemical thermodynamic state, and the
sampler state to propagate. Here we create a toy system of a charged ethylene molecule in
between two charged particles.
from simtk import unit
from openmmtools import testsystems, alchemy
from openmmtools.states import SamplerState, ThermodynamicState
from blues.systemfactories import generateAlchSystem
from blues import utils
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structure_pdb = utils.get_data_filename('blues',
'tests/data/ethylene_structure.pdb')↪→
structure = parmed.load_file(structure_pdb)
system_xml = utils.get_data_filename('blues',
'tests/data/ethylene_system.xml')↪→
with open(system_xml, 'r') as infile:
xml = infile.read()
system = openmm.XmlSerializer.deserialize(xml)
thermodynamic_state = ThermodynamicState(system=system,
temperature=200*unit.kelvin)↪→
sampler_state =
SamplerState(positions=structure.positions.in_units_of(unit.nanometers))↪→
alchemical_atoms = [2, 3, 4, 5, 6, 7]
alch_system = generateAlchSystem(thermodynamic_state.get_system(),
alchemical_atoms)↪→
alch_state = alchemy.AlchemicalState.from_system(alch_system)
alch_thermodynamic_state = ThermodynamicState(
alch_system, thermodynamic_state.temperature)
alch_thermodynamic_state = CompoundThermodynamicState(
alch_thermodynamic_state, composable_states=[alch_state])
Create reporters for storing our ncmc simulation data.
from blues.storage import NetCDF4Storage, BLUESStateDataStorage
nc_storage = NetCDF4Storage('test-ncmc.nc',
reportInterval=5,
crds=True, vels=True, frcs=True,
protocolWork=True, alchemicalLambda=True)
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state_storage = BLUESStateDataStorage('test-ncmc.log',
reportInterval=5,
step=True, time=True,
potentialEnergy=True,
kineticEnergy=True,
totalEnergy=True,
temperature=True,
volume=True,
density=True,
progress=True,
remainingTime=True,
speed=True,
elapsedTime=True,
systemMass=True,
totalSteps=10,
protocolWork=True,
alchemicalLambda=True)
Create a RandomLigandRotationMove move
rot_move = RandomLigandRotationMove(n_steps=5,
timestep=1*unit.femtoseconds,
atom_subset=alchemical_atoms,
reporters=[nc_storage,
state_storage])↪→
Perform one update of the sampler state. The sampler state is updated with the new state.
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move.apply(thermodynamic_state, sampler_state)
np.allclose(sampler_state.positions, structure.positions)
BLUESSampler
class blues.ncmc.BLUESSampler(thermodynamic_state=None,
alch_thermodynamic_state=None, sampler_state=None, dynamics_move=None,
ncmc_move=None, topology=None)
↪→
↪→
'''
BLUESSampler runs the NCMC+MD hybrid simulation.
This class ties together the two moves classes to execute the NCMC+MD
hybrid simulation. One move class is intended to carry out traditional
MD and the other is intended carry out the NCMC move proposals which
performs the alchemical transformation to given atom subset. This class
handles proper metropolization of the NCMC move proposals, while
correcting for the switch in integrators.
'''
Methods
def equil(n_iterations=1):
'''
Equilibrate the system for N iterations
'''
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def run(n_iterations=1):
'''
Run the sampler for the specified number of iterations.
'''
3.5.2 SystemFactory
SystemFactory contains methods to generate/modify the OpenMM System object.
def blues.systemfactory.generateAlchSystem(system, atom_indices,
softcore_alpha=0.5, softcore_a=1, softcore_b=1, softcore_c=6,
softcore_beta=0.0, softcore_d=1, softcore_e=1, softcore_f=2,
annihilate_electrostatics=True, annihilate_sterics=False,
disable_alchemical_dispersion_correction=True,
alchemical_pme_treatment='direct-space', suppress_warnings=True,
**kwargs)
↪→
↪→
↪→
↪→
↪→
↪→
'''
Return the OpenMM System for alchemical perturbations.
This function calls openmmtools.alchemy.AbsoluteAlchemicalFactory and
openmmtools.alchemy.AlchemicalRegion to generate the System for the
NCMC simulation.
'''
Parameters
• system (openmm.System) – The OpenMM System object corresponding to the
reference system.
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• atom_indices (list of int) – Atom indicies of the move or designated for which
the nonbonded forces (both sterics and electrostatics components) have to be al-
chemically modified.
• annihilate_electrostatics (bool, optional) – If True, electrostatics should be an-
nihilated, rather than decoupled (default is True).
• annihilate_sterics (bool, optional) – If True, sterics (Lennard-Jones or Halgren
potential) will be annihilated, rather than decoupled (default is False).
• softcore_alpha (float, optional) – Alchemical softcore parameter for Lennard-
Jones (default is 0.5).
• softcore_a, softcore_b, softcore_c (float, optional) – Parameters modifying
softcore Lennard-Jones form. Introduced in Eq. 13 of Ref. [TTPham-JChemPhys135-
2011] (default is 1).
• softcore_beta (float, optional) – Alchemical softcore parameter for electrostatics.
Set this to zero to recover standard electrostatic scaling (default is 0.0).
• softcore_d, softcore_e, softcore_f (float, optional) – Parameters modifying
softcore electrostatics form (default is 1).
• disable_alchemical_dispersion_correction (bool, optional, default=True) –
If True, the long-range dispersion correction will not be included for the alchemical
region to avoid the need to recompute the correction (a CPU operation that takes
~ 0.5 s) every time ‘lambda_sterics’ is changed. If using nonequilibrium protocols,
it is recommended that this be set to True since this can lead to enormous (100x)
slowdowns if the correction must be recomputed every time step.
• alchemical_pme_treatment (str, optional, default = ‘direct-space’ ) – Controls
how alchemical region electrostatics are treated when PME is used. Options are
‘direct-space’, ‘coulomb’, ‘exact’. - ‘direct-space’ only models the direct space con-
tribution - ‘coulomb’ includes switched Coulomb interaction - ‘exact’ includes also
the reciprocal space contribution, but it’s only possible to annihilate the charges
and the softcore parameters controlling the electrostatics are deactivated. Also,
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with this method, modifying the global variable lambda_electrostatics is not suffi-
cient to control the charges. The recommended way to change them is through the
AlchemicalState class.
Returns
• alch_system (alchemical_system) – System to be used for the NCMC simulation.
def blues.systemfactory.zero_masses(system, atomList=None)
'''Zeroes the masses of specified atoms to constrain certain degrees of
freedom. '''↪→
Parameters
• system (openmm.System) – system to zero masses
• atomList (list of ints) – atom indicies to zero masses
Returns
• system (openmm.System) – The modified system with massless atoms.
def blues.systemfactory.restrain_positions(structure, system,
selection='(@CA, C, N)', weight=5.0, **kwargs)↪→
'''Apply positional restraints to atoms in the openmm.System by the given
parmed selection.'''↪→
Parameters
• system (openmm.System) – The OpenMM System object to be modified.
• structure (parmed.Structure()) – Structure of the system, used for atom selection.
• selection (str, Default = “(@CA,C,N)”) – AmberMask selection to apply positional
restraints to
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• weight (float, Default = 5.0 ) – Restraint weight for xyz atom restraints in kcal/(mol
Aˆ2)
Returns
• system (openmm.System) – Modified with positional restraints applied.
def blues.systemfactory.freeze_atoms(structure, system,
freeze_selection=':LIG', **kwargs)↪→
'''Zero the masses of atoms from the given parmed selection.
Massless atoms will be ignored by the integrator and will not change
positions.
'''
Parameters
• system (openmm.System) – The OpenMM System object to be modified.
• structure (parmed.Structure()) – Structure of the system, used for atom selection.
• freeze_selection (str, Default = “:LIG”) – AmberMask selection for the center
in which to select atoms for zeroing their masses. Defaults to freezing protein
backbone atoms.
Returns
• system (openmm.System) – The modified system with the selected atoms
def blues.systemfactory.freeze_radius(structure, system,
freeze_distance=Quantity(value=5.0, unit=angstrom),
freeze_center=':LIG', freeze_solvent=':HOH, NA, CL', **kwargs)
↪→
↪→
'''
Zero the masses of atoms outside the given raidus of the freeze_center
parmed selection.
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Massless atoms will be ignored by the integrator and will not change
positions. This is intended to freeze the solvent and protein atoms
around the ligand binding site.
'''
Parameters
• system (openmm.System) – The OpenMM System object to be modified.
• structure (parmed.Structure()) – Structure of the system, used for atom selection.
• freeze_distance (float, Default = 5.0 ) – Distance (angstroms) to select atoms for
retaining their masses. Atoms outside the set distance will have their masses set to
0.0.
• freeze_center (str, Default = “:LIG”) – AmberMask selection for the center in
which to select atoms for zeroing their masses. Default: LIG
• freeze_solvent (str, Default = “:HOH,NA,CL”) – AmberMask selection in which
to select solvent atoms for zeroing their masses.
Returns
• system (openmm.System) – Modified system with masses outside the freeze center
zeroed.
def blues.systemfactory.addBarostat(system, temperature=Quantity(value=300,
unit=kelvin), pressure=Quantity(value=1, unit=atmosphere), frequency=25,
**kwargs)
↪→
↪→
'''Add a MonteCarloBarostat to the MD system.'''
Parameters
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• system (openmm.System) – The OpenMM System object corresponding to the
reference system.
• temperature (float, default=300 ) – temperature (Kelvin) to be simulated at.
• pressure (int, configional, default=None) – Pressure (atm) for Barostat for NPT
simulations.
• frequency (int, default=25 ) – Frequency at which Monte Carlo pressure changes
should be attempted (in time steps)
Returns
• system (openmm.System) – The OpenMM System with the MonteCarloBarostat
attached.
3.5.3 Integrators
class blues.integrators.AlchemicalExternalLangevinIntegrator(
alchemical_functions, splitting='R V O H O V R',
temperature=Quantity(value=298.0, unit=kelvin),
collision_rate=Quantity(value=1.0, unit=/picosecond),
timestep=Quantity(value=1.0, unit=femtosecond),
constraint_tolerance=1e-08, measure_shadow_work=False,
measure_heat=True, nsteps_neq=100, nprop=1, propLambda=0.3,
*args, **kwargs)
'''
Allows nonequilibrium switching based on force parameters specified in
alchemical\_functions. A variable named lambda is switched from 0 to 1
linearly throughout the nsteps of the protocol. The functions can use
this to create more complex protocols for other global parameters.
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As opposed to
openmmtools.integrators.AlchemicalNonequilibriumLangevinIntegrator,
which this inherits from, the AlchemicalExternalLangevinIntegrator
integrator also takes into account work done outside the
nonequilibrium switching portion(between integration steps).
For example if a molecule is rotated between integration steps,
this integrator would correctly account for the work caused by
that rotation.
Propagator is based on Langevin splitting, as described below. One way
to divide the Langevin system is into three parts which can each be
solved ``exactly:''
'''
Parameters
• alchemical_functions (dict of strings) – key: value pairs such as “global_parameter”
: function_of_lambda where function_of_lambda is a Lepton-compatible string
that depends on the variable “lambda”
• splitting (string, default: “H V R O V R H”) – Sequence of R, V, O (and optionally
V{i}), and { }substeps to be executed each timestep. There is also an H option,
which increments the global parameter lambda by 1/nsteps_neq for each step.
Forces are only used in V-step. Handle multiple force groups by appending the
force group index to V-steps, e.g. “V0” will only use forces from force group 0.
“V” will perform a step using all forces.( will cause metropolization, and must be
followed later by a ).
• temperature (unit.Quantity, default: 298.0*simtk.unit.kelvin) – Fictitious “bath”
temperature
• collision_rate (unit.Quantity, default: 1.0/picoseconds) – Collision rate
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• timestep (unit.Quantity, default: 1.0*femtoseconds) – Integration timestep
• constraint_tolerance (float, default: 1.0e-8 ) – Tolerance for constraint solver
• measure_shadow_work (boolean, default: False) – Accumulate the shadow
work performed by the symplectic substeps, in the global shadow_work
• measure_heat (boolean, default: True) – Accumulate the heat exchanged with
the bath in each step, in the global heat
• nsteps_neq (int, default: 100 ) – Number of steps in nonequilibrium protocol.
Default 100
• prop_lambda (float (Default = 0.3)) – Defines the region in which to add extra
propagation steps during the NCMC simulation from the midpoint 0.5. i.e. A value
of 0.3 will add extra steps from lambda 0.2 to 0.8.
• nprop (int (Default: 1)) – Controls the number of propagation steps to add in the
lambda region defined by prop_lambda.
Splitting Parameters
• R: Linear “drift” / Constrained “drift” Deterministic update of positions, us-
ing current velocities x\\textless-\x\+\v\dt
• V: Linear “kick” / Constrained “kick” Deterministic update of velocities, us-
ing current forces v\\textless-\v\+\(f/m)\dt; where f = force, m = mass
• O: Ornstein-Uhlenbeck Stochastic update of velocities, simulating interaction
with a heat bath v\\textless-\av\+\b\sqrt(kT/m)\R where:
– a = eˆ(-gamma dt)
– b = sqrt(1 - eˆ(-2gamma dt))
– R is i.i.d. standard normal
• Example
– g-BAOAB: splitting=”R V O H O V R”
– VVVR splitting=”O V R H R V O”
– VV splitting=”V R H R V”
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– An NCMC algorithm with Metropolized integrator: splitting=”O { V
R H R V } O”
We can then construct integrators by solving each part for a certain timestep in se-
quence. (We can further split up the V step by force group, evaluating cheap but
fast-fluctuating forces more frequently than expensive but slow-fluctuating forces. Since
forces are only evaluated in the V step, we represent this by including in our “alphabet”
V0, V1, . . . ) When the system contains holonomic constraints, these steps are confined
to the constraint manifold.
References
[Nilmeier, et al. 2011] Nonequilibrium candidate Monte Carlo is an efficient tool for equilib-
rium simulation
[Leimkuhler and Matthews, 2015] Molecular dynamics: with deterministic and stochastic
numerical methods, Chapter 7
Methods
def reset():
'''Manually reset protocol work and other statistics.'''
3.5.4 Utilities
Provides a host of utility functions for the BLUES engine.
def blues.utils.amber_selection_to_atomidx(structure, selection)
'''Converts AmberMask selection to list of atom indices.'''
Parameters
81
• structure (parmed.Structure()) – Structure of the system, used for atom selection.
• selection (str) – AmberMask selection that gets converted to a list of atom indices.
Returns
• mask_idx (list of int) – List of atom indices.
def blues.utils.check_amber_selection(structure, selection)
'''
Given an AmberMask selection (str) for selecting atoms to freeze or
restrain, check if it will actually select atoms. If the selection
produces None, suggest valid residues or atoms.
'''
Parameters
• structure (parmed.Structure) – The structure of the simulated system
• selection (str) – The selection string uses Amber selection syntax to select atoms
to be restrained/frozen during simulation.
• logger (logging.Logger) – Records information or streams to terminal.
def blues.utils.atomidx_to_atomlist(structure, mask_idx)
'''Goes through the structure and matches the previously
selected atom indices to the atom type.'''
Parameters
• structure (parmed.Structure()) – Structure of the system, used for atom selection.
• mask_idx (list of int) – List of atom indices.
Returns
• atom_list (list of atoms) – The atoms that were previously selected in mask_idx.
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def blues.utils.parse_unit_quantity(unit_quantity_str)
'''Utility for parsing parameters from the YAML file that require units. '''
Parameters
• unit_quantity_str (str) – A string specifying a quantity and it’s units. i.e.
‘3.024 * daltons’
Returns
• unit_quantity (simtk.unit.Quantity) – i.e unit.Quantity(3.024, unit=dalton)
def blues.utils.atomIndexfromTop(resname, topology)
'''Get atom indices of a ligand from OpenMM Topology.'''
Parameters
• resname (str) – resname that you want to get the atom indicies for (ex. ‘LIG’)
• topology (str, optional, default=None) – path of topology file. Include if the
topology is not included in the coord_file
Returns
• lig_atoms (list of ints) – list of atoms in the coordinate file matching lig_resname
def blues.utils.getMasses(atom_subset, topology)
'''Returns a list of masses of the specified ligand atoms.'''
Parameters topology (parmed.Topology) – ParmEd topology object containing atoms of
the system.
Returns
• masses (1xn numpy.array * simtk.unit.dalton) – array of masses of len(self.atom_indices),
denoting the masses of the atoms in self.atom_indices
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• totalmass (float * simtk.unit.dalton) – The sum of the mass found in masses
def blues.utils.getCenterOfMass(positions, masses)
'''Returns the calculated center of mass of the ligand as a numpy.array'''
Parameters
• positions (nx3 numpy array * nanometers) – ParmEd positions of the atoms to
be moved.
• masses (numpy.array) – numpy.array of particle masses
Returns
• center_of_mass (numpy array * unit.nanometers) – 1x3 numpy.array of the
center of mass of the given positions
def blues.utils.saveContextFrame(context, topology, outfname)
'''Extracts a ParmEd structure and writes the frame given an OpenMM Simulation.'''
Parameters
• simulation (openmm.Simulation) – The OpenMM Simulation to write a frame
from.
• outfname (str) – The output file name to save the simulation frame from. Sup-
ported extensions:
– PDB (.pdb, pdb)
– PDBx/mmCIF (.cif, cif)
– PQR (.pqr, pqr)
– Amber topology file (.prmtop/.parm7, amber)
– CHARMM PSF file (.psf, psf)
– CHARMM coordinate file (.crd, charmmcrd)
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– Gromacs topology file (.top, gromacs)
– Gromacs GRO file (.gro, gro)
– Mol2 file (.mol2, mol2)
– Mol3 file (.mol3, mol3)
– Amber ASCII restart (.rst7/.inpcrd/.restrt, rst7)
– Amber NetCDF restart (.ncrst, ncrst)
def blues.utils.print_host_info(context)
'''Prints hardware related information for the openmm.Simulation'''
Parameters
simulation (openmm.Simulation) – The OpenMM Simulation to write a frame from.
def blues.utils.get_data_filename(package_root, relative_path)
'''
Get the full path to one of the reference files in testsystems. In the
source distribution, these files are in \texttt{blues/data/}, but on
installation, they're moved to somewhere in the user's python
site-packages directory. Adapted from:
https://github.com/open-forcefield-group/smarty/blob/master/smarty/utils.py
'''
Parameters
• package_root (str) – Name of the included/installed python package
• relative_path (str) – Path to the file within the python package
Returns
• fn (str) – Full path to file
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3.5.5 Storage
Provides classes and methods for storing simulation data.
def blues.storage.setup_logging(filename=None, yml_path='logging.yml',
default_level=20, env_key='LOG_CFG')↪→
'''Setup logging configuration.'''
def blues.storage.addLoggingLevel(levelName, levelNum, methodName=None)
'''
Comprehensively adds a new logging level to the logging module and the
currently configured logging class.
levelName becomes an attribute of the logging module with the value
levelNum. methodName becomes a convenience method for both logging
itself and the class returned by logging.getLoggerClass()
(usually just logging.Logger). If methodName is not specified,
levelName.lower() is used.
To avoid accidental clobberings of existing attributes, this method
will raise an AttributeError if the level name is already an
attribute of the logging module or if the method name is
already present
'''
Parameters
• levelName (str) – The new level name to be added to the logging module.
• levelNum (int) – The level number indicated for the logging module.
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• methodName (str, default=None) – The method to call on the logging module for
the new level name. For example if provided ‘trace’, you would call logging.trace().
Example
addLoggingLevel('TRACE', logging.DEBUG - 5)
logging.getLogger(__name__).setLevel("TRACE")
logging.getLogger(__name__).trace('that worked')
logging.trace('so did this')
logging.TRACE
>>> 5
def blues.storage.init_logger(logger, level=20, stream=True,
outfname='blues-20190618-121319')↪→
'''
Initialize the Logger module with the given logger_level and outfname.
'''
Parameters
• logger (logging.getLogger()) – The root logger object if it has been created already.
• level (logging.<LEVEL>) – Valid options for <LEVEL> would be DEBUG, INFO,
warningING, ERROR, CRITICAL.
• stream (bool, default = True) – If True, the logger will also stream information to
sys.stdout as well as the output file.
• outfname (str, default = time.strftime(“blues-%Y%m%d-%H%M%S”)) – The out-
put file path prefix to store the logged data. This will always write to a file with
the extension .log.
Returns
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• logger (logging.getLogger()) – The logging object with additional Handlers added.
class blues.storage.NetCDF4Storage(file, reportInterval=1, frame_indices=[],
crds=True, vels=False, frcs=False, protocolWork=False,
alchemicalLambda=False)
↪→
↪→
'''
Class to read or write NetCDF trajectory files.
Inherited from parmed.openmm.reporters.NetCDFReporter
'''
Parameters
• file (str) – Name of the file to write the trajectory to
• reportInterval (int) – How frequently to write a frame to the trajectory
• frame_indices (list, frame numbers for writing the trajectory) – If this reporter is
used for the NCMC simulation, 0.5 will report at the moveStep and -1 will record
at the last frame.
• crds (bool=True) – Should we write coordinates to this trajectory? (Default True)
• vels (bool=False) – Should we write velocities to this trajectory? (Default False)
• frcs (bool=False) – Should we write forces to this trajectory? (Default False)
• protocolWork (bool=False,) – Write the protocolWork for the alchemical process
in the NCMC simulation
• alchemicalLambda (bool=False,) – Write the alchemicalLambda step for the al-
chemical process in the NCMC simulation.
Methods
def describeNextReport(context_state)
'''
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Get information about the next report this object will generate.
'''
Parameters context_state (|openmm.State|) – The current state of the context
Returns
• nsteps, pos, vel, frc, ene (int, bool, bool, bool, bool) – nsteps is the number
of steps until the next report pos, vel, frc, and ene are flags indicating whether
positions, velocities, forces, and/or energies are needed from the Context
def report(context_state, integrator)
'''Generate a report.'''
Parameters
• context_state (|openmm.State|) – The current state of the context
• integrator (|openmm.Integrator|) – The integrator belonging to the given con-
text
class blues.storage.BLUESStateDataStorage(file=None, reportInterval=1,
frame_indices=[], title='', step=False, time=False,
potentialEnergy=False, kineticEnergy=False, totalEnergy=False,
temperature=False, volume=False, density=False, progress=False,
remainingTime=False, speed=False, elapsedTime=False, separator='t',
systemMass=None, totalSteps=None, protocolWork=False,
alchemicalLambda=False, currentIter=False)
↪→
↪→
↪→
↪→
↪→
↪→
'''
StateDataReporter outputs information about a simulation, such as
energy and temperature, to a file. To use it, create a
StateDataReporter, then add it to the Simulation's list of reporters.
The set of data to write is configurable using boolean flags passed to
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the constructor. By default the data is written in
comma-separated-value (CSV) format, but you can specify a different
separator to use. Inherited from openmm.app.StateDataReporter
'''
Parameters
• file (string or file) – The file to write to, specified as a file name or file-like object
(Logger)
• reportInterval (int) – The interval (in time steps) at which to write frames
• frame_indices (list, frame numbers for writing the trajectory)
• title (str,) – Text prefix for each line of the report. Used to distinguish between
the NCMC and MD simulation reports.
• step (bool=False) – Whether to write the current step index to the file
• time (bool=False) – Whether to write the current time to the file
• potentialEnergy (bool=False) – Whether to write the potential energy to the file
• kineticEnergy (bool=False) – Whether to write the kinetic energy to the file
• totalEnergy (bool=False) – Whether to write the total energy to the file
• temperature (bool=False) – Whether to write the instantaneous temperature to
the file
• volume (bool=False) – Whether to write the periodic box volume to the file
• density (bool=False) – Whether to write the system density to the file
• progress (bool=False) – Whether to write current progress (percent completion)
to the file. If this is True, you must also specify totalSteps.
• remainingTime (bool=False) – Whether to write an estimate of the remaining
clock time until completion to the file. If this is True, you must also specify total-
Steps.
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• speed (bool=False) – Whether to write an estimate of the simulation speed in
ns/day to the file
• elapsedTime (bool=False) – Whether to write the elapsed time of the simulation
in seconds to the file.
• separator (string=’,’ ) – The separator to use between columns in the file
• systemMass (mass=None) – The total mass to use for the system when reporting
density. If this is None (the default), the system mass is computed by summing
the masses of all particles. This parameter is useful when the particle masses do
not reflect their actual physical mass, such as when some particles have had their
masses set to 0 to immobilize them.
• totalSteps (int=None) – The total number of steps that will be included in the
simulation. This is required if either progress or remainingTime is set to True, and
defines how many steps will indicate 100% completion.
• protocolWork (bool=False,) – Write the protocolWork for the alchemical process
in the NCMC simulation
• alchemicalLambda (bool=False,) – Write the alchemicalLambda step for the al-
chemical process in the NCMC simulation.
Methods
def describeNextReport(context_state)
'''
Get information about the next report this object will generate.
'''
Parameters context_state (|openmm.State|) – The current state of the context
Returns nsteps, pos, vel, frc, ene (int, bool, bool, bool, bool) – nsteps is the number
of steps until the next report pos, vel, frc, and ene are flags indicating whether
positions, velocities, forces, and/or energies are needed from the Context
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def report(context_state, integrator)
'''Generate a report.'''
Parameters
• context_state (|openmm.State|) – The current state of the context
• integrator (|openmm.Integrator|) – The integrator belonging to the given con-
text
3.5.6 Formats
Provides the classes for storage formatting.
class blues.formats.LoggerFormatter
'''
Formats the output of the logger.Logger object. Allows
customization for customized logging levels. This will add
a custom level `REPORT' to all custom BLUES reporters from
the blues.reporters module.
'''
Examples
Below we add a custom level ‘REPORT’ and have the logger module stream the mes-
sage to sys.stdout without any additional information to our custom reporters from the
blues.reporters module
from blues import reporters
from blues.formats import LoggerFormatter
import logging, sys
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logger = logging.getLogger(__name__)
reporters.addLoggingLevel('REPORT', logging.WARNING - 5)
fmt = LoggerFormatter(fmt="%(message)s")
stdout_handler = logging.StreamHandler(stream=sys.stdout)
stdout_handler.setFormatter(fmt)
logger.addHandler(stdout_handler)
logger.report('This is a REPORT call')
>>> This is a REPORT call
ogger.info('This is an INFO call')
>>> INFO: This is an INFO call
def format(record)
'''Format the specified record as text.
The record's attribute dictionary is used as the operand to a string
formatting operation which yields the returned string. Before formatting
the dictionary, a couple of preparatory steps are carried out. The
message attribute of the record is computed using
LogRecord.getMessage(). If the formatting string uses the time (as
determined by a call to usesTime(), formatTime() is called to format the
event time. If there is exception information, it is formatted using
formatException() and appended to the message.
'''
class blues.formats.NetCDF4Traj(fname, mode='r')
'''
Extension of parmed.amber.netcdffiles.NetCDFTraj to allow proper file
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flushing. Requires the netcdf4 library (not scipy), install with conda
install -c conda-forge netcdf4.
'''
Parameters
• fname (str) – File name for the trajectory file
• mode (str, default=’r’ ) – The mode to open the file in.
Methods
def flush()
'''Flush buffered data to disc.'''
classmethod open_new(fname, natom, box, crds=True, vels=False,
frcs=False, remd=None, remd_dimension=None, title='',
protocolWork=False, alchemicalLambda=False)
↪→
↪→
'''Opens a new NetCDF file and sets the attributes'''
Parameters
• fname (str) – Name of the new file to open (overwritten)
• natom (int) – Number of atoms in the restart
• box (bool) – Indicates if cell lengths and angles are written to the NetCDF file
• crds (bool, default=True) – Indicates if coordinates are written to the NetCDF
file
• vels (bool, default=False) – Indicates if velocities are written to the NetCDF
file
• frcs (bool, default=False) – Indicates if forces are written to the NetCDF file
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• remd (str, default=None) – ‘T[emperature]’ if replica temperature is written
‘M[ulti]’ if Multi-D REMD information is written None if no REMD information
is written
• remd_dimension (int, default=None) – If remd above is ‘M[ulti]’, this is how
many REMD dimensions exist
• title (str, default=’‘ ) – The title of the NetCDF trajectory file
• protocolWork (bool, default=False) – Indicates if protocolWork from the
NCMC simulation should be written to the NetCDF file
• alchemicalLambda (bool, default=False) – Indicates if alchemicalLambda
from the NCMC simulation should be written to the NetCDF file
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3.6 Developer Guide
3.6.1 UML Diagram
3.6.2 OpenMMTools Objects
Highlighted in red are 3 objects that we use from the openmmtools library. They are the Ther-
modynamicState, CompoundThermodynamicState, and SamplerState objects. For more
details of each class, please see the official openmmtools documentation.
Briefly, the ThermodynamicState class represents the portion of the state of an openmm.Cont
ext that does not change with integration (i.e. particles, temperature, or pressure). The Com-
poundThermodynamicState class is essentially the same as the ThermodynamicState class
except in this package, it is used for the handling the openmmtools.alchemy.AlchemicalState
object. Thus, in order to create the CompoundThermodynamicState, one needs to first create
the plain ThermodynamicState object first. If a CompoundThermodynamicState object is
not provided to the blues.ncmc.BLUESSampler class, one is created using the default parameters
from the given ThermodynamicState. Lastly, the SamplerState class represents the state of
an openmm.Context which does change with integration (i.e positions, velocities, and box_vectors).
Within the context of this package, the SamplerState is used to sync information between the
MD and NCMC simulations.
3.6.3 Integrators and Moves
Integrators
Integrators are the lowest level openmm objects this package interacts with, where each integrator
is tied to an openmm.Context that it advances. Each integrator is generated by using the embedded
function _get_integrator() function within each move class. The integrators will control whether
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Figure 3.1: BLUES UML Diagram provides an overview of the class objects involved in the
BLUES protocol. Each class object is detailed with the attributes and methods belonging
to each object.
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we are carrying out the Non-equilibrium Candidate Monte Carlo (NCMC) or Molecular Dynamics
(MD) simulation.
Every move class has 3 hidden methods: _get_integrator() for generating the integrator of each
move class, _before_integration() for performing any necessary setup before integration, and af
ter_integration for performing any cleanup or data collection after integration. Every move class
also contains the apply() method which carries out calls to the 3 hidden methods and stepping
with the integrator.
In this package, we provide the move class blues.ncmc.ReportLangevinDynamicsMove to execute
the MD simulation. As the name suggests, this will carry forward the MD simulation using Langevin
dynamics, by generating an openmm.LangevinIntegrator. This class is essentially the same as the
openmmtools.LangevinDynamicsMove but with modifications to the apply() method which allows
storing simulation data for the MD simulation.
For running the NCMC simulation, we provide a custom integrator blues.integrator.Alchemic
alExternalLangevinIntegrator. This integrator is generated in every move which inherits from
the base class blues.ncmc.NCMCMove. Every class which inherits from the base move class must
override the _propose_positions() method. If necessary, one can override the _before_integr
ation() and _after_integration() methods for any necessary setup and cleanup. Again, these
hidden methods will be called when a call is made to the apply() method from the move class.
Moves
In order to implement custom NCMC moves, inherit from the base class and override the _propos
e_positions() method. This method is expected to take in a positions array of the atoms to be
modified and returns the proposed positions. In pseudo-code, it would look something like:
from blues.ncmc import NCMCMove
class CustomNCMCMove(NCMCMove):
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def _propose_positions(positions):
"""Add 1 nanometer displacement vector."""
positions_unit = positions.unit
unitless_displacement = 1.0 / positions_unit
displacement_vector = unit.Quantity(np.random.randn(3) *
unitless_displacement_sigma, positions_unit)↪→
proposed_positions = positions + displacement_vector
return proposed_positions
In this package, we provide the blues.ncmc.RandomLigandRotationMove in order to propose a
random ligand rotation about the center of mass. This class overrides the _before_integration()
method for obtaining the masses of the ligand and overrides the _propose_positions() function for
generating the rotated coordinates. Updating the context with the rotated coordinates is handled
when the apply() method is called in the move class. Code snippet of the class is shown below:
from blues.ncmc import RandomLigandRotationMove
class RandomLigandRotationMove(NCMCMove):
def _before_integration(self, context, thermodynamic_state):
"""Obtain the masses of the ligand before integration."""
super(RandomLigandRotationMove, self)._before_integration(context,
thermodynamic_state)↪→
masses, totalmass = utils.getMasses(self.atom_subset,
thermodynamic_state.topology)↪→
self.masses = masses
def _propose_positions(self, positions):
# Calculate the center of mass
center_of_mass = utils.getCenterOfMass(positions, self.masses)
reduced_pos = positions - center_of_mass
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# Define random rotational move on the ligand
rand_quat = mdtraj.utils.uniform_quaternion(size=None)
rand_rotation_matrix =
mdtraj.utils.rotation_matrix_from_quaternion(rand_quat)↪→
# multiply lig coordinates by rot matrix and add back COM translation from
origin↪→
proposed_positions = numpy.dot(reduced_pos, rand_rotation_matrix) *
positions.unit + center_of_mass↪→
return proposed_positions
Since BLUES (v0.2.5) the API has been re-written to be more compatible with the openmmtools
API. This means one can turn a regular Markov Chain Monte Carlo (MCMC) move from the open
mmtools library into an NCMC move to be used in this package. In this case, one simply needs to
make use of dual inheritance, using the blues.ncmc.NCMCMove that we provide and override the _
get_integrator() method to generate the NCMC integrator we provide, i.e. blues.integrator.
AlchemicalExternalLangevinIntegrator. When using dual inheritance, it is important that you
first inherit the desired MCMC move and then the blues.ncmc.NCMCMove class. For example, if we
wanted to take theopenmmtools.mcmc.MCDisplacementMove class and turn it into an NCMC move,
it would look like:
from blues.ncmc import NCMCMove
from openmmtools.mcmc import MCDisplacementMove
class NCMCDisplacementMove(MCDisplacementMove, NCMCMove):
def _get_integrator(self, thermodynamic_state):
return NCMCMove._get_integrator(self,thermodynamic_state)
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3.6.4 BLUESSampler
The blues.ncmc.BLUESSampler object ties together all the previously mentioned state objects and
the two move classes for running the NCMC+MD simulation. Details of the parameters for this
class are listed in the module_doc documentation. For a more detailed example of it’s usage see the
usage documentation. To be explicit, the input parameters refer to the objects below:
• thermodynamic_state : openmmtools.states.ThermodynamicState
• alch_thermodynamic_state : openmmtools.states.CompoundThermodynamicState
• sampler_state : openmmtools.states.SamplerState
• dynamics_move : blues.ncmc.ReportLangevinDynamicsMove
• ncmc_move : blues.ncmc.RandomLigandRotationMove
• topology : openmm.Topology
When the run() method in the blues.ncmc.BLUESSampler is called the following takes place:
• Initialization: – _print_host_info() : Information print out of host
– _printSimulationTiming() : Calculation of total number of steps
– equil() : Equilibration
• BLUES iterations: – ncmc_move.apply() : NCMC simulation
– _acceptRejectMove() : Metropolization
– dynamics_move.apply() : MD Simulation
A code snippet of the run() method is shown below:
def run(self, n_iterations=1):
context, integrator =
cache.global_context_cache.get_context(self.thermodynamic_state)↪→
utils.print_host_info(context)
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self._printSimulationTiming(n_iterations)
if self.iteration == 0:
self.equil(1)
self.iteration = 0
for iteration in range(n_iterations):
self.ncmc_move.apply(self.alch_thermodynamic_state, self.sampler_state)
self._acceptRejectMove()
self.dynamics_move.apply(self.thermodynamic_state, self.sampler_state)
self.iteration += 1
Initialization
The first thing that occurs when run() is called is the initialization stage. During this stage, a
call is made to utils.print_host_info() and the _printSimulationTiming() method which will
print out some information about the host machine , the total number of force evaluations, and
simulation time. The output will look something like below:
OpenMM(7.3.1.dev-4a269c0) Context generated for CUDA platform
system = Linux
node = titanpascal
release = 4.15.0-50-generic
version = #54~16.04.1-Ubuntu SMP Wed May 8 15:55:19 UTC 2019
machine = x86_64
processor = x86_64
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DeviceIndex = 0
DeviceName = TITAN Xp
UseBlockingSync = true
Precision = single
UseCpuPme = false
CudaCompiler = /usr/local/cuda-9.2/bin/nvcc
TempDirectory = /tmp
CudaHostCompiler =
DisablePmeStream = false
DeterministicForces = false
Total BLUES Simulation Time = 4.0 ps (0.04 ps/Iter)
Total Force Evaluations = 4000
Total NCMC time = 2.0 ps (0.02 ps/iter)
Total MD time = 2.0 ps (0.02 ps/iter)
In the blues.ncmc.BLUESSampler class, there is an equil() method which lets you run iterations of
just the MD simulation in order to equilibrate your system before running the NCMC+MD hybrid
simulation. An equilibration iteration, in this case is controlled by the given attribute n_steps from
the dynamics_move class. For example, if I create a blues.ncmc.ReportLangevinDynamicsMove
class with n_steps=20 and call the blues.ncmc.BLUESSampler.equil(n_iterations=100), this
will run (n_steps x n_iterations) or 2000 steps of MD or 2 picoseconds of MD simulation time.
When the run() method is called without a prior call to the equil() method, the class will always
run 1 iteration of equilibration in order to set the initial conditions in the MD simulation. This is
required prior to running the NCMC simulation.
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BLUES Iterations
NCMC Simulation
After at least 1 iteration of equilibration, the blues.ncmc.BLUESSampler class will then proceed
forward with running iterations of the NCMC+MD hybrid simulation. It will first run the NCMC
simulation by calling the apply() method on the ncmc_move class or, for sake of this example,
the blues.ncmc.RandomLigandRotationMove class. The apply() method for the ncmc_move
will take in the alch_thermodynamic_state parameter or specifically the openmmtools.state
s.CompoundThermodynamicState object.
A code snippet of the ncmc_move.apply() method is shown below:
def apply(self, thermodynamic_state, sampler_state):
if self.context_cache is None:
context_cache = cache.global_context_cache
else:
context_cache = self.context_cache
integrator = self._get_integrator(thermodynamic_state)
context, integrator = context_cache.get_context(thermodynamic_state,
integrator)↪→
sampler_state.apply_to_context(context, ignore_velocities=False)
self._before_integration(context, thermodynamic_state)
try:
endStep = self.currentStep + self.n_steps
while self.currentStep < endStep:
alch_lambda = integrator.getGlobalVariableByName('lambda')
if alch_lambda == 0.5:
sampler_state.update_from_context(context)
proposed_positions =
self._propose_positions(sampler_state.positions[self.atom_subset])↪→
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sampler_state.positions[self.atom_subset] = proposed_positions
sampler_state.apply_to_context(context, ignore_velocities=True)
nextSteps = endStep - self.currentStep
stepsToGo = nextSteps
while stepsToGo > 10:
integrator.step(10)
stepsToGo -= 10
integrator.step(stepsToGo)
self.currentStep += nextSteps
except Exception as e:
print(e)
else:
context_state = context.getState(
getPositions=True,
getVelocities=True,
getEnergy=True,
enforcePeriodicBox=thermodynamic_state.is_periodic)
self._after_integration(context, thermodynamic_state)
sampler_state.update_from_context(
context_state, ignore_positions=False, ignore_velocities=False,
ignore_collective_variables=True)↪→
When the apply() method on ncmc_move is called, it will first generate the blues.integrato
rs.AlchemicalExternalLangevinIntegrator by calling the _get_integrator() method inherent
to the move class. Then, it will create (or fetch from the context_cache) a corresponding open
mm.Context given the alch_thermodynamic_state. Next, the sampler_state which contains
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the last state of the MD simulation is synced to the newly created context from the corresponding
alch_thermodynamic_state. Particularly, the context will be updated with the box_vectors,
positions, and velocities from the last state of the MD simulation.
Just prior to integration, a call is made to the _before_integration() method in order to store
the initial energies, positions, box_vectors and the masses of the ligand to be rotated. Then, we
actually step with the integrator where we perform the ligand rotation when lambda has reached the
half-way point or lambda=0.5, continuing integration until we have completed the n_steps. After
the integration steps have been completed, a call is made to the after_integration method to
store the final energies, positions, and box_vectors. Lastly, the sampler_state is updated from
the final state of the context.
Metropolization
After advancing the NCMC simulation, a call is made to the _acceptRejectMove() method em-
bedded in the blues.ncmc.BLUESSampler class for metropolization of the proposed move. A code
snippet of the _acceptRejectMove() is shown below:
def _acceptRejectMove(self):
integrator = self.dynamics_move._get_integrator(self.thermodynamic_state)
context, integrator =
cache.global_context_cache.get_context(self.thermodynamic_state,
integrator)
↪→
↪→
self.sampler_state.apply_to_context(context, ignore_velocities=True)
alch_energy = self.thermodynamic_state.reduced_potential(context)
correction_factor = (self.ncmc_move.initial_energy -
self.dynamics_move.final_energy + alch_energy -
self.ncmc_move.final_energy)
↪→
↪→
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logp_accept = self.ncmc_move.logp_accept
randnum = numpy.log(numpy.random.random())
logp_accept = logp_accept + correction_factor
if (not numpy.isnan(logp_accept) and logp_accept > randnum):
self.n_accepted += 1
else:
self.accept = False
self.sampler_state.positions = self.ncmc_move.initial_positions
self.sampler_state.box_vectors = self.ncmc_move.initial_box_vectors
Here, we compute a correction term for switching between the MD and NCMC integrators and factor
this in with natural log of the acceptance probability (logp_accept). Then, a random number
is generated in which: the move is accepted if the random number is less than the logp_accept
or rejected if greater. When the move is rejected, we set the positions and box_vectors on the
sampler_state to the initial positions and box_vectors from the NCMC simulation. If the move
is accepted, nothing on the sampler_state is changed so that the following MD simulation will
contain the final state of the NCMC simulation.
MD Simulation
After metropolization of the previously proposed move, a call is made to the apply() method on the
given dynamics_move object. In this example, this would refer to the blues.ncmc.ReportLange
vinDynamicsMove class to run the MD simulation. A code snippet of the dynamics_move.apply()
method is shown below:
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def apply(self, thermodynamic_state, sampler_state):
if self.context_cache is None:
context_cache = cache.global_context_cache
else:
context_cache = self.context_cache
integrator = self._get_integrator(thermodynamic_state)
context, integrator = context_cache.get_context(thermodynamic_state,
integrator)↪→
thermodynamic_state.apply_to_context(context)
sampler_state.apply_to_context(context,
ignore_velocities=self.reassign_velocities)↪→
if self.reassign_velocities:
context.setVelocitiesToTemperature(thermodynamic_state.temperature)
self._before_integration(context, thermodynamic_state)
try:
endStep = self.currentStep + self.n_steps
while self.currentStep < endStep:
nextSteps = endStep - self.currentStep
stepsToGo = nextSteps
while stepsToGo > 10:
integrator.step(10)
stepsToGo -= 10
integrator.step(stepsToGo)
self.currentStep += nextSteps
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except Exception as e:
print(e)
else:
context_state = context.getState(
getPositions=True,
getVelocities=True,
getEnergy=True,
enforcePeriodicBox=thermodynamic_state.is_periodic)
self._after_integration(context, thermodynamic_state)
sampler_state.update_from_context(
context_state, ignore_positions=False, ignore_velocities=False,
ignore_collective_variables=True)↪→
When the apply() method is called, a very similar procedure to the NCMC simulation occurs.
The first thing that happens is to generate the integrator through a call to _get_integrator(),
where in this given class, it will generate an openmm.LangevinIntegrator given the thermody-
namic_state parameter. Then, it will create (or fetch from the context_cache) a corresponding
openmm.Context given the thermodynamic_state. Next, the sampler_state, which contains
the last state of the NCMC simulation if the previous move was accepted or the initial state of
the NCMC simulation if the move was rejected, is used to update box_vectors and positions in the
newly created openmm.Context. In this case, we reassign the velocities in the MD simulation in
order to preserve detailed balance.
Following, a call is made to _before_integration() to store the intial positions, box_vectors and
energies and then we carry forward with the integration for n_steps. After the integration steps have
been completed, a call is made to the after_integration method to store the final energies and
positions. Lastly, the sampler_state object is updated from the final state of the MD simulation
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context.
This completes 1 iteration of the BLUES cycle. Here, thesampler_state is then used to sync
the final state of the MD simulation (i.e. box_vectors, positions, and velocities) from the previous
iteration to the NCMC simulation of the next iteration. Then, we repeat the cycle of NCMC->
Metropolization -> MD for the given number of iterations.
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3.7 Conclusion
On the BLUES project, my primary contribution was to incorporate the best practices in software
development such as: (1) version control, (2) testing and code coverage, (3) continuous integration,
(4) automated build systems, (5) standardized code style, and (6) documentation. Incorporation of
these design principles ensure long-term reliability, reproducibility, and viability in the code and go
towards helping others continue future work and extensions on the BLUES project. The BLUES
software package is available on Github with 80% of the code base tested, continually integrated
with Travis-CI, and the documentation available on ReadTheDocks. I have written the code to
adhere to the PEP8 format (96) and the documentation follows the numpydoc (97) format.
Furthermore, by designing the BLUES toolkit to be as modular as possible, this has enabled easy
implementation of new NCMC move types to enhance sampling beyond simple ligand rotations.
Recent work in the Mobley lab has included implementation of NCMC moves such as: sidechain
rotations (9) for enhancing protein motions, rotations in ligand torsional angles, and ‘water-hopping’
for enhanced sampling of water motions. These recent studies utilize the same code base as seen
in our studies with simple random ligand rotations, but have simply replaced the ligand rotation
function with these alternative moves. Since version 0.2.5, the BLUES code has been re-designed to
be compatibility with other software packages like ‘openmmtools’ (98) to allow simple conversion of
their Markov-chain Monte Carlo moves into NCMC moves, to be used in the NCMC+MD hybrid
simulation framework that the BLUES toolkit provides.
Incorporation of these design principles ensure long-term reliability, reproducibility, and viability in
the code and go towards helping others continue future work and extensions on the BLUES project.
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Chapter 4
Identifying the binding modes of a novel
RNA nucleoside analog
Authors: Nathan M. Lim, Sarah Nainar, Bonnie Cuthbert, David L. Mobley, Celia Goulding, Robert
Spitale
Part of: ‘An Optimized Chemical-Genetic Method for Cell-Specific Metabolic Labeling of RNA’ (10)
Submitted to Journal of Nature Methods
4.1 Introduction
The Spitale Lab at UCI had synthesized several RNA nucleoside analogs for the purpose of devel-
oping a method for cell-specific labeling of RNA. In this study, the Spitale group was interested in
understanding how their novel RNA nucleoside analogs would bind to the protein uridine-cytidine
kinase 2, which was found to allow incorporation of their RNA nucleoside analogs into nascent RNA
strands. Here, I demonstrate the use of docking and molecular dynamics (MD) simulations for val-
idating their hypothesis of their nucleoside analogs binding in the same mode as the endogenous
ligand, cytidine, as well as uncovering a novel binding mode, representative of the post-catalytic
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state. These predictions of the binding modes were then later validated by x-ray crystallography.
4.2 Computational Methods
The starting structure used for the molecular dynamics (MD) simulations was taken from the crystal
structure of human uridine-cytidine kinase 2 complex with the cytidine substrate (PDBID: 1UEJ)
(99). In this study four different MD simulations were carried out, using two different binding modes
for each of the respective ligands 2AZU and 2AZC. Here, we differentiate between the two binding
modes by the orientation of the ribose moiety on the molecule. The "canonical" binding mode
refers to the pose in which the azide (substituted on the 2’ position) is pointed inwards into the
binding site, see Figure 4.5a. We refer to this as the canonical binding mode as this pose is similar
to the pose found in the crystal structure with the bound cytidine substrate (PDBID: 1UEJ). The
"flipped" binding mode refer to the pose in which the azide is pointed outwards from the binding
site, see Figure 4.5b.
A total of 500ns of MD simulation time was conducted for each binding mode by running five
100ns simulations each, where each copy of the simulation began from the same protein structure.
The metastable binding modes sampled during our MD simulations were defined by constructing
a Markov State Model (MSM) from our pool of MD simulation data and clustering with perron-
cluster cluster analysis (PCCA). We then compared these metastable binding modes with x-ray
crystal structures for 2AZU and 2AZC by computing the root-mean-square deviation (RMSD)
between the ligand heavy atoms. We would like to note that the x-ray crystal structures of 2AZU
and 2AZC were not used for setup or seen prior to conducting our MD simulations. Our simulation
results, along with the x-ray crystal structures, support the hypothesis that the ligands must adopt
the "flipped" binding mode for catalytic turnover.
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4.2.1 MD simulation parameters
All simulations in this study were conducted using OpenMM v7.1.1 (100) at T=300K and P=1atm.
Here, we use timesteps of 4fs by employing the hydrogen mass repartitioning (HMR) scheme (101).
This scheme allows us to take larger timesteps by slowing down the fastest motions (i.e. hydrogen
bond stretching) in our MD simulations. The HMR scheme constraints the bond length between
hydrogens and their connected heavy atoms and reallocates mass from the connected heavy atom
to the hydrogens. The protein-ligand systems were placed in a periodic box with explicit TIP3P
water molecules using a 10A solvent padding distance and counter ions (NaCl) were added using a
concentration of 150mM. A 10A cut-off distance was used for the particle-mesh Ewald method for
computing long-range (e.g. electrostatic) interactions. Protein atoms were parameterized using the
‘amber99sbildn’ forcefields (102) and the ligands were parameterized using GAFF2 (103) in which
atomic charges were assigned using the AM1-BCC charge model (104).
4.2.2 Protein preparation
To prepare the protein system (PDBID: 1UEJ) for MD simulations, we used PDBFixer (105) to
model in missing residues, add missing hydrogen atoms, and solvate our system. Sidechains were
protonated in accordance with the pH=8.0 environment of the enzyme assay experiments (106)
and as described in other computational studies (107). With the cytidine molecule bound, we
energy minimized the protein-ligand complex for a maximum of 30,000 steps and followed with an
equilibration protocol as follows. The equilibration protocol occurs in four 10 ps stages, whereby a
progressively declining restraining force was used to help the protein-ligand system gradually relax.
First, we apply a restraining force of 2.0 to the heavy atoms of the protein-ligand complex, simulate
for 10ps using constant volume (NVT), and follow-up with 10ps at constant pressure (NPT). Next,
we decrease the restraining force to 0.5 and then conduct an NPT simulation for 10ps. Last, we use
a 0.1 restraining force on the alpha-carbons (protein backbone) and the ligand heavy atoms and
then NPT simulate for 10ps.
114
4.2.3 Docking
After equilibration of the UCK2-cytidine complex, we applied HYBRID docking (108) to dock our
nucleoside analogs (2AZU and 2AZC) into the binding site. HYBRID differs from the standard
docking approach such that the software will use the co-crystallized ligand as a reference point and
attempt to fit the nucleoside analogs within the binding site by overlaying the docked ligands with
the crystallographic ligand. From HYBRID docking, we generated up to 50 different conformers
for each nucleoside analog and then followed the same equilibration protocol described previously.
After equilibration, we found that the conformers tended to converge into two groups: 1 conformer
which resembled the "canonical" binding mode and another which had the ribose moiety "flipped".
We then selected 1 conformer from each representative group and carried these forward for our
production NPT 100ns MD simulations (no restraints).
4.2.4 Analysis
For each nuceloside analog (2AZC and 2AZU), we ran five 100ns MD simulations for each of the
two binding modes (canonical and flipped). They are denoted as 2AZCcanc, 2AZCflip, 2AZUcanc,
and 2AZUflip. Collectively, over the course of the 100ns of simulation time, the root-mean-square
deviation (RMSD) for the ligand atoms began to stabilize after 25ns. Thus, we discard trajectory
frames from 0-25ns as additional equilibration time and only perform further analysis from the
25ns-100ns time frame Fig.4.2a. The RMSD is calculated by:
RMSD =
√√√√ 1
n
n∑
i=1
d2i (4.1)
where di represents the distance between the n atom pairs. For construction of our Markov State
models (MSM), we use the PyEMMA v2.5.5 (109) toolkit. For residue contact analyses we use the
MDTraj v1.9.1 (89) and VMD v1.9.3 (74) toolkits.
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Defining the metastable binding modes
(a) 2AZCcanc − TICA (b) 2AZCcanc − PCCA
Figure 4.1: PCCA clustering in TICA space from simulations of 2AZCcanc. MD simulations
for 2AZCcanc show sampling of 4 different binding modes (red, yellow, blue, green), where
the primary binding mode is indicated in red.
In order to define our metastable binding modes and visualize their structures, we construct a
Markov State model (MSM) (110) from our five separate MD simulations. Our features for con-
structing the MSMs consists of the distance between the closest heavy atoms on the ligand and the
following 9 residues: ASP62, PHE83, ASP84, TYR112, PHE114, HIS117, ILE137, ARG166, and
ARG176. These residues were selected as they have been noted in the literature to play important
roles in binding (107). From this feature space, we apply the time-lagged independent component
analysis (TICA) method using a lagtime of 1ns. TICA transforms our 9 dimensional feature space
to a new set of reaction coordinates which maximizes the autocorrelation of the transformed coor-
dinates (111). In other words, TICA allows us to extract the slow order parameters and project
them into a lower dimensional space; here, we use the first two TICA coordinates (Fig. 4.1a). Then,
we apply k-means clustering to discretize our trajectory frames into discrete microstate and project
them into TICA space (denoted by individual Xs). Following, we use perron-cluster cluster analysis
(PCCA) (112) to assign each microstate to a metastable macrostate (denoted by color in Fig.4.1b).
From each of our assigned macrostates, we randomly sample 100 frames and then visualize the
frame which minimizes the RMSD to the crystallographic ligand.
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Distance to key residues
Using the ‘compute_contacts’ tool from MDTraj, we compute the distance between the closest
heavy atoms in the ligand and 4 residues: ASP62, TYR112, HIS117 and ARG176 (Fig.4.3). These
residues were chosen in particular as ASP62 is known to be the catalytic residue, while TYR112,
HIS117, and ARG176 are believed to play a key role in substrate specificity between uridine and
cytidine as they have been found to bind to the nucleobase moiety (107). Here, we calculate the
frequency in which the distance between the ligand and the residues are less than or equal to 3.0A,
which we define as the minimum distance needed to form an interactive bond.
Hydrogen Bond Contacts
We compute the frequency of hydrogen bond contacts between the ligands and surrounding residues
using the HBonds plugin v1.2 in VMD 1.9.3 (74), shown in Figure 4.4. The criterion used for defining
formation of a hydrogen bond is that the cutoff distance between a hydrogen bond donor and
acceptor must be less than 3.0Åand the angle is less than 20 degrees. Each colored bar corresponds
to the hydrogen bond frequency from an individual MD simulation.
Comparisons to X-ray Crystal Structures
Here, we compared our metastable binding modes from our MD simulations against each subunit
found in the experimental x-ray crystal structures and list the values against the subunit which
minimizes the computed RMSD. To compare the metastable binding modes from our MD simula-
tions with experimental x-ray crystal structures, we first align the two structures using the protein
backbone. Particularly, we align by the protein backbone using residues 19 to 229 but exclude
residues 48 to 52 as these were missing in the x-ray crystal structures. Once aligned by the protein
backbone, we then compute the RMSD between crystallized ligand and the matching ligand heavy
atoms from our defined metastable binding modes.
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4.3 Results
4.3.1 Binding Mode Stability
(a) 2AZCcanc − rmsdtrim (b) 2AZUcanc − rmsdtrim
(c) 2AZCflip − rmsdtrim (d) 2AZUflip − rmsdtrim
Figure 4.2: RMSDs (Å) for ligand heavy atoms from 25-100ns MD simulations for 2AZC and
2AZU in the cannonical or flipped binding mode. Each colored line represents the RMSD
over time for each individual MD simulation.
Table 4.1: Average RMSD (Å) for ligand heavy atoms over the course of the 25-100ns MD
simulations
RMSD RMSD RMSD RMSD RMSD AVG SEM
2AZC_canc 6.7 1.3 1.1 4.1 2.1 3.1 1.0
2AZU_canc 0.9 1.2 2.9 1.3 1.4 1.5 0.4
2AZC_flip 1.8 1.7 4.0 2.6 4.6 3.0 0.6
2AZU_flip 2.4 3.1 2.4 2.2 2.6 2.5 0.2
The averages and the standard errors of the mean (SEM) for the RMSD (Å) of each ligand binding
mode are shown in Fig.4.2 and Table4.1. They are 3.1+−1.0, 1.5
+
−0.4, 3.0
+
−0.6, and 2.5
+
−0.2 for
2AZCcanc, 2AZUcanc, 2AZCflip, and 2AZUflip, respectively.
Comparing the RMSD of the cannonical binding modes for 2AZC and 2AZU, we find that the 2AZU
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ligand to be much more stable than the 2AZC ligand. In 25 of our MD simulations for 2AZCcanc
(Fig.4.2a), the ligand comes nearly unbound after 30ns; while for 2AZUcanc (Fig. 4.2b) the ligand
nearly unbinds in only 15 of the simulations. When comparing 2AZCflip and 2AZUflip, the average
RMSD suggests both are about equally stable. However, this particular binding mode appears to
show slightly more instability than the cannonical binding mode with an average RMSD of 2.6 and
3.0 for the 2AZCflip and 2AZUflip, respectively.
4.3.2 Distance to key residues
In Figure 4.3, we plot the distance between the closest ligand heavy atoms and the 4 residues:
ASP62 (blue), TYR112 (orange), HIS117 (green) and ARG176 (red). One plot from each respective
binding mode was chosen from the simulation in which contact with the catalytic residue ASP62
was highest. Additional contact distance plots from the other MD simulations can be found in the
supporting information. See Figure 4.10 for 2AZCcanc, Figure 4.11 for 2AZUcanc, Figure 4.12 for
2AZCflip, and Figure 4.13 for 2AZUflip.
For the canonical binding mode, we see a maximum contact frequency of 3.9% (2AZC) and 2.5%
(2AZU) in which the ligand is d < 3.0Å away from the catalytic residue ASP62. Figure 4.3a shows
that the 2AZCcanc ligand in the canonical binding mode only rarely comes into contact with ASP62
but is in stable contact with HIS117 and ARG176. Interestingly, Figure 4.3b illustrates that even
though the 2AZUcanc ligand appears to be stably bound to the key residues (TYR112, HIS117, and
ARG176) the ligand is too far away from ASP62.
In stark contrast, we see an enormous increase in contact frequency when simulating the flipped
binding mode: 27.9% for 2AZCflip and 80.4% for 2AZUflip. Figure 4.3c shows the 2AZCflip ligand
forms stable contacts with the catalytic residue ASP62 and residues TYR112/HIS117 but does not
contact ARG176. Similarly, we see the same stable contacts being formed for 2AZUflip in Figure
4.3d.
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(a) 2AZCcanc − distance (b) 2AZUcanc − distance
(c) 2AZCflip − distance (d) 2AZUflip − distance
Figure 4.3: Distance to key residues for 2AZC and 2AZU in the cannonical and flipped
binding mode from a single MD simulation. Each colored line represents the contact distance
to a key residue. The distance to key residues plots from the other 4 MD simulations are
shown in the supplementary information.
4.3.3 Hydrogen Bond Contacts
In order to gain better insight on the interactions required for catalysis, we profile the hydrogen
bond contacts between the ligand and surrounding protein residues. When comparing the cannonical
binding modes, we see that 2AZCcanc forms hydrogen bond contacts mostly with ASP84, PHE114,
HIS117, and ARG176; but no virtually no contact with the catalytic residue ASP62 (Fig. 4.4a).
For 2AZUcanc (Fig. 4.4b), we see frequent contacts with TYR112, ARG166, ASP170, and ARG176;
also, virtually no contact with the catalytic residue ASP62. Given that we do not see hydrogen
bonding between the ligand and ASP62, this supports the hypothesis that the canonical binding
mode may not be the pose required for catalysis.
On the other hand, we see a much higher rate of contact to ASP62 with the flipped binding
mode, which supports the hypothesis that this binding mode may be what the ligand adopts
for catalytic turnover. In Figure 4.4c, we see 20% contact with ASP62 and moderate rates
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(a) 2AZCcanc −HBonds (b) 2AZUcanc −HBonds
(c) 2AZCflip −HBonds (d) 2AZUflip −HBonds
Figure 4.4: Hydrogen bond contact frequency for 2AZC and 2AZU in the cannonical and
flipped binding mode. Each colored bar represents the contact frequency from an individual
MD simulation.
of contact with ASP84, PHE114, HIS117, ARG169, and ARG174. For 2AZCflip, contact with
ASP62 (yellow/green/red) appears to be related to hydrogen bonding with ASP84 (yellow/green),
TYR112(yellow) and ARG174 (yellow). In Figure 4.4d, we see 70% contact with ASP62 and moder-
ate contacts with THR29, ASP84, TYR112, and HIS117. For 2AZUflip, contact with ASP62(green/red)
appears to be related to hydrogen bonding with THR29(red), ASP84(green) and HIS117(green/red).
4.3.4 Comparison to X-ray Crystal Structures
Here, we compared our defined metastable binding modes from our MD simulations to our x-ray
crystal structures by computing the RMSD between matching heavy atoms in the respective ligands.
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(a) 2AZCcanc (b) 2AZUflip
Figure 4.5: Fig.4.5a shows 2AZCcanc from MD (green) and the binding mode from crystal-
lography, taken from subunit A (cyan). Fig.4.5b shows 2AZUflip from MD (green) and the
binding mode from from crystallography, taken from subunit F (cyan).
2AZCxtal BBRMSD
2AZCcanc 0.7 1.2
2AZCflip 5.0 1.5
2AZUxtal BBRMSD
2AZUcanc 4.8 2.7
2AZUflip 2.3 2.8
The minimum computed RMSD of 2AZCcanc was 0.7Åand was 5.0 for 2AZCflip. Figure 4.5a illus-
trates the crystallized ligand (cyan) directly overlays with the most populated metastable binding
mode obtained from our MD simulation (green), except for the additional phosphate group found
on the crystallized ligand. The minimum computed RMSD of 2AZUflip from our MD simulation
against the x-ray crystal structure was 2.3Å; while for 2AZUcanc was 4.8Å. Figure 4.5b shows that
orientation of the nucleobase moiety from our MD simulation (green) differs from the crystallized
ligand (cyan). Additionally, the ribose moiety sits nearly perpendicular to the nucleobase moiety in
the binding mode from MD; while in the crystal structure, the nucleobase and ribose moieties are
nearly in the same plane.
4.4 Discussion and Conclusion
Prior to running our MD simulations, we had no experimental evidence which suggests the existence
of an alternative binding mode. We first discovered evidence of a flipped binding mode after our
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HYBRID docking approach with our short equilibration protocol. After conducting our MD simu-
lations, we later confirmed the existence of the flipped binding mode by comparing our metastable
binding modes against the x-ray crystal structures.
From this study, we believe that the canonical binding mode may not be the binding mode the
ligand adopts for catalytic turnover. Considering the crystallized 2AZC ligand was found to contain
an additional phosphate group–indicative of the post-catalytic state–and this coincided with our
findings from the MD simulations, we have strong evidence that the canonical binding mode repre-
sents the pose after catalysis. This is illustrated by the extremely low RMSD value (0.7Å) against
the crystal structure for 2AZCcanc and the low rate of contact with the catalytic residues ASP62
for both 2AZCcanc and 2AZUcanc (Fig. 4.3a and Fig. 4.3b). Contrary to the literature (107),
our simulations suggest that ARG176 plays no role in substrate specificity, where we see roughly
equivalent hydrogen bonding frequency for both 2AZUcanc and 2AZCcanc. Residue ARG176 seems
to only serves a role in stabilizing the ligand in the binding site when in the canonical binding
mode. From Figure 4.12, we observe several moments in which the ligand 2AZCflip comes into
closer contact with ARG176 we see the distance with ASP62 increases and vice versa.
Given that we see a much higher contact frequency with ASP62 for the flipped binding mode over the
canonical binding mode, we believe that the ligand must adopt the flipped conformation to stably
contact ASP62 for catalytic turnover. Based on the hydrogen bond contact profiles (Fig. 4.4),
we believe ASP84 plays a critical role in binding both nuceloside analogs and additional contacts
with residues TYR112/HIS117 appear to be necessary for facilitating the interaction with ASP62
(Fig. 4.3c and Fig. 4.3d) when in the flipped binding mode. The binding of 2AZCflip appears to
specifically require contact with either ARG174/ARG176 residues and potentially forms interactions
with TYR112 for additional stability (Fig. 4.4c). In contrast, binding of 2AZU with TYR112 does
not appear to facilitate contact with ASP62 (Fig. 4.4d) but does appear important for stabilizing
the canonical binding mode (Fig. 4.4b). For specificity of binding 2AZU, it appears that hydrogen
bonding with HIS117 is required and that contact with THR29 serves for additional stability (Fig.
4.4d).
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Overall, these results provide strong supporting evidence that the flipped binding mode represents
the conformer of the ligand before catalysis; while the canonical binding mode represents the post-
catalytic state.
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4.6.1 MSM and Clustering
(a) 2AZCcanc − TICA (b) 2AZCcanc − PCCA
Figure 4.6: PCCA clustering in TICA space from simulations of 2AZCcanc. MD simulations
for 2AZCcanc show sampling of 4 different binding modes (red, yellow, blue, and green),
where the dominant binding mode is indicated in red.
(a) 2AZUcanc − TICA (b) 2AZUcanc − PCCA
Figure 4.7: PCCA clustering in TICA space from simulations of 2AZUcanc. MD simulations
for 2AZUcanc show sampling of 2 different binding modes (pink and red), where the dominant
binding mode is shown in pink.
125
(a) 2AZCflip − TICA (b) 2AZCflip − PCCA
Figure 4.8: PCCA clustering in TICA space from simulations of 2AZCflip. MD simulations
for 2AZCflip show sampling of 4 different binding modes (red, pink, blue, and green), where
the primary binding mode is indicated in blue.
(a) 2AZUflip − TICA (b) 2AZUflip − PCCA
Figure 4.9: PCCA clustering in TICA space from simulations of 2AZUflip. MD simulations
for 2AZUflip show sampling of 3 different binding modes (red, blue and green), where the
primary binding mode is indicated in green.
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4.6.2 Distance to key residues
Figure 4.10: Distance to key residues for 2AZC in the canonical binding mode from the other
4 MD simulations, not shown in Fig.4.3a. Each colored line represents the contact distance
to a key residue.
Figure 4.11: Distance to key residues for 2AZU in the canonical binding mode from the other
4 MD simulations, not shown in Fig.4.3b. Each colored line represents the contact distance
to a key residue.
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Figure 4.12: Distance to key residues for 2AZC in the flipped binding mode from the other
4 MD simulations, not shown in Fig.4.3c. Each colored line represents the contact distance
to a key residue.
Figure 4.13: Distance to key residues for 2AZU in the flipped binding mode from the other
4 MD simulations, not shown in Fig.4.3d. Each colored line represents the contact distance
to a key residue.
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Chapter 5
Microsecond molecular dynamics
simulations for fragment pose prediction
Authors: Nathan M. Lim*, Linh P. Nguyen*, Gregory Warren, David L. Mobley
* denotes Co-First Authors
Abstract
One of the major challenges medicinal chemists face in early drug discovery is the determination of
ligand binding modes. By understanding how a ligand orients itself within a binding site, chemists
can gain insight on key interactions for binding and may begin to rationalize how to improve or
design a potential lead compound. In this retrospective blinded study, we apply routine computa-
tional methods such as docking and molecular dynamics (MD) simulations to identify the binding
modes on a set of fragment-like molecules bound to soluble epoxide hydrolase (sEH). Here, we
investigate each method’s effectiveness in predicting the dominant binding mode and identifying
any additional binding modes (if any), then validate our predictions to experimentally obtained
X-ray crystal structures. A set of 19 small molecules were docked into the apo protein crystal
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structure and then subsequently simulated for 1 microsecond each via MD. To define ligand bind-
ing modes from our MD simulations, we construct Markov state models (MSMs) and analyze our
results through a combination of Time-lagged Component Analysis (tICA) with Perron-clustering
Cluster Analysis (PCCA). We are particularly interested in determining whether exchanges between
different stable binding modes can happen an adequate number of times at this timescale. Given
that these molecules are small and fragment-like, we expect switching of binding modes to occur
relatively more quickly than typical drugs or biomolecules. In this study, even with simulations at
the microsecond timescale for small fragment-like molecules, we do not observe sufficient enough
transitions to adequately sample and identify all crystallographic binding modes.
5.1 Introduction
Early stage drug discovery commonly employs high-throughput screening (HTS), where millions of
molecules (from small fragments to drug-like compounds) are screened against a target of interest
to reveal potential hits. However, HTS campaigns are expensive and often have low hit rates due
to the vastness of chemical space and complexity of therapeutic targets (113). Fragment-based
drug discovery (FBDD) campaigns often begin their search through chemical libraries starting with
smaller molecules (fragments) to cover a larger fraction of chemical space with the hope of yielding
a higher probability of viable hits, even if initially less potent. Hits obtained from FBDD are often
weak binders but serve as a starting point for building lead compounds(114).
Medicinal chemists typically use hits as a starting scaffold or connect fragments together in order to
improve binding. It is at this point in which determining the binding mode may be key for further
improvement in the compounds’ design (115). Knowledge of how a fragment binds suggests key
interactions to target for improving binding and the consequences of scaffold modification. It is
also possible that a fragment may bind in several ways, whereby multiple binding modes contribute
to the overall binding affinity (116). Thus, in order to improve ligand binding affinity, a medicinal
chemist must gain structural insight on the fragments binding mode or binding modes to have some
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guidance for further design and optimization.
Gaining structural insight to fragment binding modes by experimental methods often poses some
challenges. Experimental methods for the determination of ligand binding modes include X-ray
crystallography, nuclear magnetic resonance (NMR), and surface plasmon resonance. However, these
experimental methods can be costly, time-consuming, and difficult overall(117; 115). Experimental
methods such as X-ray crystallography often describe only the single (dominant) binding mode,
if one is able to obtain crystals in high enough resolution. The common problem in FBDD, with
x-ray crystallography is that densities obtained in crystal structures can be ambiguous or in too low
resolution to definitively resolve the binding mode of their compound. Inherent to their size, small
molecules and fragments often bind in multiple orientations which produce ambiguous densities
in the crystal structure (118). This is where computational techniques and modelling may aid in
the drug development process, by resolving ambiguities in crystal structures and predicted binding
modes from computational techniques can help to make sense of partial occupancy data, helping to
rescue structure-based design work for fragments. When computational techniques become accurate
enough, it could be employed even when structures aren’t available(113).
Docking and molecular dynamics provide valuable tools to help determine fragment binding modes
(? 119; 120). Docking is a computationally inexpensive method that takes a static structure of
a protein and places a given molecule in a variety of poses, generating a substantial number of
candidate binding poses. This approach sacrifices accuracy but achieves high speeds by neglecting
dynamics in the protein structure. Although docking can be fast, there is difficulty in determining
which of the generated candidate poses represent the relevant or true binding modes. Dependent
on the docking software used, each will score the placement of the ligand using a variety of metrics,
usually based on fit within the binding site and scores which might provide rough estimates of
protein-ligand interaction energies. From docking scores, one may guess which molecules to carry
forward to subsequent experiments, but docking scores are an unreliable metric for separating
molecules that bind from those that do not bind (121; 122; 123; 124; 125). Docking has shown
success in surveying the conformational space of the ligand, but has not proven completely accurate
in producing experimentally discovered ligand binding modes (126; 125).
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Molecular dynamics (MD) is a computational method that solves Newton’s equation of motions in
discrete time steps to estimate the dynamics of the system, simulating in full atomistic detail the
motions of a protein-ligand system over time (127; 128). MD simulations allow protein dynamics
to be studied in greater temporal and spatial resolution than experimental methods by simulating
molecules in time steps compatible with the fastest motion in the system (i.e. bond vibration at
1-2 fs). Protein folding and other large conformational changes have timescales ranges from 10−6s
(µs) to 100s or slower (129). Atomistic MD simulations can routinely simulate timescales ranging
from 10−15s (fs) to 10−6s (µs).
Due to computational cost and lack of adequate conformational sampling, MD simulations are lim-
ited to shorter timescales than biologically relevant functions because a great amount of time steps
are required to visualize these slow-order processes (130). In the case of FBDD, MD can capture the
transition between ligand binding modes to reveal important stabilizing protein-ligand interactions
on expected timescales ranging from nanoseconds to milliseconds. In some cases, ligand binding
mode transitions may even require conformational changes in the protein, where these timescales
can go beyond milliseconds, however these longer timescales require a significant amount of compu-
tational resources (131; 132). This ‘timescale gap’ between computational methods and biologically
relevant timescales has been mediated by recent advancements towards increased sampling of the
conformational space and Markov State Model (MSM) construction. Here, we will evaluate whether
sufficient sampling can even occur at the microsecond timescale using MD simulations and MSM
construction. Particularly, we are interested in determining if we can sufficiently sample enough
binding mode transitions for our fragment set to obtain the correct populations and identify the
dominant binding mode and/or additional binding modes.
5.1.1 Fragment binding mode predictions to SEH
Soluble epoxide hydrolase (SEH) is a protein which is responsible for binding to specific epoxides,
converting them to diols, and is found in nearly all tissues (but are highly concentrated in the
liver). The primary function of SEH is in detoxification, catabolism, and regulation of signaling
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molecules. SEH catalyzes the breakdown of epoxyeicosatrienoic acids (EETs), acids with cardiovas-
cular effects such as vasodilation and anti-inflammatory actions. Inhibition of SEH will slow the
degradation of EETs, which can enhance neuroprotection, cardioprotection, and anti-inflammatory
effects. In vitro studies with murine models have shown SEH inhibition significantly lowers blood
pressure, supporting the hypothesized role of SEH in blood pressure regulation. The development
of SEH inhibitors have therapeutic potential in cardiovascular diseases, inflammatory diseases, and
neurological diseases. (133; 134; 135)
In this retrospective study, we apply docking and MD techniques on a set of small fragment-like
ligands in soluble epoxide hydrolase (SEH) in order to predict fragment binding modes. We will
determine whether docking and MD simulations can successfully identify the binding mode(s). Bind-
ing modes are defined for the remainder of this paper as experimentally or simulation-determined
metastable bound states. Ligand poses are defined as the positions outputted from docking. Predic-
tion of ligand binding modes using a docking-MD combined approach has seen success in discrim-
inating the experimental binding mode from challenging decoy poses, when compared to docking
techniques alone (136; 137) and long MD simulations (e.g. 1 microsecond) have been used to visual-
ize ligand entry and exit into the binding site (138). Thus, we will evaluate whether 1 microsecond
MD simulations provide any additional value after docking in uncovering additional ligand binding
modes in this system.
The main objective of this study is to assess the performance of computational techniques such
as docking and a combined docking and MD approach in identifying the relevant and dominant
ligand binding modes (verified with experimental structures). We aim to provide some insight to
determine how effective computational methods can be in identifying the crystallographic binding
mode, finding additional binding modes, or resolve ambiguities in experimental structures.
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5.2 Methods
5.2.1 Preparation
RMSD vs Frame: pEH_l4XH_1_0_c0-prod01.pdb
Frame
RMSD (Å)
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"pEH_l4XH_1_0_c0-prod01.pdb:(protein) and name C CA N O"
Figure 5.1: RMSD of the SEH backbone, relative to the starting positions, after deleting the
N terminal domain over the course of an 80ns MD simulation, averaging at 1.8Å
Information given to us by our OpenEye scientific collaborators (Christopher Bayly and Gregory
Warren) consisted of the apo-protein SEH structure, the binding site in which to dock, the set of
ligands to dock (given as SMILES strings), and the protein-ligand crystal structures after refinement
by Warren. All docking and MD simulations of the ligands were conducted without seeing the
protein-ligand crystallographic structures. The provided SEH structure contained missing residues
and was not suitable input for MD simulations. Instead, we used the apo structure of SEH taken
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from the Protein Data Bank (PDBID: 5AHX) and filled missing residues using PDBFixer (139).
The apo SEH structure was uploaded to PDB2PQR () to strip waters from the system and assign
protonation states at pH 8.5, as recommended by our collaborators, with AMBER parameters using
PROPKA3.0(140; 141; 142). Parmed (v3.0.1) was used to convert the PQR file back to a PDB file
by loading the structure then saving as a PDB (143). This corrected apo SEH structure was then
aligned to the given SEH structure from OpenEye scientific to utilize the same defined binding site
for docking.
The full SEH protein features two domains connected by a natural flexible linker, where the SEH
binding site given to us was located in the C-terminal domain. To reduce computational cost, the
opposing domain which did not contain the pre-defined binding site was deleted from our simulated
protein structure. Specifically, resides 225 to 546 from the N-terminus of the protein system were
deleted and the structural integrity of the protein was evaluated by analyzing the RMSD of the
protein backbone. The RMSD of the protein backbone averaged at 1.8 Å over the course of a 80
ns MD simulation, indicating that deletion of the N-terminal domain did not affect the integrity of
the C-terminal domain 5.1. A similar trend in RMSD is observed when the N-terminal domain is
retained.
5.2.2 Docking
A set of 47 ligands was obtained from collaborators at OpenEye Scientific which we separated into
groups based on similarities in complexity. Using OpenEye packages to determine various molecular
properties, the molecules were divided into 4 groups based on the number of rotatable bonds and
their shape volume. In this study, we examined the group with few rotatable bonds and small
molecular volumes, which consists of 19 molecules. Rotatable bonds for our data set range from 0
to 3 bonds and the volume of each molecule ranges approximately from 1333 to 1723. We examined
the group of small-fragment like molecules as we expected to observe more binding mode transitions
within the microsecond timescale. The remainder of the molecules will be reserved for subsequent
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studies.
Figure 5.2: Soluble Epoxide hydrolase binding site divided by the center cleft, defining two
sub cavities denoted as left and right. As we rarely observed transitions between the two
sub-caivities, we conduct our analysis of binding modes within each sub-cavity, shown here.
The 19 molecules (Fig. 5.3) were docked into the binding site, as defined by Warren, using the apo
protein structure that we prepared for MD simulations. In Figure 5.2, we divide the SEH binding
site into two general regions (left and right) which are separated by two loops which form a cleft
in the center 5.2. At least one study on SEH has suggested that the left region of the binding site
serves as a point of entry/exit to the catalytic domain on the right end of the binding side(144).
Using Openmoltools (0.8.3)(145) and OpenEye toolkits, each ligand’s SMILES string was used
to generate a 3D structure and assigned charges through the AM1BCCSym charging scheme via
QUACPAC 2017.10.1 (146). Then, we used OpenEye’s OMEGA (20180212) to generate up to
1000 conformers for each ligand to be docked and scored(147). The ligands (with their multiple
conformers) were docked–into the docking region defined by Warren–using FRED through OEDock
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Figure 5.3: 2D representations of the ligands used in this study. Each molecule is identified
by a 3 character code, where alternate protonation states of select ligands are denoted with
a 4 character code (i.g. GVG1/2, and 6TZ1/2). These codes are given to us by Warren.
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version 3.2.0.2. and then scored by the Chemgauss4 scoring function(148).
From docking, 50 potential poses were generated and subsequently, up to 2-3 unique binding modes
were hand-picked by visual inspection and used for the following for MD simulations. The unique
poses were selected to give us a variety of starting configurations for our MD simulations, and
selecting docked poses that were in the different sub-cavities of the protein ensured reasonable
coverage of all possible binding modes. With enough simulation time, we expect the fragments to
be able to transition between the sub-cavities and eventually find the correct binding mode.
Figure 5.4: Relationship between the top scoring pose from docking and RMSD to the
crystallographic binding mode. Scores from docking do not correlate with the closeness to
the crystallographic pose.
The choice to manually select docked poses for increasing the variety of starting MD configurations
over selecting poses with the highest docking score is based on the assumption that the docking
score is a poor metric for identifying the actual binding mode (125). Figure 5.4, illustrates the
calculated RMSD of the top scoring poses in this study, does not correlate with closeness to the
crystallographic binding mode. This finding validates our choice to utilize manual selection of the
docked poses for starting our MD simulations.
138
5.2.3 Molecular Dynamics
The system, compromising of only the C-terminal domain, was parameterized using amber99sbildn
force field for the protein (149), the TIP3P water model (79) for the solvent, and GAFF2 force
field for the ligands (150). The following stages were carried out using OpenMM (version 7.1.1)
(151; 152). A maximum of 30,000 minimization steps was applied and the protein-ligand system was
equilibrated for 10ps at 1 atm, 300K, and a pH of 8.5 in three stages where the restraint force used
to keep the ligand and protein in their starting positions is decreased with each progressing stage.
The restraint force constant for each progressive stage was 2.0 kcal
mol·Å2
, 0.5 kcal
mol·Å2
, and 0.1 kcal
mol·Å2
,
respectively. Unrestrained molecular dynamics simulations of the protein-ligand system were then
carried out for 1 microsecond for each of the chosen docked poses.
5.2.4 Determining Binding Modes by TICA and PCCA
From our 1 microsecond MD simulations, we rarely observed transitions between the two sub-
cavities. Thus, we divided the analysis of our simulations, separately analyzing cases where the
starting pose was in the left sub-cavity and those where the poses were started in the right sub-
cavity. By separating analysis between each respective side of the binding site, we are able to better
distinguish between different binding modes sampled during the course of the simulation. This
allows us to better understand the transitions among these binding modes rather than the timescale
to transition between the two sub-regions in the binding site. For the rare cases in which we
observed transitions between the sub-cavities, the simulation data was treated collectively. Analysis
was conducted on the entirety of the 1 microsecond simulation, with trajectory frames stored for
analysis every 40ps.
We use PyEMMA (v2.5.2) to analyze the ligand binding modes sampled during our 1 microsecond
MD simulations and used the results to construct Markov State Models (MSM)(153). Here, we chose
the distance from the closest heavy ligand atom to key residues as our feature set and apply time-
lagged independent component analysis (tICA) (154) to determine the slowest order parameters.
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Figure 5.5: TICA analysis of the conformational dynamics of ligand II6 during a 1 microsec-
ond MD simulation yields three possible metastable binding modes as recognized by the
(blue, violet, or black) metastable free energy basins.
Previous studies on the SEH system suggested key residue-ligand interactions were among residues
ASP110, TYR158, MET194, TYR241, and VAL273 (144). After applying a tICA transformation
on the distances from the closest heavy ligand atom to key residues, we then used the first two
TICA components and generate discrete microstates by k-means clustering (Figure 5.5).
In tICA space, we plot N discrete microstates (representing individual simulation frames), where N
is the square root of the total number of simulation frames (i.e. 5000 simulation frames). Following
this, we build up our macrostates by assigning each discrete microstate to a macrostate using perron-
cluster cluster analysis (PCCA) (155; 156) (Figure 5.6). For each macrostate, we store 100 frames
to represent our metastable binding modes sampled from MD.
Choosing an appropriate lag time is crucial in properly analyzing the MD trajectories, where a long
lag time may gloss over significant ligand movement and a short lag time may unnecessarily be
computationally expensive. The implied timescales provided insight on the timescales to transition
into different states. Plotting the implied timescales against lag time helps select an MSM lag time
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Figure 5.6: Ligand II6 TICA coordinates plot with marked discrete microstates colored to
indicate different clusters which define our metastable macrostates or stable ligand binding
modes. Adjacent macrostates suggest possible transitions between binding modes.
that will be long enough to indicate Markovian dynamics and short enough to resolve the processes
(157). A lag time of 300ps was selected as the implied timescale appeared to become independent
of lag time (Figure 5.7).
The number of metastable states was determined from spectral analysis by plotting the number of
clusters vs. their respective timescales, then selecting the number of appropriate clusters based on
the elbow method (Figure 5.8).
To illustrate the change in binding modes over time, we plot the ligand RMSD from the starting
frame and color each time point by the minimizing the RMSD from our 100 frames representing
each macrostate or our metastable binding modes. We then calculate the populations by computing
the frequency or the amount of simulation time spent in each defined binding mode. This effectively
shows the occupancy of each binding mode during the 1 microsecond MD simulation and the RMSD
of the ligand over time 5.12 from the initial docked pose.
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Figure 5.7: Relaxation timescales of ligand II6 implied by a Markov model transition matrix
estimated at various lag times up to 300ps. Implied timescales should be independent of
the lag time and appear to converge at 100ps. With increasing lag time, implied timescales
become more constant. The black line with gray area defines the limit of the timescale at
which the model can be resolved, where any processes within this area are generally not
resolved. With increasing lag time, more process are not resolved. All the processes for
II6 are well resolved. Solid lines correspond to the maximum likelihood MSMs. Shaded
areas depict confidence intervals containing 95 percent of the samples generated by Bayesian
MSM. The confidence intervals remain constant with increasing lag time for II6. Dashed
lines correspond to samples means.
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Figure 5.8: Ligand II6 number of clusters against their respective MSM timescales. With
increased clusters, the duration of the timescale each cluster represents decreases. Using
the elbow method, we select the number of clusters that will best separate the discrete
microstates into macrostates. A suitable number of clusters appears to be 3 clusters.
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5.2.5 Comparison to the crystallographic pose
We evaluated docking and MD for their effectiveness in determining ligand binding modes by cal-
culating the RMSD to the crystallographic pose. Given our (validated) assumption that docking
scores does poorly in indicating closeness to the crystallographic binding mode (Fig. 5.4), we have
no way of knowing which single pose would minimize the RMSD. The docked poses simulated in MD
should not represent docking RMSD because the docked poses were selected based on increasing
the variety of starting configurations for MD and are irrelevant to docking abilities in effectively
predicting ligand binding modes. Reporting the RMSD of the best single docked pose would bias
the results in favor of docking and not accurately represent the process of using docking to deter-
mine ligand binding modes but would show a rare best case scenario of utilizing docking. Thus,
we report the average RMSD from docking to best represent selecting a pose at random from a
pool of generated docked poses. For docking, we computed the average RMSD (with confidence
intervals at 95%) by randomly drawing 50,000 docked poses (without replacement) from our initial
50 generated docked poses.
Similarly, for MD, we report the average RMSD (with confidence intervals at 95%) by randomly
drawing 10,000 frames from our 100 frames we saved as are representatives of each binding mode
sampled from MD. Average MD RMSD values were calculated to best represent the process of
selecting a single frame at random from each macrostate, which represent the metastable binding
modes sampled during our MD simulations. Since we do not know which frame sampled during our
MD simulation would minimize the RMSD to the crystallographic binding mode, we cannot report
the minimum RMSD from our MD simulations.
In cases where the molecule had a single crystallographic binding mode, the most populated cluster
was selected as the predicted pose from MD. In cases where the molecule had two crystallographic
binding mode, the top two populated clusters were selected to represent the predicted binding modes
from MD. In cases where the molecules had multiple crystallographic binding modes, we present
the average RMSD of each macrostate that minimizes the computed RMSD to the crystallographic
binding mode. Given that we did not know ahead of the study whether any given molecule would
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exhibit more than two binding modes in crystallography, nor did we observe more than 3 binding
mode transitions in our simulations, we believe our procedure for analysis represents a fair assess-
ment for a blind prediction challenge. Experimental MD ligand pose RMSD values within 2Å of
the crystallography binding mode were considered to have sufficiently predicted the binding mode
(125) (122).
We remind the reader that we started simulations using poses from each sub-cavity in the SEH
binding site and if the crystallographic pose was only found in one sub-cavity, we discarded the
simulation data in the opposing sub-cavity–except if we saw transitions between sub-cavities in our
simulations. Given that we rarely observed transitions between sub-cavities in our 1 microsecond MD
simulations, in some sense, our predictions put forth represent an ‘ideal’ scenario, where one knows
which sub-cavity that the molecule may bind in before running their simulations. In subsequent
work we hope to explore methods to enhance the transition rate between sub-cavities.
5.3 Results
Given that we do not know ahead of time which docked pose or simulation frame would minimize the
RMSD, we remind the reader that we report average RMSDs to replicate the scenario of randomly
picking a docked pose or a single simulation frame from MD to compare against the crystal structure
(See Methods:Comparison to the crystallographic pose).
5.3.1 Single binding mode predictions
Molecules JF6, 4XH, KJU, TGX, 6N6, 6N4, 8NY, ONR, II6, and K2T each had single crystallogra-
phy binding mode. Docking had an average RMSD (Å) of 14.63, 8.82, 5.65, 8.52, 13.83, 7.95, 6.06,
5.27, 7.85, and 4.90 for the molecules respectively. Our reported confidence intervals (at 95%) for
the average RMSDs for each molecule was under 0.05 Å. The average RMSD (Å) from the most
populated binding mode during MD was 5.43, 3.93, 12.09, 2.97, 11.54, 7.46, 2.43, 1.30, 1.79, 3.24,
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Figure 5.9: RMSD between crystallographic ligand binding mode and predicted binding
mode from docking (blue) and MD (green) for cases with a single crystallographic binding
mode. Ligand RMSD values are sorted in ascending order according to MD RMSD. We
judge success as predicting a binding mode to be less than or equal to 2 Å (black dashed
horizontal line). For ligands with single binding modes, MD simulations generally improve
RMSD values from docking.
Ligand Dock DockErr MD MDErr
JF6 14.6 0.1 5.4 0.1
4XH 8.8 0.1 3.9 0.0
KJU 5.7 0.0 3.4 0.0
TGX 8.5 0.1 3.0 0.0
6N6 13.8 0.0 11.5 0.2
6N4 7.9 0.0 7.5 0.1
8NY 6.1 0.0 2.4 0.0
ONR 5.3 0.0 1.3 0.0
II6 7.8 0.1 1.8 0.0
K2T 4.9 0.0 3.2 0.0
Table 5.1: Average RMSDs and error Å for molecules with a single binding mode.
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for the molecules respectively. These values are noted in Table 6.1. None of the molecules with
single binding modes yielded an average docking RMSD under the 2 Å cutoff. From MD, 2/10
molecules (ONR and II6) had an average RMSD under the 2 Å cutoff for ligands. The average
docking RMSD for molecules with a single binding mode was 8.3 ± 1.1. The average MD RMSD
for molecules with a single binding mode was 4.3± 1.0.
5.3.2 Dual binding mode predictions
Figure 5.10: RMSD between crystallographic ligand binding modes and predicted binding
modes from docking (blue) and MD (green) for cases with dual crystallographic binding
modes. We judge success as predicting a binding mode to be less than or equal to 2 Å (black
dashed horizontal line).
Molecules 6NX, 4VY, and 1P8 each had two crystallographic binding modes. Average docking
RMSD values against the two crystallographic binding modes for each molecule were 16.6 & 15.4
(6NX), 10.1 5.7 (4VY), and 8.4 & 9.1 (1P8). The average RMSD from the top two most populated
binding modes from MD were 6.6 15.8 (6NX), 11.8 & 4.7 (4VY), 0.9 & 7.1 (1P8) (Table 5.2). None
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Ligand Dock DockErr MD MDErr
1P8-0 16.6 0.0 6.5 0.0
1P8-1 15.4 0.0 15.8 0.1
4VY-0 10.1 0.0 8.8 0.0
4VY-1 5.7 0.0 5.4 0.0
6NX-0 8.4 0.0 0.9 0.0
6NX-1 9.1 0.0 7.1 0.0
Table 5.2: Average RMSDs and error Å for molecules with two binding modes.
of the 3 cases with dual binding modes yielded an average docking RMSD under 2 Å. After MD,
molecule 6NX yielded an average RMSD value under 2 Å for only one of the two crystallographic
binding modes.
The average docking RMSD for the molecules with dual binding modes was 10.9±1.8. The average
MD RMSD for the molecules with dual binding modes was 7.8± 2.0.
5.3.3 Multi binding mode predictions
Molecules 6TZ, GVG, YPN, and KUF have 3, 5, 3, and 6 crystallographic binding modes, respec-
tively. Molecules 6TZ and GVG were simulated twice with different protonation states, denoted as
6TZ1/6TZ2 and GVG1/GVG2. Docking and MD did not yield average RMSDs under 2Å, failing
to predict any crystallographic pose for molecules with multiple binding modes. We note that in
cases like GVG1, GVG2, and KUF, our simulations did not sample an equal amount of binding
modes as found by crystallography; these are denoted with NF in Table 6.2. The average docking
RMSD for the molecules with multiple binding modes was 9.9 ± 0.5. The average MD RMSD for
the molecules with multiple binding modes was 7.3± 0.8.
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Figure 5.11: RMSD between crystallographic ligand binding modes and predicted binding
modes from docking (blue) and MD (green) for cases with multiple crystallographic binding
modes. We judge success as predicting a binding mode to be less than or equal to 2 Å (black
dashed horizontal line).
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Ligand Dock DockErr MD MDErr
6TZ1-0 16.6 0.0 6.5 0.0
6TZ1-1 15.4 0.0 15.8 0.1
6TZ1-2 10.1 0.0 8.8 0.0
6TZ2-0 5.7 0.0 5.4 0.0
6TZ2-1 8.4 0.0 0.9 0.0
6TZ2-2 9.1 0.0 7.1 0.0
GVG1-0 9.4 0.0 9.8 0.0
GVG1-1 6.7 0.0 5.2 0.0
GVG1-2 13.4 0.0 14.0 0.0
GVG1-3 8.3 0.0 10.0 0.0
GVG1-4 6.4 0.0 5.1 0.0
GVG2-0 12.0 0.0 13.9 0.0
GVG2-1 10.5 0.0 4.3 0.0
GVG2-2 11.0 0.1 NF NF
GVG2-3 7.8 0.0 5.9 0.0
GVG2-4 10.2 0.0 4.2 0.0
YPN-0 10.1 0.0 4.0 0.0
YPN-1 10.6 0.1 4.8 0.0
YPN-2 10.6 0.1 NF NF
KUF-0 8.0 0.0 11.7 0.1
KUF-1 9.9 0.0 NF NF
KUF-2 7.9 0.0 NF NF
KUF-3 12.5 0.0 NF NF
KUF-4 13.4 0.0 NF NF
KUF-5 13.1 0.0 NF NF
Table 5.3: Average RMSDs and error Å for molecules with multiple binding modes. NF
indicates that the binding mode was not found.
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5.4 Discussion
Our MD simulations were initiated from up to three unique docked poses, giving preference to
selecting at least one docked pose for each side of the binding pocket. The docked poses were
selected to increase the variety of starting positions for MD, ideally a docked position in the left
and right sub-cavities and a docked position near the center cleft region. Ligands with less than
three poses were often a result of the docking program not placing the ligand near one of the correct
region. Here, we hypothesized that docked poses and their scores would not adequately identify the
crystallographic pose–which we confirmed at the conclusion of this study 5.4. Instead, docking was
used as a means for generating starting positions for our MD simulations and hypothesized that
the occupancy (i.e. amount of simulation time spent) for each binding mode would be indicative of
finding the crystallographic pose.
In the 50 docked poses generated for each molecule, we found that there were indeed a handful of
poses which were within 2 Å of the crystallographic pose. But, given that the docking score did
not correlate with closeness to the crystallographic pose, we could not know a priori which of the
50 docked poses represented the crystallographic binding mode. This suggests that docking and
scoring is not an effective approach in itself in general and suggests that a better method, perhaps
one like MD, may be more successful at identifying dominant binding modes.
Among the bound structures considered in this study, ligands differed in how many crystallographic
binding modes were resolved. Some had a single binding mode, others two, and some even exhibited
larger numbers of binding modes. If 1 microsecond long MD simulations were long enough to
adequately sample enough binding mode transitions, we expect that the populations from MD
should be roughly equivalent to the occupancies found via crystallography. Given that, we expected
fragments which exhibit a single binding mode to be easy to identify, fragments with dual binding
modes to be moderately challenging, and fragments with multiple binding modes to be the most
difficult. Surprisingly, we found that 1 microsecond of MD did not result in adequate enough
sampling for us to get a high success rate in identifying the crystallographic poses. It may be
possible that an incorrect force field was selected for our system, preventing a simulation of any
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length from adequately sampling the binding site. In the following sections, we present and discuss
our findings for ligands which exhibited single, two, or more binding modes.
5.4.1 Single binding modes: MD simulations can refine poorly docked
poses
For molecules with a single binding mode, we only had a few success cases (ONR and II6). Here,
we present our observations from II6 to illustrate a successful scenario. Molecule II6 represents one
case where docking does poorly, but 1 microsecond of MD results in the molecule eventually finding
the crystallographic binding mode.
The other molecules in this subset (besides ONR and II6), illustrate that running 1 microsecond
MD simulations after docking generally decreases the RMSD to the crystallographic binding mode,
but not within the 2 Å cutoff. We believe that given more simulation time for the other molecules,
we would observe similar behaviors to our observations from our II6 simulations.
Molecule II6 has one crystallographic pose (PDB:5ALL) which was not found by docking but was
identified by MD. On average, docking generated poses which were 7.9 Å away from the crystallo-
graphic pose.
Our MD simulations of II6 began by selection of one docked pose situated on the right side of
the SEH binding pocket. Figure 5.12, illustrates that a short amount of time ( 150ns) was spent
in the initial docked pose (green). During the time spent in the initial docked pose (green), we
observe high fluctuations in the ligand RMSD, indicating that docking has placed the fragment in
an unfavorable pose. After 200ns, we see a transition into a second binding mode (blue) which
the fragment resides in for the remainder of the simulation, indicating favorability, representing the
dominant binding mode in this simulation. This (blue) binding mode from MD was 1.8 Å away
from the crystallographic pose.
Our observations from II6 suggests that docking has a tendency to place the fragments in an
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Figure 5.12: Top: Populations (% simulation time) of 3 (red, green, blue) binding modes
sampled in 1 microsecond of MD for ligand II6. Bottom: RMSD of ligand II6 relative to
starting positions over time. Each time point is colored according to the binding mode the
ligand is in.
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Figure 5.13: The dominant binding mode for ligand II6 represented in orange and the crys-
tallographic pose II6 in gray.
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unfavorable pose and that after enough simulation time, MD allows the fragment to eventually
relax into a new stable configuration. Generally, we observe the same trend with the other single
binding mode fragments. That is, docking on average does a poor job in placing the fragment in
a favorable configuration but relaxation via MD allows the fragment to settle into a new stable
configuration. Once the fragment has stabilized into this new binding mode, the fragment resides
there for the remainder of the simulation. It is often this second binding mode found–following
the initial pose from docking–is representative of the dominant binding mode such as in the case
of II6 and ONR or somewhat close (within 4A) such as in 8NY, TGX, K2T, KJU, and 4XH (6/10
cases). It is important to note that, in cases in which we were successful or close, the simulations
started within the right sub-cavitity–a more compact region, in which ligand stabilization occurs
more quickly (Fig. 5.2). For these cases, ligand stabilization into the dominant binding mode often
occurs between 200-600ns, well within the 1 microsecond timescale of our simulations.
Crystallographic poses for JF6, 6N4, and 6N6 were found to be in the left side of the binding site,
where the pocket is much larger and wider. The larger sub-cavity allows for there to be many more
possible metastabile binding modes that the ligand here explores only slowly because of barriers
separating them. Given this, it is unsurprising that we performed poorly in trying to identify the
crystallographic pose via MD. Here, a larger pocket means we must simulate long enough for the
fragment to wander away from the initial docked pose and explore enough different metastable
binding modes that it can find the dominant binding mode and remain there for a long period of
time. From figure 5.14, we see that JF6 begins in the initial (red) docked pose and then deviates
up to 15 Å away into another binding mode (green). This (green) binding mode was 5.4 Å away
from the crystallographic pose, which is likely a result from not allowing enough simulation time for
the fragment to find a more favorable binding mode. On average, the poses generated from docking
were 14.6 Å away from the crystallographic pose. These findings suggest that for larger pockets, one
may need to simulate longer than 1 microsecond in order to get enough simulation time to recover
from poor initial placements from docking.
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Figure 5.14: Top: Populations (% simulation time) of 2 (red and green) binding modes
sampled in 1 microsecond of MD for ligand JF6. Bottom: RMSD of ligand JF6 relative to
starting positions over time. Each time point is colored according to the binding mode the
ligand is in.
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5.4.2 Dual and Multiple binding modes: Microsecond MD simula-
tions do not capture enough binding mode transitions
Here, we present our observations on simulations of 6NX, the sole success case in the subset of
ligands which have more than one binding mode. Generally, across this subset of molecules with
multiple binding modes, our observations suggest that 1 microsecond of MD simulations do not
capture enough binding mode transitions for us to successfully find the correct dominant binding
mode. In our single successful case of identifying 1 binding mode for 6NX, we do not observe any
transitions during the course of the simulation, which furthers our claim that 1 microsecond of MD
simulations is not sufficient enough of a timescale to get the correct populations for finding the
crystallographic binding mode.
Molecule 6NX has two crystallographic poses (PDB:5AKZ), referred to as 6NX-0 and 6NX-1. The
two crystallographic binding poses for 6NX are located by the cleft region of the SEH binding
pocket, on the left side of the protein. On average, docking generated poses which were 8.4 Å from
6NX-0 and 9.1 Å from 6NX-1.
Our MD simulations of 6NX began by selection of three uniquely docked poses named 6NX-c0,
6NX-c1, and 6NX-c2 situated on the right, left, and left side of the of the SEH binding pocket,
respectively 5.15. Populations from MD simulations that are on the same side of the binding site
were combined, therefore 6NX-c1 and 6NX-c2 simulations were combined and 6NX-c0 was analyzed
separately. Populations for 6NX-c0 are not included in this analysis because the crystallographic
binding modes are not located in the right side of the binding pocket. The populations of 6NX-c1
and 6NX-c2 are combined to yield red, green, and blue binding modes with populations of 16% ,
34% , and 50% , respectively (Fig. 5.16 and Fig. 5.17).
Figure 5.16 illustrates that 6NX-c2 in the cleft region of the SEH binding site (left side) spent the
entirety of the simulation in the initial docked pose (blue) and does not transition to any additional
binding mode. This is indicative that binding mode transitions for this particular ligand is either
very slow or that additional simulation time is required for observing a transition out of this initial
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Figure 5.15: Ligand 6NX in the 3 chosen docked poses 6NX-c0 (right), 6NX-c1 (left), and
6NX-c2 (left) used to start our MD simulations.
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Figure 5.16: Top: Populations (% simulation time) of 1 (blue) binding modes sampled in
1 microsecond of MD for ligand 6NX (pose 2). Bottom: RMSD of ligand 6NX relative to
starting positions over time. Each time point is colored according to the binding mode the
ligand is in.
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binding mode. By chance, the docked pose 6NX-c2 we selected as a starting point for our MD
simulations, was already close to the crystallographic pose by 0.9 Å which likely partialy explains
the lack of binding mode transitions in this simulation.
Figure 5.17: Top: Populations (% simulation time) of 2 (red/green) binding modes sampled
in 1 microsecond of MD for ligand 6NX (pose 1). Bottom: RMSD of ligand 6NX relative to
starting positions over time. Each time point is colored according to the binding mode the
ligand is in.
Figure 5.17 shows that 6NX-c1 on the left of the binding pocket begins in the initial docked pose
(red) and has high fluctuations in the ligand RMSD during the first 30ns of the simulation. The red
binding mode remains for approximately 325ns, then transitions to another binding mode (green),
where it remains till the end of the simulation ( 675ns). This secondary binding mode (green) was
7.1 Å away from the secondary crystallographic binding mode. In this case, we see that from the
initial docked pose the ligand drifts 12Å away over the course of the 1 microsecond MD simulation.
Here, docking had placed the ligand so far away from the crystallographic pose that the simulation
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was not long enough for the ligand to find the second crystallographic pose (6NX-1).
In the case of 6NX, even with two simulated poses on the same side of the binding site exploring
three total different binding modes, 1 microsecond of MD simulations was not sufficient to identify
both crystallographic poses. In one simulation (6NX-c1), we happened to select a docked pose that
was very close to one of the crystallographic poses but saw no binding mode transitions during
the MD simulation to uncover the secondary binding mode. In our other simulation (6NX-c2),
docking had poorly placed the ligand so far away that we our simulations did not sample either of
the crystallographic poses. In this case, MD captured only one binding mode transition from one
simulated pose (6NX-c2), but neither the binding modes sampled were close to the crystallographic
poses due to poor initial placement from docking.
Our observations from 6NX indicate that 1 microsecond of MD does not sufficiently capture enough
binding mode transitions, nor does it appear to be a long enough timescale to correct the poor
placements from docking. We observe the same trend with the other fragments, where there is a
lack of binding mode transitions, only seeing at most 3 transitions per simulation. In all (dual and
multiple) binding mode cases but one, neither docking or 1 microsecond of MD proved sufficient in
identifying the crystallographic binding modes. Had the microsecond timescale been sufficient to
reliably sample at least two binding modes, we would have at least observed a transition in the 6NX-
c1 simulation, allowing us to potentially find the secondary binding mode. Our findings suggest that
MD simulations at the microsecond timescale may be able to find at least one crystallographic pose,
but identifying secondary or even more binding modes is not likely without much longer simulations.
5.5 Conclusion
In this study, we used docking and MD on a set of fragment-like molecules binding to soluble
epoxide hydrolase to evaluate each method’s effectiveness in predicting the crystallographic poses
and whether sufficient sampling of relevant fragment binding modes can occur at a 1 microsecond
timescale. Although docking typically produces a few poses close to the crystallographic binding
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mode, docking on average performs poorly in predicting the crystallographic binding mode. Our
findings show that in the case of fragments with a single binding mode, a relatively small amount
of MD ( 250ns) can refine the poses generated from docking and get close to identifying the crystal-
lographic pose. In cases where there are multiple binding modes, we anticipated observing multiple
binding mode transitions based on the fragment sized ligands and the relatively weak binding such
molecules typically exhibit. However we generally do not see more than 3 transitions in our simula-
tions. MD may find one crystallographic binding mode, however the lack of binding mode transitions
restricts MD from revealing multiple crystallographic binding modes despite simulating for a rel-
atively long timescale of 1 microsecond. Here, the binding site of SEH was relatively large and
we divided the entirety of the binding site into two sub-cavities, expecting to observe transitions
between them. However, transitions between the divided sub-cavities of SEH were rarely observed
in our simulations of the molecules on a microsecond timescale. Without more binding mode transi-
tions, we cannot rely on the populations from MD because we do not observe enough binding mode
transitions at the microsecond timescale.
This highlights the necessity of using enhanced sampling techniques in the future, which could help
address the fact that microsecond MD simulations did capture multiple binding mode transitions or
transition between sub-cavities. Improved sampling would allow better predictions of ligand binding
modes and collection of more accurate populations, which we could use to identify the ligand binding
modes that would be found in crystallography. In this study, we effectively selected docked poses
at random to initiate our MD simulations, but for the most part, these docked poses were too far
away from the crystallographic pose in that a microsecond MD simulation was not sufficient enough
of a timescale to allow for finding the crystallographic pose.
Instead, future studies could investigate using an automated protocol for selecting a more diverse
set of docked poses to have a larger variety of poses as starting structures for our MD simulations. A
wider selection of docked poses could improve the chances that refinement by short MD simulations
of approximately 250ns would result in finding the crystallographic binding modes. Though, this
process could generate multiple poses not related to the experimental binding modes. This improved
approach for selecting initial docked poses in combination with enhanced sampling techniques, could
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result in starting closer to equilibrium during our simulations, where we would observe sufficient
enough transitions between the relevant ligand binding modes. Through proper sampling, we could
rely on the populations in our simulations to determine the likely binding modes as found by
crystallography. An alternate approach which can supplement the analysis of populations is to
analyze protein-ligand contacts.
In this study, we show that even when simulating small fragment-like molecules in a large spacious
binding pocket, sampling reasonable ligand binding mode transitions is challenging, even with rel-
atively long MD simulations. This illus rates that convergence, solely with MD simulations, is very
slow and highlights the necessity of using an enhanced sampling technique to adequately sample
and determine ligand binding modes. We plan to explore these issues in future work.
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Fragment pose prediction using
non-equilibrium candidate Monte Carlo
and molecular dynamics simulations
Authors: Nathan M. Lim, Meghan Osato, Gregory Warren, David L. Mobley
6.1 Abstract
Part of early stage drug discovery involves determining how molecules may bind to the target pro-
tein. Through understanding where and how your molecules bind, chemists can begin to build
ideas on how to design improvements to increase binding affinities. In this retrospective study,
we compare how computational approaches like docking, molecular dynamics (MD) simulations,
and a non-equilibrium candidate Monte Carlo (NCMC) based method (NCMC+MD) perform in
predicting binding modes for a set of 12 fragment-like molecules which bind to soluble epoxide
hydrolase. We evaluate each method’s effectiveness in identifying the dominant binding mode and
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finding any additional binding modes (if any). Then, we compare our predicted binding modes
to experimentally obtained X-ray crystal structures. We dock each of the 12 small molecules into
the apo-protein crystal structure and then run simulations up to 1 microsecond each. By studying
small and fragment-like molecules, we expect to observe switching of binding modes relatively more
quickly than with drug-like or larger molecules. Following this, we build Markov State Models
(MSM) to define our stable ligand binding modes. We investigate if adequate sampling of ligand
binding modes and transitions between them can occur at the microsecond timescale using tradi-
tional MD or a hybrid NCMC+MD simulation approach. Our findings suggest that even with small
fragment-like molecules, we do not observe sufficient binding mode sampling and fail to identify all
the crystallographic binding modes using microsecond MD simulations, but using NCMC+MD we
succeed in sampling all binding modes but do not obtain the correct populations.
6.2 Introduction
High-throughput screening (HTS) is commonly used in early stage drug discovery to identify po-
tential binders or hits. HTS involves taking a large library of molecules and screening them against
a target (e.g. protein) Hit rates in HTS campaigns are often low, simply due to how vast chemical
space can be and the complexity of therapeutic targets (113). One common strategy in fragment-
based drug discovery (FBDD) projects is to conduct the screen using smaller molecules (fragments)
to cover a larger portion in chemical space which may lead to higher hit rates. Often in this ap-
proach hits tend to be weak binders, but they can serve as a starting point for building a potential
lead molecule (114). From the pool of hits, medicinal chemists may find a desirable starting scaffold
or they can build up new molecules by connecting fragments together in hopes to improve binding
affinity. While doing this optimization, chemists must gain an understanding of where and how their
molecule binds to their target protein, before they can begin to theorize how to make improvements.
Some experimental approaches to gaining structural insight on ligand binding include X-ray crystal-
lography, nuclear magnetic resonance (NMR), and surface plasmon resonance (SPR). Each of these
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approaches present its own set of benefits and challenges but most are costly, time-consuming and
difficult (117; 115). For example, X-ray crystallography provides structural information with near
atomic-resolution, but obtaining high resolution crystal can be extremely challenging. Especially
with FBDD, resolving the binding mode(s) for small molecules and fragments proves challenging
as fragments often bind in several different configurations. This often produces x-ray structures
which have ambiguous densities around the bound ligand or are generally in too low resolution to
definitively resolve the fragment binding mode(s) (118).
Here, with these ambiguous densities in the crystal structures, computational approaches may aid in
the design process by resolving ambiguities through predicting fragment binding modes. Computa-
tional methods like docking or molecular dynamics (MD) simulations are some common approaches
used in helping to determine fragment binding modes (119; 120). If these techniques are accurate
enough, computational chemists can apply them to make sense of partial occupancy data and help
save structure-based design work which are based on fragments.
Docking is a computationally inexpensive technique which generates a variety of configurations or
poses by placing the ligand into a static structure of the apo-protein and subsequently scoring
each generated candidate. It can be performed at high-speeds by neglecting any conformational
changes in the protein structures–which often results in sacrificing accuracy–making it difficult to
distinguish binders from non-binders (121; 122; 123; 124; 125). Instead, docking can often be used
to understand the conformational space of the ligand and provide some initial insight on how a
ligand may fit in the binding site. Several studies have shown that docking does not reliably find
experimental binding modes of ligands (126; 125). Thus, we use docking to generate a variety of
configurations which provide coverage of the entire binding site and use these as starting points for
our simulations.
Unlike docking, MD simulations resolve—in full atomistic detail—the overall dynamics of the
protein-ligand system by solving Newton’s equations of motions in discrete timesteps(127; 128).
This can get very computationally expensive if one wants to simulate biological timescales as MD
simulations must take timesteps which are constrained by the fastest motion in the system (i.e.
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bond vibrations at 1-2 femtoseconds). One may use schemes like hydrogen mass re-partitioning
(158) to enable one to take longer timesteps (i.e. 4fs) by slowing down hydrogen bond stretching,
but interesting biological motions occur at much larger timescales necessitating large numbers of
timesteps and great computational cost. Interesting biological motions like protein folding or other
large conformational changes have timescales ranges from 10−6s (µs) to 100s or even longer (129),
requiring extremely long compute times if one aims to capture these types of motions.
Fortunately, recent advancements in technology, like the introduction of computing using graphics
processing units (GPUs), have made achieving microsecond (or even millisecond) long MD simu-
lations fairly routine. Despite using longer timesteps and newer technologies, the utility of MD
simulations in the drug discovery process has been hindered by MD’s inability to adequately sample
the conformational space. Often, MD simulations of a protein-ligand complex will see the ligand
remain trapped in the binding mode the simulation had started in and will fail to capture any
transition into alternative binding modes.
For FBDD, MD simulations may hold some value given that fragments are small and rigid enough
that transitions between binding modes may occur at shorter timescales. In this case, MD simu-
lations could then resolve potential binding modes and reveal important stabilizing protein-ligand
contacts–that is, if such contacts form on reasonable timescales (nanoseconds to milliseconds). But
in some cases, binding mode transitions may require conformational changes in the protein which
may take beyond the millisecond timescale before a transition can even occur (131; 132). Although
these challenges in adequate sampling of the biologically relevant timescales remain an issue to this
day, recent advancements in the field have resulted in new ways to address sampling challenges which
we apply within this study. We note that in this study, we are mostly focused on addressing prob-
lems of sampling ligand binding modes that occur in the abscence of slow protein conformational
degrees of freedom.
One example of an enhanced sampling approach is a hybrid simulation approach which combines
non-equilibrium candidate Monte Carlo (NCMC)(6) move proposals with traditional MD simula-
tions. We previously implemented this NCMC+MD approach in a software package called BLUES:
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Binding modes of Ligands Using Enhanced Sampling (159), which aims to accelerate sampling of
ligand binding modes by proposing random rotational moves on the ligand and then runs a conven-
tional MD simulation. BLUES is similar to using traditional Monte Carlo (MC) moves with MD,
except that it uses a gradual non-equilibrium based switching protocol while performing perturba-
tions to the ligand instead of an instantaneous perturbation. In theory, this allows us to perform
larger changes to the ligand, while also increasing acceptance of proposed moves over traditional
MC. With the BLUES approach, we hypothesize that we will observe better sampling of ligand
binding modes and be able to identify the experimental ligand binding modes over using traditional
MD simulations. Previous work using BLUES has shown success in accelerating sampling of ligand
binding modes in the simple model systems of toluene and iodotoluene bound to the T4 lysozyme
L99A mutant (159). Here, we are interested in applying BLUES to a more complex target with
pharmaceutical relevance to evaluate its utility beyond a simple model system.
In this retrospective study, we are interested in using computational methods to identify binding
modes for fragments which bind to a protein called soluble epoxide hydrolase (SEH). SEH has been
hypothesized to have therapeutic potential in cardiovascular diseases, inflammatory diseases, and
neurological diseases, which has spurred efforts in developing SEH inhibitors. Specifically, SEH is
involved in the breakdown of epoxyeicosatrienoic acids (EETs), acids with cardiovascular effects
such as vasodilation and anti-inflammatory actions. Through slowing the degradation of EETS (via
SEH inhibition), it has been hypothesized to induce neuroprotective, cardioprotective, and anti-
inflammatory effects. In vitro studies with murine models found that SEH inhibition significantly
lowered blood pressure, bolstering its hypothesized role in blood pressure regulation (133; 134; 135).
Here, we apply docking, MD, and (NCMC+MD) BLUES simulations on a small set of 12 frag-
ments which bind to SEH and evaluate their effectiveness in identifying their binding modes. For
the remainder of this paper, we define binding modes as experimentally or simulation-determined
metastable bound states; ligand poses are defined as the configurations generated from docking.
Prediction of ligand binding modes using MD simulations (in comparison to docking alone) has
seen some successes in distinguishing experimental binding modes from decoy poses (136; 137).
Thus, we will investigate if using microsecond MD simulations or our BLUES (NCMC+MD) en-
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hanced sampling approach provide any value, beyond docking, for identifying the SEH fragment
binding modes. We will compare poses generated from docking and the metastable binding modes
sampled from MD and BLUES against experimentally obtained x-ray crystal structures. Through
this study, we aim to provide insight on the value computational methods can provide in identifying
the crystallographic binding modes and finding additional binding modes.
6.3 Methods
6.3.1 SEH apo-protein preparation
Prior to beginning this study, our OpenEye Scientific collaborators provided the SEH structure,
the location of the binding site where ligands would be docked, and a set of 47 ligands in the
form of SMILES strings. The initial SEH structure from OpenEye Scientific was missing residues.
We found the apo SEH structure in the Protein Data bank (PDBID:5AHX), built in the missing
residues with PDBFixer, and used this structure for the remainder of the study (139). The apo
SEH structure was altered using the PDB2PQR web server (160), which uses PROPKA2.0 to assign
residue protonation states. We protonated residues at pH 8.5 to match experimental conditions,
using AMBER parameters (140; 141; 142) and we removed crystallographic waters from the system.
The PQR file was then converted back to a PDB file with ParmEd (v3.0.1). We aligned the corrected
apo SEH structure to the SEH structure provided by OpenEye Scientific to ensure the pre-defined
docking site was the same.
The SEH protein contains 2 domains, a phosphatase domain (N-terminus) and a hydrolase domain
(C-terminus) connected by a flexible proline rich linker (161). The pre-defined docking site was
only located in the C-terminal hydrolase domain, so to reduce computational cost, we removed the
N-terminal domain from residue 0 to residue 224 (Fig. 6.1). We analyzed the structural integrity
of the truncated protein by averaging the RMSD of the protein backbone over a 1 microsecond MD
simulation. The average RMSD of the truncated protein backbone was 2.1 Angstroms suggesting
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Figure 6.1: The complete SEH protein structure with the C-terminal domain (left) and the
N-terminal domain (right). The docking site is highlighted (blue) in a mesh representation.
The N-terminal domain (right) was removed to reduce computational costs, keeping the
C-terminal domain with the defined docking site.
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Figure 6.2: Calculated RMSD Å of the protein backbone relative to the starting position
for 1 microsecond of MD with an average RMSD of 2.1 Å after removal of the N-terminal
domain. The protein backbone eventually stabilizes at 3 Å from the starting position. This
indicates that removal of the N-terminal domain did not largely affect the protein structure.
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the C-terminus was relatively unaffected by the removal of N-terminus. In Figure 6.3.4, we show
the entire binding site located in the C-terminus domain as defined by our collaborators.
Figure 6.3: Truncated SEH protein structure (C-domain only) with the the docking site is
highlighted (blue) in a mesh representation. We divide the full cavity into two sub-cavities
denoted by left and right. The sub-cavity division is best denoted at the two loops marked
as A and B in the figure. In the SEH apo protein structure, point A is closest to residue
VAL381 and point B is closest to residue VAL499. We treat each sub-cavity separately in
our analysis to better resolve binding modes within each sub-cavity.
Here, we define two sub-cavities (left/right) which are separated by two loops which form at residues
VAL381 (A) and VAL499 (B), creating a cleft in the center of the SEH binding site (Fig. 6.3.4).
Throughout this study, we treat the left and right sub-cavity separately as we did not observe tran-
sitions between them in our simulations. By performing our analysis on each sub-cavity separately,
we are better able to resolve the binding modes and timescales for transitions between binding
modes, over trying to resolve the transition timescales between the sub-cavities.
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Figure 6.4: 2D representation of molecules used in this study which bind to SEH.
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6.3.2 Ligand preparation and docking
From a set of 47 ligands given to us by our OpenEye Scientific collaborators, we chose to study a
smaller subset of 12 ligands (Fig. 6.4). Here, we chose ligands based on the overall size and number
of rotatable bonds. Particularly, we were interested in only studying small and rigid fragment
molecules as we expected to observe more binding mode transitions during our simulations, due to
their size and rigidity. The molecule set ranged from 133.13 to 156.73 3 in shape volume with 0 to
1 rotatable bonds.
We used openmoltools (v0.8.1) (145) and OpenEye toolkits (162) to convert each ligand SMILES
string to a 3D structure and then we assigned charges using the OEAM1BCC (146). charging
scheme from the OEQUAPAC library (146). . Then, we generated 1000 conformers of each charged
ligand using OpenEye’s OMEGA (20180212) (147). These conformers were then docked into the
SEH apo protein structure using FRED from OEDock(v3.2.0.2), generating 1000 docked poses, and
scored with the Chemgauss4 scoring function (148).
Figure 6.5: Docking score and the calcualted RMSD Å to the crystallographic binding modes
from the top scoring docked poses.
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From the 1000 generated docked poses, we wanted to select the most distinct and use them as our
starting positions for our simulations. Here, we define distinct docked poses as poses which are
dissimilar from one another. Some studies have shown that docking is an unreliable method for
identifying the true binding mode using the top scoring pose (125). Given this, we believed that
the top scoring poses would often be far from the true binding mode and thus, we did not retain
them and use them as starting points for our MD simulations. Later, we confirmed that the top
scoring docked poses are not generally close to the crystallographic binding modes (Fig. 6.5).
By selecting the distinct poses generated from docking, we have a variety of starting configurations
in our simulations and provide reasonable coverage of the protein binding site. Regardless of the
starting positions, given enough simulation time and the fragment-like properties (i.e. small and
rigid properties) of the molecules we are simulating, we should see convergence to the true binding
mode given the forcefields, protonation states, accuracy of our model, and simulation timescales
used in this study. We describe the filtering and selection process below.
MDS-RMSD Filtering: Unique pose selection
First, we generate a RMSD-based similarity matrix of the 1000 generated docked poses. That is,
we compute the RMSD, using only the ligand heavy atoms, from each docked pose to every other
docked pose. This gives us an NxN similarity matrix (N=1000), in which our measure of similarity
is based on the calculated RMSD between the docked poses (Fig. 6.6). Next, we apply a technique
called Multi-Dimensional Scaling (MDS) through scikit-learn (v0.19.0) (163) in order to reduce our
NxN dimensional space into a 2D space, where we can then apply clustering techniques. MDS is
a method which transforms our similarity matrix and projects each object (i.e pose) into a lower
dimensional space in such a way that the distance between objects (i.e poses) are preserved as best
as possible. In other words, when we project into a 2D space, poses which are similar (low RMSD)
will appear closer together and poses which are dissimilar (high RMSD) will appear farther away.
After applying MDS to our RMSD similarity matrix, we transform our NxN dimensional space
and take our first two MDS components to project the data into a 2D scatter plot. This enables us
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Figure 6.6: RMSD Å similarity matrix from 1000 docked poses for GVG1. Poses which are
similar will have a low RMSD represented by darker colors (blue to purple) and poses which
are dissimilar will have a high RMSD represented by brighter colors (green to yellow). This
shows the raw similarities between docked poses.
Figure 6.7: Left: Silhouette scores from 1000 docked poses for GVG1 using 6 clusters from
K-means clustering. Right:MDS-RMSD scatter plot for 1000 docked poses for GVG1 with
K-means clustered points using 6 clusters. The cluster centroids are denoted by a number
in white circles.
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to easily apply K-means clustering (164) (from scikit-learn) to group up similar poses and separate
dissimilar poses with the first two components which best represent the pair-wise similarity distances.
A notable downside to K-means clustering is that one has to specify the number of clusters to be
used to separate the data points. To avoid bias, we use silhouette scoring (165) (from scikit-learn) to
automatically determine the best number of clusters to use to separate our data points. Silhouette
scoring is a method which ranges from -1 to +1 and evaluates how similar objects belonging to the
same cluster are (cohesion) and how dissimilar those objects are with other clusters (separation)
(Left: Fig. 6.7). High values (closer to +1) indicate that the object is similar to other objects
within the same cluster and dissimilar to objects in neighboring clusters. Low values (closer to -1)
indicate that the object is dissimilar to others within the same clusters and similar to objects in
neighboring clusters. A low total silhouette score indicates that the clustering configuration is likely
incorrect with either too many or too few clusters, so we can use the total silhouette score as a way
to select the optimal number of clusters.
We apply K-means clustering using a range of 2-9 (K) clusters on our MDS-RMSD scatter plot
and score each round of clustering using silhouette scores. We selected the number of clusters K
maximizing total silhouette score, and then used this to partition our 1000 docked poses in MDS-
RMSD space and set the number of starting poses to be used for our simulations. Using the K
clusters which maximized the silhouette score, we then selected the centroid of each cluster as the
representative pose for starting our simulations (Right: Fig. 6.7).
6.3.3 Molecular Dynamics and BLUES Simulations
In this study, we used two simulation approaches: traditional molecular dynamics (MD) simulations
and our hybrid approach called BLUES: Binding modes of Ligands Using Enhanced Sampling (159),
which combines Non-equilibrium Candidate Monte Carlo (NCMC) (6) move proposals with MD.
Both MD and BLUES simulations using OpenMM (v7.1.1) (100) with the same solvated SEH
system. For our simulations, the truncated SEH protein (consisting of only the C-terminal domain)
was paramterized with amber99sbildn forcefield for the protein and GAFF2 for the ligands, and
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solvated with TIP3P waters (150).
We performed a maximum of 30,000 energy minimization steps and a 3 stage (NVT, NPT, NPT)
equilibration protocol which we describe as follows. In each equilibration stage, a restraint force is
placed on the α-Carbons of the protein backbone and the ligand heavy atoms, where we successively
decrease the force from 2.0 kcal
mol·Å2
to 0.5 kcal
mol·Å2
to 0.1 kcal
mol·Å2
at each stage. After equilibration, we
ran 1 microsecond (µs) using molecular dynamics (MD) and 600 nanoseconds (ns) using BLUES for
each pose selected by our MDS-RMSD filtering protocol (described in the previous section). Our
simulations were run using 4 femtosecond (fs) timesteps and with the hydrogen-mass repartioning
scheme (158).
Briefly, we describe our protocol for BLUES simulations. A BLUES simulation begins with the
NCMC phase, which involves proposing a random rotation about the ligand center of mass and then
relaxes via a series of non-equilibrium switching steps which alchemically scale the ligand interations
off/on over N steps. This is in contrast to traditional Monte Carlo, which involves performing
an instantaneous change to the ligand coordinates. Specifically, interactions are controlled via a
parameter (λ0→1) which scales the ligand interactions with the surrounding environment. Our non-
equilibrium switching protocol begins with the fully interacting ligand at λ0 and then we alchemically
scale the ligand forces off until λ0.5, where the ligand is no longer interacting with surrounding atoms.
We perform the proposed random rotation on the non-interacting ligand and then alchemically scale
the ligand forces back on until λ1, where the ligand is fully interacting and in the proposed positions.
Over the series of N NCMC switching steps, we accumulate the total non-equilibrium work done
and use this in acceptance or rejection of the proposed move (following the Metropolis-Hasting
acceptance criterion (166)). After the Metropolization step, we follow-up using traditional MD
methodology and repeat the cycle (NCMC -> MD -> NCMC...etc.) for I iterations.
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6.3.4 Determination of Binding Modes with TICA and PCCA
We divide the SEH binding site (Figure ) into two sub-cavities denoted as “left” and “right” and
analyze simulation data from these two sub-cavities separately, as we rarely observed transitions
between them. That is, simulations which started with dock poses in the right sub-cavity were
pooled together and vice versa, but simulations in each sub-cavity were kept separate, since very few
simulations exhibited transitions and thus pooling data across sub-cavities would have complicated
analysis. By treating the two sub-cavities separately, we are better able to distinguish between
binding modes sampled within each sub-cavity and understand their timescales, over the timescale to
transition between sub-cavities. In other words, we can better distinguish rapid transitions between
binding modes within each sub-cavity over the slow transitions between sub-caivities. Additionally,
if we had pooled together simulation data from both sub-cavities, our silhouette scores would always
suggest 2 binding modes, which is actually just the separation of binding modes between the two
cavities.
Using PyEMMA (v2.5.5), we analyzed and built Markov State Models (MSM) separately be-
tween our MD and BLUES simulations. MD simulation frames were stored every 25,000 steps
(100ps/frame) and BLUES simulation frames were stored every 10,000 steps (40ps/frame). In this
study, we apply a method called time-lagged indepdent component analysis (TICA) with perron-
cluster cluster analysis (PCCA) to define our metastable binding modes sampled during our simu-
lation. The appropriate lagtime for TICA was chosen by plotting the implied timescales versus a
series of lagtimes and selecting a lagtime where the timescales appeared to be independent of lag
time (Figure 6.8). Here, N is defined as the square root of the total number of simulation frames,
which is the default choice for PyEMMA. We used lagtimes of 250ps for MD and 400ps for BLUES
simulations.
In this study, we analyzed the distances between the ligand heavy atoms and each of residues
ASP110, TYR158, MET194, TYR241 and VAL273. These were chosen because they were high-
lighted in an experimental study as being key residues for binding ((144)). With these distances to
key residues as our feature set, we applied TICA (154) to extract the slow order parameters and
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Figure 6.8: Implied timescales plot for GVG1 from our BLUES simulatinos. This plots a
series of lag times (picoseconds) versus timescales of various states. The choice of lagtime to
discretize our simulation frames was chosen by selecting a lagtime where it begins to become
independent of timescales. We chose a lagtime of 400ps.
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Figure 6.9: Time-lagged indepdent component analysis (TICA) plot for binding modes of
GVG1 located in the right sub-cavity using the first two TICA components. Discrete mi-
crostates (i.e. simulation frames are denoted by black Xs. Metastable states sampled during
the simulation are indicated in darker colors (blue-purple) in the contours or where Xs are
more dense.
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Figure 6.10: TICA plot for binding modes of GVG1 located in the right sub-cavity using the
first two TICA components. Each X denotes a discrete microstate (i.e. simulation frame).
Each microstate has been assigned to a macrostate by PCCA which define our metastable
binding modes sampled during our simulation. We find 3 states (red, green ,blue) or binding
modes sampled from simulations of GVG1 in the right sub-cavity.
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mapped our simulation frames via k-means clustering. This gives us a set of N discrete microstates
(i.e. simulation frames) into the coordinate space of the first 2 TICA components (Fig. 6.9).
In Figure 6.10, we define our macrostates or metastable binding modes, by assigning each microstate
to a given K number of macrostates via PCCA (155; 156). To determine the appropriate number
of K macrostates to use, we evaluate the clustering using silhouette scoring (164) (discussed previ-
ously). In our analysis we represent each macrostate by randomly draw 100 simulation frames from
the pool of microstates assigned to each K macrostates.
In Fig 6.20, we plot the RMSD of the ligand heavy atoms relative to the starting configuration and
color each time point by assigning it to the macrostate which minimizes the RMSD. Specifically, we
compute the ligand heavy atom RMSD to the 100 representative microstates (simulation frames)
belonging to each macrostate; then, assign it to the macrostate which minimizes the RMSD. We
can then compute the populations or amount of simulation time spent within each binding mode
by counting the membership assignment of the simulation frames.
6.3.5 Crystallographic Binding Mode Predictions
To evaluate the ability to predict dominant binding modes as determined by crystallography using
docking, MD, or BLUES, we report two RMSD (Å) metrics: an ‘averaged’ RMSD and the minimum
RMSD. Here, our reported average RMSD is calculated by averaging over 10,000 randomly drawn
(with replacement) values from the remaining (MDS-RMSD filtered) docked poses or 100 simulation
frames which we saved to represent each binding mode. We believe this ‘average’ RMSD best
represents random selection of a single docked pose from a pool of poses or a single frame from the
whole simulation to compare against the crystallographic structure. We also report the minimum
RMSD as this represents the best case or ‘ideal’ scenario where we could identify which structure
generated from docking or sample from our simulations would be closest to the crystallographic
binding mode. H owever, we are not aware of any method which could identify such poses so we
view minimum RMSD to be useless as a performance metric. Here, we include it simply to provide a
183
way to assess whether any poses were sampled that were close to the crystallographic bining mode.
We remind the reader that our analysis treats each sub-cavity 6.3.4, separately. There were a total
of 29 crystallographic binding modes to be identified out of the 12 ligand we simulated, where
molecules fell into 2 groups: those with a single binding mode and those with multiple binding
modes (2+). For ligands with a single binding mode, we report the average and minimum RMSDs
(described previously) of the ligand atoms in the crystallographic structure against those in the
representative frames from the binding mode with the highest occupancy (i.e simulation time).
When ligands have multiple crystallographic binding modes, we report the lowest RMSD from the
binding modes found from simulations, relative to each crystallographic binding mode. We describe
a successful prediction as being within 2 Å of the crystallographic binding mode and close predictions
as predictions within 4 Å of the crystallographic binding mode.
6.4 Results
Here, we analyze the success of docking, standard MD and BLUES at recovering crystallographic
binding modes of a series of 12 ligands which have a total o 29 binding modes between them. In our
analysis, we consider data only from docked poses or binding modes sampled during our simulations
which are in the correct sub-cavity. That is, if the crystallographic structure was found in the right
sub-cavity, we computed the RMSD using docked poses or simulation frames that were only in the
right sub-cavity (and vice versa). In this study, we consider predictions successful when they are
within 2 Å of the crystallographic binding mode and we label predictions “close” when they are
within 4 Å. There were a total of 29 binding modes to be predicted from our set of 12 molecules
simulated.
We remind the reader that we report an ‘averaged’ RMSD from each method (See Methods:Comparison
to the crystallographic pose). Since we cannot determine which docked pose or single simulation
frame would result in minimizing the RMSD to the crystallographic binding mode without bias,
an averaged RMSD represents randomly picking from a pool of docked poses or a single simulation
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frame representative of a metastable binding mode. Note, the reported RMSD from docking is
representative of the remaining docked poses after applying our RMSD-MDS filter to the initial
pool of 1000 generated docked poses. Here, we will also report the minimum RMSD to show the
best case or ‘ideal’ scenario for each method. The minimum RMSD reflects the performance which
would be expected if one could determine somehow, without knowing the crystal structure, which
docked pose or simulation frame would be closest to the true binding mode.
Figure 6.11: Minimum/Average RMSD for each method: docking (pink/red), MD
(lime/green), and BLUES (cyan/blue) for all ligands in this study. Dashed line at 2 Å
represents successful predictions and dotted line at 4 Å represents close predictions. This
reports the averaged RMSD from all 12 ligands used in this study.
Here, we find that no method always correctly identifies the crystallographic binding mode (as evi-
denced by average RMSD) but both MD and BLUES substantially outperform docking at sampling
binding modes near the crystallographic one, and of these, BLUES performs better. Averaged across
all of the ligands in this study, the minimum RMSDs for docking (pink), MD (lime), and BLUES
(cyan) were 3.9 ± 0.2, 2.7 ± 0.3, and 1.9 ± 0.2 respectively; the average RMSD for docking (red),
MD (green), and BLUES were 5.9± 0.2, 5.1± 0.4, and 4.8± 0.3 respectively ( (Fig. 6.11).
On average, when considering both cases of single and multiple crystallographic binding modes to
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Ligand Side MinDock AvgDock MinMD AvgMD MinBLUES AvgBLUES
4XH R 3.6 5.4 1.3 4 1.1 4.3
6N6 L 4.4 5.7 3.3 6.7 1.8 4.6
8NY R 3.1 5.1 0.6 1.9 0.5 1.5
JF6 L 4.5 6.3 3.6 9.1 1.5 6.6
KJU R 2.9 5.3 1.3 3.8 0.8 3.8
ONR R 3 4.1 0.8 2.6 1.1 3.8
TGX R 2.3 3.7 0.4 2.5 0.4 1.7
Table 6.1: Minimum and average RMSDs Å from docking, MD, and BLUES for ligands
with a single crystallographic binding mode. The ‘Side’ column denotes which sub-cavity
the crystallographic binding mode was located in.
identify, none of the 3 methods considered here appear to make predictions which are close (within
4 Å) to the crystallographic binding mode. Across the dataset, both BLUES and MD were able
to identify the crystallographic binding mode in 2/29 cases when considering the average RMSDs
and none from docking. If we consider the ideal scenario–that is, considering the minimum RMSD–
docking will make predictions which are within 4Å of the crystallographic binding mode, with some
improvement in RMSD via MD simulation. At best (considering the minimum RMSD), BLUES
predictions may be within at least within 2 Å to the crystallographic binding mode. Across the
dataset, considering the minimum RMSDs, docking can identify 2/29 (7%) binding modes, MD can
identify 11/29 (38%) binding modes and BLUES can identify 16/29 (55%) of the binding modes.
This suggests that BLUES does better than MD and docking at sampling near the crystallographic
binding mode.
6.4.1 Analysis of Molecules with a Single Binding Mode
Molecules with a single crystallographic binding mode were 4XH, 6N6, 8NY, JF6, KJU, ONR, and
TGX. Calculated RMSDs are measured in units of Å and are shown in Figure 6.12 and Table 6.1.
Docking had minimum RMSDs (pink) of 3.6, 4.4, 3.1, 4.5, 2.9, 3, and 2.3 and average RMSDs (red)
of 5.4, 5.7, 5.1, 6.3, 5.3, 4.1, and 3.7. The minimum RMSDs (lime) from the highest populated
binding mode sampled during our MD simulations were 1.3, 3.3, 0.6, 3.6, 1.3, 0.8, and 0.4 with
average RMSDs (green) of 4.0, 6.7, 1.9, 9.1, 3.8, 2.6, and 2.5. From the most populated binding
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Figure 6.12: Left: Calculated RMSDs (minimum/average) relative to the crystallographic
ligand binding mode and binding modes from docking (pink/red), MD (lime/green), and
BLUES (cyan/blue) simulations for ligands with a single binding mode. Successful prediction
in binding mode is judged to be less than or equal to 2 Å (black dashed horizontal line).
Right: Averaged RMSD for each method: docking, MD, and BLUES for ligands with a
single binding mode. Considering the minimum RMSD averaged across ligands with a single
binding mode, MD and BLUES can both make predictions with 2Å to the true binding
mode.
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mode sampled during our BLUES simulations, the minimum RMSD (cyan) for each molecule was
1.1, 1.8, 0.5, 1.5, 0.8, 1.1, and 0.4 with average RMSDs (blue) of 4.3, 4.5, 1.5, 6.6, 3.7, 3.8, and 1.7.
These results indicate that BLUES performs better at sampling near the crystallographic binding
mode over docking and MD.
When considering the averages (Left-Fig.6.12)–representing random selection–only predictions for
8NY from MD/BLUES and TGX from BLUES were successful in identifying the crystallographic
binding mode within 2 Å. In the ideal scenario–represented by the minimum RMSDs–we see suc-
cesses in 4XH, 8NY, KJU, ONR, and TGX (5/7 single binding mode cases) using MD simulations.
Using BLUES simulations, we see successes in all 7 of the single binding mode cases when considering
the minimum RMSD. On the other hand, docking had no successful predictions when considering
both the minimum and average RMSD.
Across this subset of molecules with a single binding mode, the minimum RMSDs for docking
(pink), MD (lime), and BLUES (cyan), were 3.4± 0.3, 1.6± 0.5, and 1.0± 0.2 respectively; average
RMSDs for docking (red), MD (green), and BLUES (blue) were 5.1± 0.3, 4.4± 1.0, and 3.7± 0.7
respectively (Right-Fig. 6.12). At best, if we consider the minimum RMSD from docking and MD,
these methods can make predictions which are close (within 4Å) to a single crystallographic binding
mode. On the other hand, BLUES may be able to make predictions which are within 2 Å if there
is a single crystallographic binding mode.
6.4.2 Analysis of Molecules with Multiple Binding Modes
Molecules with multiple binding modes were 6TZ(1/2), GVG(1/2), and KUF2 which had 3, 5, and
6 crystallographic binding modes, respectively. We note that simulations of 6TZ(1/2) or GVG(1/2)
are simply the same molecules but different tautomers. We consider these separately as we did not
know prior, which were the correct tautomers to be simulating. We compare binding modes sampled
in simulations of 6TZ(1/2) and GVG(1/2) to the same crystallographic structures, respectively.
The RMSD for each molecule to each crystallographic structure is denoted with a 3 letter code, a
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Figure 6.13: Left: Calculated RMSDs (minimum/average) relative to the crystallographic
ligand binding mode and binding modes from docking (pink/red), MD (lime/green), and
BLUES (cyan/blue) simulations for ligands with a single binding mode. Successful prediction
in binding mode is judged to be less than or equal to 2 Å (black dashed horizontal line).
Right: Averaged RMSDs for each method: docking, MD, and BLUES for ligands with a
single binding mode. Considering the minimum RMSD averaged across ligands with a single
binding mode, BLUES can make predictions with 2Å to the true binding mode.
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Ligand Side MinDock AvgDock MinMD AvgMD MinBLUES AvgBLUES
6TZ1-0 L 4 9.1 8 9.8 2.4 7.1
6TZ1-1 R 4.7 7.9 3.5 5.8 3.2 6.2
6TZ1-2 L 5.1 6.4 3.2 5.5 3 5.6
6TZ2-0 L 3.9 7 4.4 9.7 3.2 8.9
6TZ2-1 R 6.2 6.2 3.5 5.7 2.5 6.3
6TZ2-2 L 4.3 5.5 3.8 7.1 3.3 5.8
GVG1-0 R 3.7 5.5 1.9 4.9 1.8 4.1
GVG1-1 R 4.3 5.9 1.6 4.7 2.8 4.9
GVG1-2 L 4.3 6.2 0.9 2.6 1.2 2.9
GVG1-3 L 1.8 6.3 0.8 2.3 0.8 3.3
GVG1-4 L 4.9 6.6 NF NF 2.9 6.2
GVG2-0 R 4.4 6.1 0.7 1.7 1.3 3.2
GVG2-1 R 1.8 4.8 3.4 4.3 2.2 4.2
GVG2-2 L 4.4 6.5 5.3 8.8 0.6 3.8
GVG2-3 L 2.2 6.9 2.1 3.7 2 4.8
GVG2-4 L 4.8 6.7 3 5.6 2.4 6
KUF2-0 R 4.9 6.1 2.4 4.3 2.6 4.7
KUF2-1 R 3.8 4.3 4 4.7 2.2 4.7
KUF2-2 R 2.1 3.6 2.3 4.5 1.6 4
KUF2-3 L 4 5.1 1.6 3.1 1.1 5
KUF2-4 L 4.5 6 4.3 6.5 3 5.2
KUF2-5 L 6.1 6.6 4.4 7.4 1.9 6
Table 6.2: Minimum and average RMSDs Å from docking, MD, and BLUES for ligands with
multiple crystallographic binding modes. The ‘Side’ column denotes which sub-cavity the
crystallographic binding mode was located in. NF (Not Found) denotes the binding mode
not being sampled such as in the case of GVG1-4 from MD simulations.
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number to denote the tautomer, followed by a dash and a number (i.e. XXX#−#) For example,
6TZ1-(0,1,2) is the comparison from the simulations of 6TZ1 against the 3 crystallographic binding
structures; whereas 6TZ2-(0,1,2) refers to the comparison from simulations of 6TZ2. The minimum
and average RMSDs are shown in Figure 6.13 and Table 6.2.
6TZ1 had 3 crystallographic binding modes with minimum RMSDs of 4.0, 4.7, and 5.1 from docking;
8.0, 3.5, and 3.2 from MD; and 2.4, 3.2, and 3.0 from BLUES. The average RMSDs were reported
to be 9.1, 7.9, and 6.4 from docking; 9.8, 5.8, and 5.5 from MD; and 7.1, 6.2, and 5.6 from BLUES.
Likewise for 6TZ2, the minimum RMSDs were 3.9, 6.2, and 4.3 from docking; 4.4, 3.5 and 3.8 from
MD; and 3.2, 2.5, and 3.3 from BLUES. The average RMSDS were reported to be 7.0, 6.2, and
5.5 from docking; 9.7, 5.7, and 7.0 from MD; and 8.9, 6.3, and 5.8 from BLUES. There were no
successful predictions for 6TZ(1/2) using either docking, MD or BLUES when considering either the
minimum or average RMSDs. In the cases of 6TZ(1/2), using MD and BLUES generally resulted in
predictions which were close (within 4Å of the crystallographic structure, with docking only coming
close in 2 out of the 6 cases (represented in 6TZ1/2-0). From this data, we cannot definitively say
which tautomer for 6TZ was the correct one to be simulating.
GVG1 and GVG2 had 5 crystallographic binding modes to compare our predictions to, which are
denoted with GVG(1/2)-(0,1,2,3,4). Here, we note that MD simulations of GVG1 did not sample
enough metastable states to have a prediction for each crystallographic binding mode–missing 1
prediction for GVG1-4. The minimum RMSDs to GVG1 were 3.7, 4.3, 4.3, 1.8, and 4.9 for docking;
1.9, 1.6, 0.9, 0.8, and NF (NF-Not Found) for MD; and 1.8, 2.8, 1.2, 0.8, and 2.9 for BLUES. The
average RMSDs to GVG1 were 5.5, 5.9, 6.2, 6.3, and 6.6 from docking; 4.9, 4.7, 2.5, 2.3, and NF for
MD; and 4.1, 4.9, 2.9, 3.3, and 6.2 for BLUES. When considering the average RMSD, there were
no successful predictions of the crystallographic binding mode with any method for GVG1. If we
consider the minimum RMSD for GVG1, we see successful predictions using docking in GVG1-3
(1/5), using MD in GVG1-0,1,2,3 (4/5) and using BLUES in GVG1-0,2,3 (3/5).
The minimum RMSDS to GVG2 were 4.4, 1.8, 4.4, 2.2, and 4.8 from docking; 0.7, 3.4, 5.3, 2.1, and
3.0 from MD; and 1.3, 2.2, 0.6, 2.0, and 2.4 from BLUES. The average RMDs to GVG2 were 6.1,
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4.8, 6.5, 6.9, and 6.7 from docking; 1.7, 4.3, 8.8, 3.7, and 5.6 from MD; and 3.2, 4.2, 3.8, 4.8, and
6.0 from BLUES. Based on the average RMSDs for GVG2, we see 1/5 successful case (GVG2-0)
with MD but not for any other method. Considering the minimum RMSDs, we see successes in 1/5
cases for docking (GVG2-1) and MD (GVG2-0), while with BLUES we see successes in 3/5 cases
(GVG2-0,2,3). In comparing the results of GVG1 versus GVG2, we believe the data suggests that
simulations of GVG1 was the correct tautomer to be simulating.
Finally, KUF2 had 6 crystallographic binding modes to compare our predictions to. The minimum
RMSDs were 4.9, 3.8, 2.1, 4.0, 4.5, and 6.1 from docking; 2.4, 4.0, 2.3, 1.6, 4.3 and 4.4 from MD;
and 2.6, 2.2, 1.6, 1.1, 3.0, and 1.9 from BLUES. The average RMSDs were 6.1, 4.3, 3.6, 5.1, 6.0,
and 6.6 from docking; 4.3, 4.7, 4.5, 3.1, 6.5, and 7.4 from MD; and 4.7, 4.7, 4.0, 5.1, 5.2, and 6.0
from BLUES. There we no successes when considering the average RMSD for KUF2. For KUF2,
successes were seen in 3/6 cases when considering the minimum RMSD using BLUES simulations
(KUF2-2,3,5) and in 1/6 cases using MD (KUF2-3).
For this subset of ligands which multiple binding modes, the collective minimum RMSD was 4.1±0.3,
3.1± 0.4, and 2.2± 0.2 from docking, MD, and BLUES, respectively. The collective average RMSD
was 6.1±0.2, 5.4±0.5, and 5.1±0.3 from docking, MD and BLUES, respectively. When considering
the minimum RMSD from docking and MD, these methods can make predictions which are close
(within 4Å) to the crystallographic structures, if there are multiple binding modes. With BLUES,
one may be able to make predictions which are within 2 Å as we observe sampling which is much
closer to the true binding modes even if there are several.
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Figure 6.14: Left: Docked pose of JF6 (pink) and simulation frames from MD (lime) and
BLUES (cyan) which minimizes the RMSD to the crystallographic structure. This binding
mode for JF6 was located in the left sub-cavity. The minimum RMSDs were 4.5, 3.6, and
1.5 for docking, MD, and BLUES, respectively. Right: BLUES (cyan) simulation frame with
the crystallographic binding mode (gray) for molecule JF6. Nearby residues TYR117 and
MET243 are shown.
6.5 Discussion
6.5.1 Single Binding Mode: Both MD and BLUES eventually find
1 crystallographic binding mode
When considering the minimum RMSDs, for cases with a single crystallographic binding mode, we
see that both MD and BLUES are within 2 Å of the crystallographic binding mode. On the other
hand, docking will–at best–make predictions which are close (within 4Å) to the crystallographic
binding mode. We note that here, we simulate 1 microsecond of MD and 600ns of BLUES for
each remaining pose after our MDS-RMSD filter, so our relative success with BLUES indicates that
BLUES may find the crystallographic binding mode much faster than traditional MD.
We will first discuss our observations from JF6, where BLUES is able to find the crystallographic
binding mode while MD did not, as this case helps illustrate the relative advantages of the BLUES
approach. In this case, the closest docked pose for JF6 was 4.5 Å away from the crystallographic
binding mode (Fig. 6.14), where the molecule is completely flipped in the opposite orientation from
the crystallographic binding mode. Following that, we will present our findings from 8NY where
both BLUES and MD successfully identify the crystallographic binding mode (notably faster with
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MD over BLUES), but we will show that BLUES facilitates sampling of more binding modes than
MD–even if they are not found by crystallography.
Figure 6.15: Top: 250ns MD populations (% simulation time) of 2 (red/green) binding modes
sampled for ligand JF6. Bottom: RMSD of ligand JF6 relative to starting positions over
time. Each time point is colored according to the binding mode the ligand is in. We note
that the red samples correspond to an unbound state. Thus, this shows that with MD we
only sample 1 binding mode (green).
In Figure 6.15, we show the first 250ns from MD for JF6, where we see sampling of primarily only
a single binding mode (green). Shortly after 100ns, JF6 was observed to unbind from the binding
site (indicated in red) and then return to the binding site, where it samples the same primary
binding mode (green). The primary binding mode sampled during MD was 9.1 Å away from the
crystallographic binding (on average) and at best was 3.6 Å away (Fig. 6.14). For the remainder of
the 1 microsecond simulation, JF6 remains trapped in the green binding mode and never transitions
out in order to find the crystallographic binding mode or at the very least, another binding mode
which is close to it.
In contrast, we see from Figure 6.16 a 200ns BLUES simulation, where we observe sampling of 5
different binding modes, with the dominant binding mode represented in green. Most notably, with
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Figure 6.16: Top: 200ns BLUES populations (% simulation time) of 5 (red, yellow, green,
cyan, blue) binding modes sampled for ligand JF6. Bottom: RMSD of ligand JF6 relative to
starting positions over time. Each time point is colored according to the binding mode the
ligand is in. This shows BLUES can sample far more binding modes than MD in a shorter
timeframe. Note: we see no red bar due to extremely low sampling during the simulation.
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BLUES, we see fairly good sampling as we observe several transitions in and out of the dominant
binding mode (green). This is indicative that BLUES does indeed accelerate sampling of ligand
binding modes for this particular fragment. Here, the dominant (green) binding mode had an
average RMSD of 6.6 Å but at best sampled 1.5 Å away (Fig. 6.14) from the crystallographic
binding mode. Although the average RMSD was much higher than the 2 Å cutoff in this case, we
believe this could be due to the fact that JF6 doesn’t reside in the green binding mode for a very
a long period of time, which would lower our averaged RMSD calculation. Instead, we see many
transitions into the green binding mode for brief periods of time, where at some point the ligand was
very close to the crystallographic binding mode. Regardless, this shows that our BLUES approach
does facilitate sampling of more than just a single binding mode in a shorter time span; which is in
stark contrast to what we observed in our 1 microsecond MD simulation.
Figure 6.17: Top: 250ns MD populations (% simulation time) of 3 (red, green, blue) binding
modes sampled for ligand 8NY. Bottom: RMSD of ligand 8NY relative to starting positions
over time. Each time point is colored according to the binding mode the ligand is in.
In Figure 6.17, we show the first 250ns from MD for 8NY, where we see sampling of the dominant
binding mode (blue) and very brief sampling of 2 other binding modes (red/green)–albeit not stably.
Here, the blue binding mode was calculated to be 1.8 Å away from the crystallographic binding
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mode (on average), demonstrating MD can indeed identify the crystallographic binding mode within
a short time frame. Despite an accurate prediction, we highlight that we primarily only see stable
sampling of the blue binding mode using MD rather than observing sampling of alternative binding
modes.
Figure 6.18: Top: 200ns BLUES populations (% simulation time) of 3 (red, green, blue)
binding modes sampled for ligand 8NY. Bottom: RMSD of ligand 8NY relative to starting
positions over time. Each time point is colored according to the binding mode the ligand is
in.
From Figure 6.18, we see better sampling of ligand binding modes with BLUES. Here, we observe
fairly stable sampling of 3 different binding modes in a shorter time frame than MD (200ns). Here,
BLUES begins in the red binding mode before transitioning into the green binding mode after 10ns,
where it remains in until we observe another transition at 60ns into the blue binding mode. This
blue binding mode observed after 60ns ends up as the most populated binding mode over the course
of the simulation and was calculated to be 1.5 Å away from the crystallographic binding mode.
In this case, we note that BLUES did take longer to find the crystallographic binding mode than
MD, but we see better sampling of alternative ligand binding modes which are not seen in the
crystallographic structure. We hypothesize that these alternative binding modes found via BLUES
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represent metastable states in which the fragment may bind in, before settling on the primary
binding mode represented in the crystallographic structure.
For all ligand with a single binding mode, when we consider the averaged RMSDs, we find that
both MD and BLUES are equally able to make close predictions (within 4 Å) to the crystallographic
binding mode, when there is only 1 binding mode to identify (Right: Figure 6.12). On average, for
this subset of fragments, MD identified the crystallographic binding mode in 1/7 cases and in 2/7
cases using BLUES. If we consider the minimum RMSD–representing having sampled near the true
binding mode–we find that MD and BLUES also both are able to identify a single crystallographic
binding mode within 2 Å (Right: Figure 6.12). Here, considering the minimum RMSDs to the
crystallographic structure, MD identified 5/7 and BLUES identified 7/7 cases.
While both BLUES and MD are able to sample and find the crystallographic binding mode, BLUES
seems to facilitate sampling of alternative ligand binding modes rather than remaining trapped in
1-2 binding modes like with MD. In some cases (like with JF6) BLUES may be able to find the
crystallographic binding mode much faster than MD and in other cases it may not (like with 8NY).
In general, with BLUES, we observe not only more sampling of other ligand binding modes (8NY),
but we also observe more transitions between binding modes (JF6), which gives us better estimates
of the populations for these small and rigid fragments. Here, we highlight that with accelerated
sampling from BLUES, one may be able to gain more structural insight on alternative ways the
ligand may bind in the binding site, which are not be captured in the crystallographic structure.
6.5.2 Multiple Binding Modes: Sampling binding mode transitions
leads to more accurate predictions
In our observations from the single binding mode cases, we highlighted the importance of sampling
more ligand binding modes and transitions between them. That is, when we observed more binding
mode transitions (particularly with BLUES), we saw that the minimum RMSD (and in some cases
the average) was much closer to the crystallographic binding mode. For cases with multiple binding
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modes, we believe sampling of more binding mode transitions during our simulations is even more
critical as there are more crystallographic binding modes to be identified.
Figure 6.19: 5 crystallographic binding modes (gray) for molecule GVG1 overlaid with the
starting poses from docking (pink).
Here, we will present our observations from MD and BLUES simulations of GVG1, where we
surprisingly observed more binding mode transitions using MD in the right sub-cavity. This led
to more accurate predictions (when considering the minimum RMSD) for MD over BLUES; where
with BLUES, we saw sampling of only 1 binding mode and thus failed to identify the secondary
binding mode in the right sub-cavity. This is an atypical case, where much like we have shown
previously, BLUES facilitates sampling of more binding modes and transitions between them much
more over traditional MD.
For the case of GVG1, there were 2 binding modes to identify in the right sub-cavity and 3 in the
left sub-cavity (Fig. 6.19). For the left sub-cavity, we started simulations from 3 different docked
poses, where each of these independent simulation were able to find the 3 crystallographic binding
modes. In these simulations we did not observe transitions between the 3 binding modes in the
left sub-cavity. On the other hand, in the right sub-cavity (Fig. 6.21), we were able to find both
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Figure 6.20: Top: 1 microsecond MD populations (% simulation time) of 3 (red, green,
blue) binding modes sampled for ligand GVG1. Bottom: RMSD of ligand GVG1 relative to
starting positions over time. Each time point is colored according to the binding mode the
ligand is in.
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crystallographic binding modes from a single MD simulation which captured several binding mode
transitions, which we discuss next.
Figure 6.21: 2 crystallographic binding modes (gray/white) of GVG1 found in the right
sub-cavity, overlaid with one docked pose (pink) used as our simulation starting point.
In Figure 6.20, we show our simulation data for GVG1 which started from one docked pose, located
in the right sub-cavity (Fig. ??). In the 0-500ns timeframe, we primarily see sampling of a single
binding mode (blue), but from 500-1000ns we observe several transitions between two other binding
modes (red/green). The top two most populated binding modes during our MD simulations were
represented by the blue and green binding modes. These blue and green binding modes sampled from
MD were, at best (considering the minimum RMSD), 1.6Å and 1.9Å away from the crystallographic
binding mode, respectively. From a single 1 microsecond MD simulation, starting from one docked
pose, we see sampling of 3 binding modes which enabled MD to find 2/2 crystallographic binding
modes (GVG1-0,1) located in the right sub-cavity. Since we observed sampling of additional binding
modes from our simulations starting from this docked pose (c4), we would not have had to run
additional MD simulations from starting from the other docked poses to identify the the secondary
binding mode for GVG1.
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Figure 6.22: Top: 200ns BLUES population (% simulation time) of 1 (blue) binding mode
sampled for ligand GVG1 starting from docked pose c4. Bottom: RMSD of ligand GVG1
relative to starting positions over time. Each time point is colored according to the binding
mode the ligand is in.
202
In contrast, we ran a total of 600ns of BLUES simulations (in 3 independent 200ns simulations)
starting from the same docked pose (c4) and–surprisingly–found that within each simulation, they
remained trapped in the starting configuration(Fig. 6.22). That is, we only observe sampling of
a single binding mode (blue) which contrasts our MD simulations which had sampled 3 binding
modes. Only by running more BLUES simulations from an alternative docked pose (Fig. 6.23),
were we able to briefly sample a secondary binding mode (green). The minimum RMSD of the blue
binding mode to one of the crystallographic binding modes was calculated to be 1.8 Å away, while
the green binding mode was calculated to be 2.8 Å away from the secondary binding mode found
in the crystal structure. When considering the minimum RMSD, we find that with BLUES, we
are able to identify at least 1/2 crystallographic binding modes (GVG1-0), but was unable to find
the secondary binding mode which we attribute to poor sampling of the green binding mode in our
BLUES simulations.
Figure 6.23: Top: 200ns BLUES populations (% simulation time) of 2 (green, blue) binding
mode sampled for ligand GVG1 starting from docked pose c3. Bottom: RMSD of ligand
GVG1 relative to starting positions over time. Each time point is colored according to the
binding mode the ligand is in.
Overall, when we consider the average RMSDs for each method, neither method will be able to
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make predictions which are at least close (within 4Å) to the crystallographic structures, if there
are multiple binding modes to identify. If we consider the minimum RMSDs–as in having sampled
near the crystallographic binding mode–docking will make close predictions with a slight improve-
ment using MD simulations and BLUES may be able to make successful predictions (within 2 Å).
Through GVG1, we saw the importance of sampling binding modes and transitions between them
during the simulation as these would potentially lead to more successful or close predictions to the
crystallographic structure. This is especially important when there are multiple crystallographic
binding modes to identify. In this atypical case, we saw more transitions with MD over BLUES
which lead to more success using MD in sampling near the crystallographic binding mode For the
remainder of the multiple binding mode dataset, we observed more transitions and binding mode
sampling using the BLUES approach over traditional MD, which lead to more successful predictions
with BLUES (Supplementary Info). For this subset, in the best case scenario (considering the min-
imum RMSDs), docking had identified 2/22 (9%) cases, MD had identified 6/22 (27%) and BLUES
had identified 9/22 (41%).
6.6 Conclusion
In this study, we evaluated the effectiveness in identifying the crystallographic binding modes using
docking, MD, and (NCMC+MD) BLUES on a set of fragment-like molecules bound to soluble-
epoxide hydrolase (SEH). We note, again, that the reported minimum RMSDs illustrates the ability
to sample close to the crystallographic structure and our reported average RMSDs represents ran-
dom selection of a docked pose or representative simulation frame. When considering the minimum
RMSD from docking, the closest poses would fall within 4Å of the crystallographic structure and
confirmed our hypothesis that the top scoring poses from docking would not be close to the crys-
tallographic structure (Fig. 6.5).
In general, we found that with our BLUES approach we sampled alternative binding modes (and
transitions between them) much more, than in our microsecond MD simulations. When considering
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minimum RMSD, BLUES performs much better than MD and docking (Fig. 6.11). This suggests
that with the BLUES approach, we sample much closer to the crystallographic structure than MD
or from a docked pose. We believe that this is due to the enhanced sampling of alternative binding
modes from the random rotational moves performed during our BLUES simulations. In very rare
cases, we may observe sufficient sampling of alternative binding modes using 1 microsecond of MD,
such as with GVG1; but, generally, we mainly observe the simulation remaining trapped in the
starting configuration or sampling 1-2 alternative binding modes (at best). Our findings highlight
the importance of capturing binding mode transitions during simulations, which increase the chances
of sampling near the true binding mode.
Overall, we showed that microsecond MD simulations of small fragment-like molecules in the large
SEH binding site were unable to reasonably sample ligand binding mode transitions, even within
a given sub-cavity. While MD did do better at docking at discovering crystallographic binding
modes, even with the relatively long MD simulation time, we found most simulations remained
trapped in or near the binding mode they started in. Since they often remained trapped their
starting configuration, our conclusion is that the best general approach is to use a variety of starting
poses from docking to get good coverage of the binding site and potentially identify the alternative
binding modes. Using BLUES, we were able to enhance the sampling of ligand binding modes
over traditional MD, while even using slightly shorter simulation times (600ns of BLUES vs 1
microsecond of MD). Ultimately, enhanced sampling via BLUES lead to an improvement in finding
the crystallographic binding modes over traditional MD simulations.
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Conclusion
In this dissertation, I demonstrate molecular dynamics (MD) simulations can be a useful tool for
calculating binding affinities (Chapter 1), studying the importance of key residues in the membrane-
protein insertion process (Chapter 2), and in identifying ligand binding modes (Chapters 4, 5, 6).
This illustrates that MD simulations can be a powerful tool in the pharmaceutical drug discovery
process, particularly, at the lead optimization stage where chemists are often interested in predicting
binding affinities and ligand binding modes. Throughout the studies presented in this dissertation,
I demonstrate that the valuable insights MD simulations can provide are largely hindered by chal-
lenges in sampling.
In Chapters 1, 5, and 6, I encounter challenges in sampling which prevent accurate calculation of
binding free energies and lead to failures in identifying the crystallographic binding modes. From
Chapter 1, I showed that accurate binding free energy calculations largely depended on sufficient
sampling of a protein conformational change. Only by sampling the protein conformational change–
by including it in the enhanced sampling region–was I able to get calculated free energies which no
longer depended on the initial configuration. From Chapter 5, I demonstrate that even microsecond
long MD simulations do not adequately capture binding mode transitions which lead to failures in
identifying the true binding modes for fragments which bind to soluble epoxide hydrolase (SEH).
Then, in Chapter 6, I revisit the study from Chapter 5 using an enhanced sampling toolkit called
BLUES: Binding modes of Ligands Using Enhanced Sampling (Chapter 3) to sample near the true
binding mode which lead to some successes in identifying the true binding modes found by X-ray
crystallography.
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Future studies could investigate alternative methods for enhancing sampling using the BLUES
framework. Specifically, BLUES with alternative non-equilibrium candidate Monte Carlo move
types, instead of simple random ligand rotations, could be applied to the SEH study detailed in
Chapter 6. One example could be to use a move which would propose moves to directly hop
into pre-defined configurations, such as a selection of docked poses. This type of move would
sample ligand binding modes more efficiently than random ligand rotations as the perturbations
to the ligand would be much larger and more directed; whereas with random ligand rotations,
simulation time is often wasted on performing small rotations. In Chapter 6, we restricted ourselves
to applying BLUES to small, rigid, and fragment-like molecules as these were more suitable for
random rotational moves. With a move which would allow directly changing the ligand into pre-
defined configurations, we could study larger, more complex, or drug-like molecules which normally
result in rejected moves due to large steric clashes via random rotations. If such a move could be
developed for BLUES and can be applied to accelerate binding mode sampling enough to obtain the
correct populations, BLUES can become a powerful tool for the pharmaceutical drug development
process. Given that binding mode populations are related to the binding free energy, if we can
obtain the correct populations from a single BLUES simulation, we could then more efficiently and
accurately compute the binding free energies over traditional MD simulations.
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